https://ir.elekta.com/investors/https://ir.elekta.com/investors/investment-case/https://ir.elekta.com/investors/investment-case/strong-demand/https://ir.elekta.com/investors/investment-case/attractive-business/https://ir.elekta.com/investors/investment-case/strategic-focus/https://ir.elekta.com/investors/investment-case/leading-innovations/https://ir.elekta.com/investors/outlook/https://ir.elekta.com/investors/market-and-trends/https://ir.elekta.com/investors/market-and-trends/drivers-for-radiotherapy-adoption/https://ir.elekta.com/investors/market-and-trends/healthcare-trends/https://ir.elekta.com/investors/market-and-trends/market-characteristics/https://ir.elekta.com/investors/the-share/https://ir.elekta.com/investors/the-share/total-return/https://ir.elekta.com/investors/the-share/share-price-calculator/https://ir.elekta.com/investors/the-share/market-estimates/https://ir.elekta.com/investors/the-share/analysts/https://ir.elekta.com/investors/the-share/ownership-structure/https://ir.elekta.com/investors/the-share/share-history/https://ir.elekta.com/investors/financials/https://ir.elekta.com/investors/financials/definitions/https://ir.elekta.com/investors/funding/https://ir.elekta.com/investors/funding/mtn-program/https://ir.elekta.com/investors/funding/key-debt-ratios/https://ir.elekta.com/investors/funding/key-debt-ratios/mtn-program-2/https://ir.elekta.com/investors/funding/cp-program/https://ir.elekta.com/investors/reports-presentations/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjuly-202324/https://ir.elekta.com/investors/reports-presentations/interim-report-first-quarter-mayjuly-202526/https://ir.elekta.com/investors/reports-presentations/q3-report-novemberjanuary-202425/https://ir.elekta.com/investors/reports-presentations/elektas-annual-report-for-202324-available/https://ir.elekta.com/investors/reports-presentations/year-end-report-mayapril-202324/https://ir.elekta.com/investors/reports-presentations/second-quarter-augustoctober-202526/https://ir.elekta.com/investors/reports-presentations/year-end-report-mayapril-202425/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjanuary-202324/https://ir.elekta.com/investors/reports-presentations/interim-report-mayoctober-202324/https://ir.elekta.com/investors/reports-presentations/third-quarter-novemberjanuary-202526/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjuly-202425/https://ir.elekta.com/investors/reports-presentations/q2-report-augustoctober-202425/https://ir.elekta.com/investors/reports-presentations/elektas-annual-report-for-202425-available/https://ir.elekta.com/investors/reports-presentations/interim-report-mayoctober-202122/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjuly-202122/https://ir.elekta.com/investors/reports-presentations/220214-preliminary-results-q3-202122/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjanuary-202122/https://ir.elekta.com/investors/reports-presentations/year-end-report-mayapril-202122/https://ir.elekta.com/investors/reports-presentations/annual-report-202122-in-ixbrl/https://ir.elekta.com/investors/reports-presentations/elektas-annual-report-for-202122-available/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjuly-202223/https://ir.elekta.com/investors/reports-presentations/interim-report-mayoctober-202223/https://ir.elekta.com/investors/reports-presentations/interim-report-mayjanuary-202223/https://ir.elekta.com/investors/reports-presentations/year-end-report-mayapril-202223/https://ir.elekta.com/investors/reports-presentations/elektas-annual-report-for-202223-available/https://ir.elekta.com/investors/reports-presentations/annual-report-202223-print/https://ir.elekta.com/investors/reports-presentations/cmd-2023/https://ir.elekta.com/investors/reports-presentations/annual-report-202324-print-2/https://ir.elekta.com/investors/reports-presentations/annual-report-202425-print/https://ir.elekta.com/investors/press-releases/https://ir.elekta.com/investors/press-releases/2026/elekta-receives-fda-510k-clearance-for-elekta-evo-linear-accelerator/https://ir.elekta.com/investors/press-releases/2026/invitation-to-elektas-strategic-update-event-on-january-30/https://ir.elekta.com/investors/press-releases/2026/third-quarter-novemberjanuary-202526/https://ir.elekta.com/investors/press-releases/2026/change-in-elektas-nomination-committee-for-the-annual-general-meeting-2026/https://ir.elekta.com/investors/press-releases/2026/invitation-to-elektas-q3-202526-call-at-900-a-m-cet-march-5/https://ir.elekta.com/investors/press-releases/2026/elekta-presents-strategic-update-growth-innovation-and-operations/https://ir.elekta.com/investors/press-releases/2026/elekta-appoints-tomas-eliasson-as-vice-chair-of-the-board/https://ir.elekta.com/investors/press-releases/2025/invitation-to-the-presentation-of-elektas-second-quarter-202526/https://ir.elekta.com/investors/press-releases/2025/study-shows-mri-guided-adaptive-radiotherapy-with-elekta-unity-improves-patient-reported-urinary-symptoms-in-men-with-prostate-cancer/https://ir.elekta.com/investors/press-releases/2025/report-from-the-annual-general-meeting-2025-of-elekta/https://ir.elekta.com/investors/press-releases/2025/elekta-announces-changes-in-executive-management/https://ir.elekta.com/investors/press-releases/2025/elekta-marks-two-millionth-patient-treated-with-leksell-gamma-knife-radiosurgery/https://ir.elekta.com/investors/press-releases/2025/second-quarter-augustoctober-202526/https://ir.elekta.com/investors/press-releases/2025/new-impact-report-reveals-radiotherapys-role-in-cancer-care/https://ir.elekta.com/investors/press-releases/2025/elektas-nomination-committee-for-the-annual-general-meeting-2026/https://ir.elekta.com/investors/press-releases/2025/elekta-leaders-present-retrospective-and-future-developments-to-investor-community/https://ir.elekta.com/investors/press-releases/2025/elekta-appoints-jakob-just-bomholt-as-new-president-and-ceo/https://ir.elekta.com/investors/press-releases/2025/elekta-to-enhance-cancer-treatment-in-croatia-through-strategic-acquisition/https://ir.elekta.com/investors/press-releases/2025/invitation-to-the-presentation-of-elektas-fiscal-year-202425/https://ir.elekta.com/investors/press-releases/2025/clinical-trial-shows-more-precise-radiotherapy-using-elekta-unity-mr-linac-preserves-sexual-function-in-men-with-prostate-cancer/https://ir.elekta.com/investors/press-releases/2025/invitation-to-elektas-investor-update-event-on-june-10-2025/https://ir.elekta.com/investors/press-releases/2025/elektas-annual-report-for-202425-available/https://ir.elekta.com/investors/press-releases/2025/invitation-to-the-presentation-of-elektas-first-quarter-202526/https://ir.elekta.com/investors/press-releases/2025/notice-to-the-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2025/elekta-receives-u-s-fda-510k-clearance-for-its-gamma-knife-radiosurgery-system-to-treat-patients-with-refractory-drug-resistant-mesial-temporal-lobe-epilepsy/https://ir.elekta.com/investors/press-releases/2025/year-end-report-mayapril-202425/https://ir.elekta.com/investors/press-releases/2025/interim-report-first-quarter-mayjuly-202526/https://ir.elekta.com/investors/press-releases/2025/nomination-committees-proposal-for-the-board-of-directors-prior-to-elektas-annual-general-meeting-2025/https://ir.elekta.com/investors/press-releases/2025/elekta-and-azra-ai-announce-partnership-to-enhance-cancer-registry-operations-with-ai-powered-automation/https://ir.elekta.com/investors/press-releases/2025/elekta-secures-major-win-with-imss-eight-linacs-to-revolutionize-cancer-treatment-in-mexico/https://ir.elekta.com/investors/press-releases/2025/elekta-unity-to-become-cornerstone-of-moffitt-cancer-centers-mrgrt-program/https://ir.elekta.com/investors/press-releases/2025/invitation-to-the-presentation-of-elektas-third-quarter-202425/https://ir.elekta.com/investors/press-releases/2025/elekta-one-ois-secures-top-spot-in-2025-best-in-klas-software-and-services-report/https://ir.elekta.com/investors/press-releases/2025/q3-report-novemberjanuary-202425/https://ir.elekta.com/investors/press-releases/2025/gustaf-salford-to-leave-position-as-president-and-ceo-of-elekta-as-of-march-6/https://ir.elekta.com/investors/press-releases/2024/elekta-further-strengthens-its-elekta-one-software-suite-with-acquisition-of-philips-treatment-planning-patent-portfolio/https://ir.elekta.com/investors/press-releases/2024/elekta-launches-ai-powered-adaptive-ct-linac-for-next-level-cancer-care/https://ir.elekta.com/investors/press-releases/2024/elekta-and-ge-healthcares-mim-software-enter-significant-collaboration-to-deliver-leading-cancer-treatment-planning-solutions/https://ir.elekta.com/investors/press-releases/2024/elekta-partners-with-msd-to-enhance-kidney-cancer-care-using-digital-solutions/https://ir.elekta.com/investors/press-releases/2024/elekta-announces-resignation-of-board-member-kelly-londy/https://ir.elekta.com/investors/press-releases/2024/invitation-to-the-presentation-of-elektas-first-quarter-202425/https://ir.elekta.com/investors/press-releases/2024/invitation-to-investor-meeting-at-estro-2024-in-glasgow/https://ir.elekta.com/investors/press-releases/2024/elekta-evo-submitted-to-u-s-fda-for-premarket-approval-to-be-featured-at-astro/https://ir.elekta.com/investors/press-releases/2024/caroline-leksell-cooke-to-lead-elekta-neuro-solutions/https://ir.elekta.com/investors/press-releases/2024/elektas-ai-powered-adaptive-ct-linac-elekta-evo-receives-ce-mark/https://ir.elekta.com/investors/press-releases/2024/report-from-the-annual-general-meeting-2024-in-elekta/https://ir.elekta.com/investors/press-releases/2024/interim-report-mayjuly-202425/https://ir.elekta.com/investors/press-releases/2024/elekta-and-software-partner-ansheng-enter-joint-venture-to-strengthen-market-position-in-china/https://ir.elekta.com/investors/press-releases/2024/invitation-to-the-presentation-of-elektas-fiscal-year-202324/https://ir.elekta.com/investors/press-releases/2024/elekta-receives-usd-64-million-order-for-state-of-the-art-linacs-and-gamma-knife-in-mexico/https://ir.elekta.com/investors/press-releases/2024/notice-to-the-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2024/elektas-nomination-committees-proposal-for-the-board-of-directors-prior-to-the-annual-general-meeting-2024/https://ir.elekta.com/investors/press-releases/2024/elektas-annual-report-for-202324-available/https://ir.elekta.com/investors/press-releases/2024/elekta-to-become-new-issuer-in-the-swedish-commercial-paper-market/https://ir.elekta.com/investors/press-releases/2024/year-end-report-mayapril-202324/https://ir.elekta.com/investors/press-releases/2024/elekta-issues-a-sek-1-5-billion-bond-and-signs-a-revolving-credit-facility-of-sek-1-billion/https://ir.elekta.com/investors/press-releases/2024/german-cancer-center-treats-first-patient-in-the-world-with-elekta-evo-ct-linac/https://ir.elekta.com/investors/press-releases/2024/invitation-to-elektas-deep-dive-event-on-december-19/https://ir.elekta.com/investors/press-releases/2024/q2-report-augustoctober-202425/https://ir.elekta.com/investors/press-releases/2024/invitation-to-the-presentation-of-elektas-second-quarter-202425/https://ir.elekta.com/investors/press-releases/2024/caroline-leksell-cooke-steps-down-from-elektas-board-of-directors/https://ir.elekta.com/investors/press-releases/2024/elektas-nomination-committee-for-the-annual-general-meeting-2025/https://ir.elekta.com/investors/press-releases/2024/first-major-advance-in-radiation-treatment-for-high-grade-gliomas-in-more-than-25-years-presented-at-astro-2024/https://ir.elekta.com/investors/press-releases/2024/elektas-mosaiq-leads-the-pack-in-2024-best-in-klas-software-and-services-report/https://ir.elekta.com/investors/press-releases/2024/invitation-to-the-presentation-of-elektas-third-quarter-202324/https://ir.elekta.com/investors/press-releases/2024/interim-report-mayjanuary-202324/https://ir.elekta.com/investors/press-releases/2023/invitation-to-elektas-capital-markets-day-2023/https://ir.elekta.com/investors/press-releases/2023/elektas-nomination-committee-for-the-2024-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2023/interim-report-mayjanuary-202223/https://ir.elekta.com/investors/press-releases/2023/first-gamma-knife-esprit-patient-resumes-life-as-usual-only-days-after-brain-surgery/https://ir.elekta.com/investors/press-releases/2023/elekta-to-strengthen-market-position-in-asia-through-acquisition-of-thai-distributor/https://ir.elekta.com/investors/press-releases/2023/cancer-care-teams-can-more-efficiently-plan-and-manage-oncology-specific-workflows-with-new-elekta-software/https://ir.elekta.com/investors/press-releases/2023/elekta-receives-fda-510k-clearance-for-advanced-radiotherapy-motion-management-using-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2023/elekta-and-sinopharm-collaborate-to-improve-access-and-quality-of-cancer-care-in-china/https://ir.elekta.com/investors/press-releases/2023/elektas-climate-targets-validated-by-the-science-based-targets-initiative-sbti/https://ir.elekta.com/investors/press-releases/2023/invitation-to-the-presentation-of-elektas-third-quarter-202223/https://ir.elekta.com/investors/press-releases/2023/elekta-foundations-cancer-care-successes-in-rwanda-to-be-expanded-in-other-low-income-countries/https://ir.elekta.com/investors/press-releases/2023/invitation-to-the-presentation-of-elektas-second-quarter-202324/https://ir.elekta.com/investors/press-releases/2023/indias-krishna-institute-of-medical-sciences-hyderabad-orders-radiation-therapy-systems-for-usd-40-million-from-elekta/https://ir.elekta.com/investors/press-releases/2023/elekta-expands-market-and-treatment-application-of-brachytherapy-with-acquisition-of-icad-incs-xoft-business/https://ir.elekta.com/investors/press-releases/2023/elekta-continues-to-support-ukrainian-cancer-patients-with-latest-radiation-therapy-equipment/https://ir.elekta.com/investors/press-releases/2023/ability-to-comprehensively-manage-motion-with-elekta-unity-mr-linac-highlighted-at-astro-2023/https://ir.elekta.com/investors/press-releases/2023/elekta-foundation-raises-usd-50000-for-women-with-advanced-stage-cervical-cancer-with-ride4rwanda-cycling-challenge/https://ir.elekta.com/investors/press-releases/2023/elekta-and-the-international-atomic-energy-agency-iaea-partner-to-improve-access-to-cancer-care-in-underserved-countries/https://ir.elekta.com/investors/press-releases/2023/report-from-the-annual-general-meeting-2023-in-elekta/https://ir.elekta.com/investors/press-releases/2023/interim-report-mayjuly-202324/https://ir.elekta.com/investors/press-releases/2023/interim-report-mayoctober-202324/https://ir.elekta.com/investors/press-releases/2023/elekta-and-bristol-myers-squibb-partner-on-digital-solution-for-patients-with-melanoma/https://ir.elekta.com/investors/press-releases/2023/elekta-signs-first-sustainability-linked-revolving-credit-facility-valued-at-eur-250-million/https://ir.elekta.com/investors/press-releases/2023/year-end-report-mayapril-202223/https://ir.elekta.com/investors/press-releases/2023/elekta-unity-clinical-users-report-seeing-and-treating-cancer-like-never-before-at-european-radiation-oncology-conference/https://ir.elekta.com/investors/press-releases/2023/elekta-esprit-receives-red-dot-design-award-for-its-focus-on-patients-and-clinicians/https://ir.elekta.com/investors/press-releases/2023/mercurius-health-equips-robert-janker-klinik-with-integrated-oncology-solutions-from-elekta-and-philips/https://ir.elekta.com/investors/press-releases/2023/invitation-to-the-presentation-of-elektas-fiscal-year-202223/https://ir.elekta.com/investors/press-releases/2023/invitation-to-the-presentation-of-elektas-first-quarter-202324/https://ir.elekta.com/investors/press-releases/2023/notice-to-the-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2023/elektas-annual-report-for-202223-available/https://ir.elekta.com/investors/press-releases/2023/elektas-nomination-committees-proposed-board-of-directors-to-the-2023-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2023/elektas-flexitron-has-benefitted-cancer-patients-with-millions-of-brachytherapy-treatments/https://ir.elekta.com/investors/press-releases/2023/elekta-focuses-on-innovation-software-and-value-creation-at-2023-capital-markets-day/https://ir.elekta.com/investors/press-releases/2022/year-end-report-mayapril-202122/https://ir.elekta.com/investors/press-releases/2022/elekta-and-healthcare-global-enterprises-ltd-launch-a-collaborative-clinical-educational-facility-in-mumbai/https://ir.elekta.com/investors/press-releases/2022/kaiku-health-to-improve-cancer-care-through-partnership-with-global-medicines-company/https://ir.elekta.com/investors/press-releases/2022/elektas-new-radiosurgery-system-elekta-esprit-receives-ce-mark/https://ir.elekta.com/investors/press-releases/2022/invitation-to-the-presentation-of-elektas-first-quarter-202223/https://ir.elekta.com/investors/press-releases/2022/notice-to-the-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2022/aapm-2022-meeting-highlights-ever-growing-evidence-for-radiation-therapy-with-elekta-unity/https://ir.elekta.com/investors/press-releases/2022/elektas-annual-report-for-202122-available/https://ir.elekta.com/investors/press-releases/2022/elekta-increases-value-added-services-and-strengthens-its-position-as-a-life-time-companion/https://ir.elekta.com/investors/press-releases/2022/interim-report-mayjanuary-202122/https://ir.elekta.com/investors/press-releases/2022/first-ever-patient-treated-for-pancreatic-cancer-with-new-advanced-radiotherapy-motion-management-using-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2022/interim-report-mayoctober-202223/https://ir.elekta.com/investors/press-releases/2022/swedish-and-jordanian-royalty-inaugurate-elekta-radiation-therapy-devices-for-cancer-and-brain-disease/https://ir.elekta.com/investors/press-releases/2022/invitation-to-the-presentation-of-elektas-second-quarter-202223/https://ir.elekta.com/investors/press-releases/2022/elektas-nomination-committee-for-the-2023-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2022/elekta-unity-demonstrates-promising-quality-of-life-outcomes-for-pancreas-and-prostate-cancers-at-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2022/elekta-esprit-the-latest-leksell-gamma-knife-receives-fda-510k-clearance/https://ir.elekta.com/investors/press-releases/2022/elekta-makes-cancer-care-accessible-to-123-million-more-people-executing-its-strategic-target-of-availability-of-care/https://ir.elekta.com/investors/press-releases/2022/elekta-and-karkinos-healthcare-expand-access-to-modern-cancer-care-treatment-across-india/https://ir.elekta.com/investors/press-releases/2022/report-from-the-annual-general-meeting-2022-in-elekta/https://ir.elekta.com/investors/press-releases/2022/interim-report-mayjuly-202223/https://ir.elekta.com/investors/press-releases/2022/elektas-nomination-committees-proposed-board-of-directors-to-the-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2022/elekta-unitys-motion-management-capabilities-herald-a-new-era-in-precision-radiation-therapy/https://ir.elekta.com/investors/press-releases/2022/the-power-of-seeing-what-you-treat-with-elekta-unity-reported-in-71-abstracts-at-estro-2022/https://ir.elekta.com/investors/press-releases/2022/elekta-wins-majority-of-italian-public-tender-for-advanced-cancer-care-2022-10-18/https://ir.elekta.com/investors/press-releases/2022/kaiku-health-enters-a-strategic-partnership-to-further-improve-patient-outcomes-through-digital-patient-monitoring/https://ir.elekta.com/investors/press-releases/2022/elekta-and-the-netherlands-cancer-institute-co-develop-the-next-generation-of-radiotherapy-solutions/https://ir.elekta.com/investors/press-releases/2022/elekta-to-appoint-tobias-hagglov-as-chief-financial-officer/https://ir.elekta.com/investors/press-releases/2022/elekta-launches-new-radiosurgery-system-elekta-esprit/https://ir.elekta.com/investors/press-releases/2022/invitation-to-the-presentation-of-elektas-fiscal-year-202122/https://ir.elekta.com/investors/press-releases/2022/elekta-harmony-linear-accelerator-earns-red-dot-award-for-product-design/https://ir.elekta.com/investors/press-releases/2022/elekta-and-ge-healthcare-collaborate-to-expand-access-to-precision-radiation-therapy-solutions/https://ir.elekta.com/investors/press-releases/2022/englands-nhs-to-improve-cancer-treatment-using-elektas-proknow-solution/https://ir.elekta.com/investors/press-releases/2022/invitation-to-investor-meeting-at-estro-in-copenhagen/https://ir.elekta.com/investors/press-releases/2022/elekta-and-iba-collaborate-to-optimize-quality-assurance-in-radiation-therapy/https://ir.elekta.com/investors/press-releases/2022/elekta-interim-report-may-january-202122/https://ir.elekta.com/investors/press-releases/2022/elekta-announces-preliminary-third-quarter-results-2022-02-14/https://ir.elekta.com/investors/press-releases/2022/invitation-to-the-presentation-of-elektas-third-quarter-202122-2022-02-04/https://ir.elekta.com/investors/press-releases/2022/elekta-increases-customer-focus-with-direct-presence-in-philippines-2022-02-02/https://ir.elekta.com/investors/press-releases/2021/elektas-new-sustainability-linked-bond-oversubscribed/https://ir.elekta.com/investors/press-releases/2021/more-cancer-patients-in-africa-to-benefit-from-advanced-radiation-therapy-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2021/interim-report-mayoctober-202122/https://ir.elekta.com/investors/press-releases/2021/invitation-to-the-presentation-of-elektas-second-quarter-202122/https://ir.elekta.com/investors/press-releases/2021/award-winning-abstracts-confirm-benefits-of-elekta-unity-in-precision-radiation-therapy/https://ir.elekta.com/investors/press-releases/2021/elekta-establishes-a-framework-for-sustainability-linked-bonds/https://ir.elekta.com/investors/press-releases/2021/elektas-nomination-committee-for-the-2022-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2021/elekta-receives-initial-investment-grade-rating-from-sp-global-ratings/https://ir.elekta.com/investors/press-releases/2021/genesiscare-extends-us-brachytherapy-service-with-27-elekta-flexitron-treatment-devices/https://ir.elekta.com/investors/press-releases/2021/elekta-acquires-turkish-distributor-to-strengthen-market-position/https://ir.elekta.com/investors/press-releases/2021/data-from-14-leading-cancer-centers-presented-at-aapm-highlight-global-adoption-of-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2021/elekta-unity-mr-linac-featured-in-72-abstracts-at-european-radiation-oncology-congress/https://ir.elekta.com/investors/press-releases/2021/notice-to-the-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2021/elektas-board-announces-establishment-of-philanthropic-elekta-foundation/https://ir.elekta.com/investors/press-releases/2021/elektas-annual-report-for-202021-available/https://ir.elekta.com/investors/press-releases/2021/report-from-the-annual-general-meeting-2021-in-elekta/https://ir.elekta.com/investors/press-releases/2021/interim-report-mayjuly-202122/https://ir.elekta.com/investors/press-releases/2021/elekta-optimizes-treatment-times-for-cancer-patients-via-proactive-service-innovation/https://ir.elekta.com/investors/press-releases/2021/elekta-radiotherapy-system-designed-for-changing-cancer-landscape-now-available-for-us-patients/https://ir.elekta.com/investors/press-releases/2021/elekta-to-address-indonesias-cancer-care-gap-with-direct-presence/https://ir.elekta.com/investors/press-releases/2021/elektas-new-strategy-to-focus-on-growth-and-access-to-radiation-therapy/https://ir.elekta.com/investors/press-releases/2021/elekta-and-philips-deepen-strategic-partnership-in-precise-and-individualized-oncology-care/https://ir.elekta.com/investors/press-releases/2021/invitation-to-the-presentation-of-elektas-first-quarter-202122/https://ir.elekta.com/investors/press-releases/2021/elekta-nomination-committees-proposed-board-of-directors-for-the-2021-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2021/100th-elekta-unity-mr-linac-goes-to-st-georges-hospital-in-new-zealand/https://ir.elekta.com/investors/press-releases/2021/year-end-report-mayapril-202021/https://ir.elekta.com/investors/press-releases/2021/invitation-to-elektas-capital-markets-day-2021/https://ir.elekta.com/investors/press-releases/2021/invitation-to-the-presentation-of-elektas-fiscal-year-202021/https://ir.elekta.com/investors/press-releases/2021/report-from-the-extraordinary-general-meeting-2021-in-elekta/https://ir.elekta.com/investors/press-releases/2021/notice-to-the-extraordinary-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2021/elektas-board-of-directors-proposes-additional-dividend-of-sek-090-per-share/https://ir.elekta.com/investors/press-releases/2021/elekta-wins-lawsuit-against-livian-gmbh/https://ir.elekta.com/investors/press-releases/2021/elekta-and-iba-strengthen-partnership-to-help-cancer-centers-integrate-proton-therapy/https://ir.elekta.com/investors/press-releases/2021/interim-report-mayjanuary-202021/https://ir.elekta.com/investors/press-releases/2021/elekta-appoints-johan-adeback-as-chief-financial-officer/https://ir.elekta.com/investors/press-releases/2021/first-cancer-centers-begin-using-initial-release-of-elektas-mosaiq-3-series/https://ir.elekta.com/investors/press-releases/2021/for-third-year-straight-elekta-named-one-of-the-worlds-most-ethical-companies-by-ethisphere/https://ir.elekta.com/investors/press-releases/2021/elekta-establishes-office-in-egypt-to-meet-growing-need-for-precision-radiation-medicine/https://ir.elekta.com/investors/press-releases/2021/invitation-to-the-presentation-of-elektas-third-quarter-202021/https://ir.elekta.com/investors/press-releases/2021/elektas-proknow-to-help-standardize-radiotherapy-for-veterans/https://ir.elekta.com/investors/press-releases/2021/elektas-mosaiq-and-versa-hd-earn-top-honors-in-2021-best-in-klas-software-and-services-report/https://ir.elekta.com/investors/press-releases/2021/elekta-divests-its-stake-in-viewray/https://ir.elekta.com/investors/press-releases/2020/elekta-reports-major-milestones-achieved-in-mr-guided-radiotherapy/https://ir.elekta.com/investors/press-releases/2020/interim-report-mayoctober-202021/https://ir.elekta.com/investors/press-releases/2020/gustaf-salford-appointed-elekta-ceo-by-board-of-directors/https://ir.elekta.com/investors/press-releases/2020/with-elekta-studio-elekta-brings-complete-image-guided-brachytherapy-workflow-to-a-single-room/https://ir.elekta.com/investors/press-releases/2020/invitation-to-the-presentation-of-elektas-second-quarter-202021/https://ir.elekta.com/investors/press-releases/2020/elektas-newest-radiotherapy-system-elekta-harmony-receives-ce-mark/https://ir.elekta.com/investors/press-releases/2020/elektas-nomination-committee-for-the-2021-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2020/elekta-early-out-in-securing-mdr-certificates-for-its-linac-portfolio/https://ir.elekta.com/investors/press-releases/2020/elekta-introduces-new-radiotherapy-solution-to-help-address-worldwide-cancer-burden/https://ir.elekta.com/investors/press-releases/2020/invitation-to-attend-the-virtual-launch-of-elektas-new-linear-accelerator/https://ir.elekta.com/investors/press-releases/2020/report-from-the-annual-general-meeting-2020-in-elekta/https://ir.elekta.com/investors/press-releases/2020/licensing-agreement-in-india-enables-advanced-cancer-treatment-with-elekta-unity/https://ir.elekta.com/investors/press-releases/2020/interim-report-mayjuly-202021/https://ir.elekta.com/investors/press-releases/2020/invitation-to-the-presentation-of-elektas-first-quarter-202021/https://ir.elekta.com/investors/press-releases/2020/elekta-unity-mr-linac-receives-clearance-by-chinas-national-medical-products-administration/https://ir.elekta.com/investors/press-releases/2020/new-treatment-solution-for-us-cervical-cancer-patients-now-available-for-clinical-use/https://ir.elekta.com/investors/press-releases/2020/turkish-hospital-launches-mr-guided-radiotherapy-program-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2020/notice-to-the-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2020/genesiscare-at-st-vincents-hospital-sydney-treats-first-patients-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2020/elektas-annual-report-for-201920-available/https://ir.elekta.com/investors/press-releases/2020/proposed-dividend-for-elekta-for-fiscal-year-201920/https://ir.elekta.com/investors/press-releases/2020/dr-richard-hausmann-resigns-as-president-and-ceo-of-elekta/https://ir.elekta.com/investors/press-releases/2020/elekta-nomination-committees-proposed-board-of-directors-for-the-2020-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2020/year-end-report-may-april-201920/https://ir.elekta.com/investors/press-releases/2020/richard-hausmann-elekta-ceo-named-best-medtech-ceo/https://ir.elekta.com/investors/press-releases/2020/invitation-to-the-presentation-of-elektas-fiscal-year-201920/https://ir.elekta.com/investors/press-releases/2020/acquisition-of-kaiku-health-strengthens-elekta-digital-offering-with-personalized-digital-health-interventions/https://ir.elekta.com/investors/press-releases/2020/genesiscare-makes-major-investment-in-elekta-cancer-treatment-equipment-as-it-enters-us-market/https://ir.elekta.com/investors/press-releases/2020/elekta-launches-leksell-gamma-knife-lightning-a-cutting-edge-solution-for-intracranial-stereotactic-radiosurgery/https://ir.elekta.com/investors/press-releases/2020/elekta-transfers-ownership-of-its-patient-positioning-activities/https://ir.elekta.com/investors/press-releases/2020/elekta-changes-outlook-for-201920-and-addresses-challenges-related-to-covid-19/https://ir.elekta.com/investors/press-releases/2020/elekta-launches-geneva-brachytherapy-applicator-for-precise-treatment-of-gynecological-cancers/https://ir.elekta.com/investors/press-releases/2020/radiotherapeutisch-instituut-friesland-rif-to-acquire-elekta-unity-for-innovative-cancer-treatment/https://ir.elekta.com/investors/press-releases/2020/edogawa-hospital-first-in-japan-to-order-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2020/elekta-offers-doctors-free-use-of-proknow-software-to-facilitate-cancer-treatments-during-covid-19/https://ir.elekta.com/investors/press-releases/2020/elekta-receives-ce-mark-approval-for-proknow-web-based-storage-and-retrieval-software/https://ir.elekta.com/investors/press-releases/2020/access-to-cancer-treatment-gets-major-boost-in-mexico/https://ir.elekta.com/investors/press-releases/2020/elekta-named-a-silver-winner-of-the-2020-edison-awards/https://ir.elekta.com/investors/press-releases/2020/elekta-named-one-of-the-worlds-most-ethical-companies-by-ethisphere-for-the-second-time/https://ir.elekta.com/investors/press-releases/2020/invitation-to-investor-meeting-at-estro-in-vienna/https://ir.elekta.com/investors/press-releases/2020/interim-report-may-january-201920/https://ir.elekta.com/investors/press-releases/2020/correction-regarding-press-release-quebec-to-acquire-advanced-linear-accelerators-to-meet-growing-need-for-advanced-cancer-care/https://ir.elekta.com/investors/press-releases/2020/invitation-to-the-presentation-of-elektas-third-quarter-201920/https://ir.elekta.com/investors/press-releases/2020/elekta-appoints-new-head-of-region-north-and-central-america/https://ir.elekta.com/investors/press-releases/2020/quebec-to-acquire-12-elekta-versa-hd-linear-accelerators-to-meet-growing-need-for-advanced-cancer-care/https://ir.elekta.com/investors/press-releases/2020/elektas-versa-hd-and-mosaiq-selected-as-category-leaders-in-2020-best-in-klas-software-and-services-report/https://ir.elekta.com/investors/press-releases/2020/switzerlands-hopital-riviera-chablais-treats-its-first-patient-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2020/institut-jules-bordet-invests-in-elektas-latest-cancer-treatment-technology/https://ir.elekta.com/investors/press-releases/2020/chinas-hedy-group-acquires-10-elekta-cancer-treatment-systems/https://ir.elekta.com/investors/press-releases/2019/fda-approves-diffusion-weighted-images-for-elekta-unity-expanding-options-for-assessment-during-therapy/https://ir.elekta.com/investors/press-releases/2019/townsville-hospital-treats-first-australian-patient-with-elekta-unity-mr-linac-a-transformative-approach-to-precision-radiation-therapy/https://ir.elekta.com/investors/press-releases/2019/elekta-completes-its-investment-in-viewray/https://ir.elekta.com/investors/press-releases/2019/elekta-announces-collaboration-with-viewray-for-the-advancement-of-mr-guided-radiation-therapy-and-investment-in-minority-stake-through-a-public-offering/https://ir.elekta.com/investors/press-releases/2019/interim-report-mayoctober-201920/https://ir.elekta.com/investors/press-releases/2019/invitation-to-the-presentation-of-elektas-second-quarter-201920/https://ir.elekta.com/investors/press-releases/2019/elekta-announces-preliminary-q2-results-and-updated-guidance-for-fiscal-year-201920/https://ir.elekta.com/investors/press-releases/2019/uppsala-university-hospital-first-in-sweden-to-treat-patient-with-elekta-unity-cancer-treatment-system/https://ir.elekta.com/investors/press-releases/2019/elektas-nomination-committee-for-the-2020-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2019/sacro-cuore-don-calabria-cancer-care-center-treats-its-first-patient-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2019/invitation-to-attend-a-live-elekta-unity-treatment-at-university-hospital-tubingen/https://ir.elekta.com/investors/press-releases/2019/elekta-wins-the-technology-services-industry-association-star-award/https://ir.elekta.com/investors/press-releases/2019/elekta-unity-mr-linac-receives-innovation-award-from-the-institute-of-physics/https://ir.elekta.com/investors/press-releases/2019/multiple-abstracts-presented-at-astro-demonstrate-the-technical-capabilities-and-clinical-utility-of-the-elekta-unity-mr-linac-system/https://ir.elekta.com/investors/press-releases/2019/elekta-awarded-sole-source-agreement-with-premier/https://ir.elekta.com/investors/press-releases/2019/lithuania-is-first-of-baltic-states-to-begin-intracranial-radiosurgery-with-elektas-leksell-gamma-knife/https://ir.elekta.com/investors/press-releases/2019/elekta-announces-exclusive-agreement-with-dosisoft-for-distribution-of-key-patient-specific-qa-solutions/https://ir.elekta.com/investors/press-releases/2019/elekta-to-highlight-precision-radiation-medicine-solutions-that-improve-patient-outcomes-at-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2019/elekta-fortifies-treatment-planning-offering-with-acquisition-of-proknow/https://ir.elekta.com/investors/press-releases/2019/bulletin-from-elektas-annual-general-meeting-2019/https://ir.elekta.com/investors/press-releases/2019/interim-report-mayjuly-201920/https://ir.elekta.com/investors/press-releases/2019/sunnybrook-health-sciences-centre-treats-its-first-patient-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2019/invitation-to-investor-meeting-at-astro-2019-in-chicago/https://ir.elekta.com/investors/press-releases/2019/invitation-to-the-presentation-of-elektas-first-quarter-201920/https://ir.elekta.com/investors/press-releases/2019/genesiscare-to-acquire-nine-elekta-unity-systems-for-advanced-cancer-treatment/https://ir.elekta.com/investors/press-releases/2019/hksh-medical-group-brings-precision-radiation-medicine-to-cancer-patients-in-asia-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2019/correction-of-press-release-on-notice-of-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2019/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2019/elekta-unity-mr-linac-receives-clearance-from-the-canadian-nuclear-safety-commission/https://ir.elekta.com/investors/press-releases/2019/elekta-to-demonstrate-leadership-in-precision-radiation-medicine-at-aapm-with-launch-of-new-qa-portfolio/https://ir.elekta.com/investors/press-releases/2019/clinicians-and-cancer-patients-to-benefit-from-advanced-image-guided-radiation-therapy-solutions-agreement-between-elekta-and-c-rad/https://ir.elekta.com/investors/press-releases/2019/elektas-annual-report-for-201819-available/https://ir.elekta.com/investors/press-releases/2019/university-hospital-tubingen-delivers-1000th-fraction-with-its-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2019/elekta-increases-focus-on-digitization--hires-sukhveer-singh-to-drive-elekta-digital-strategy/https://ir.elekta.com/investors/press-releases/2019/elekta-wins-2019-medical-device-engineering-breakthrough-award-from-medtech-breakthrough/https://ir.elekta.com/investors/press-releases/2019/elekta-nomination-committees-proposed-board-of-directors-for-the-2019-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2019/year-end-report-may-april-201819/https://ir.elekta.com/investors/press-releases/2019/elekta-unity-mr-linac-receives-regulatory-approval-from-japanese-ministry-of-health-labour-and-welfare/https://ir.elekta.com/investors/press-releases/2019/the-christie-nhs-foundation-trust-brings-personalized-precision-radiotherapy-to-cancer-patients-with-elekta-unity/https://ir.elekta.com/investors/press-releases/2019/conference-call-regarding-elektas-year-end-report-for-201819/https://ir.elekta.com/investors/press-releases/2019/vietnams-k-hospital-uses-elekta-solutions-to-make-precision-radiation-medicine-available-to-cancer-patients/https://ir.elekta.com/investors/press-releases/2019/radiotherapiegroep-in-the-netherlands-to-acquire-elekta-unity-and-versa-hd-cancer-treatment-systems/https://ir.elekta.com/investors/press-releases/2019/elekta-files-patent-infringement-lawsuit-against-zap-surgical-systems-inc/https://ir.elekta.com/investors/press-releases/2019/elekta-demonstrates-leadership-in-precision-radiation-medicine-at-estro-38/https://ir.elekta.com/investors/press-releases/2019/austin-healths-olivia-newton-john-cancer-wellness-and-research-centre-to-acquire-first-elekta-unity-in-victoria/https://ir.elekta.com/investors/press-releases/2019/elekta-to-offer-improved-clinical-quality-assurance-through-investment-in-irt-systems/https://ir.elekta.com/investors/press-releases/2019/elekta-unity-mr-linac-receives-red-dot-award-for-high-design-quality/https://ir.elekta.com/investors/press-releases/2019/elekta-unity-mr-linac-receives-medical-device-license-from-health-canada/https://ir.elekta.com/investors/press-releases/2019/elekta-signs-partnership-agreement-with-rtsafe-for-delivery-of-safe-and-efficient-stereotactic-cancer-treatments/https://ir.elekta.com/investors/press-releases/2019/elekta-hits-radiotherapy-milestone-with-5000th-linear-accelerator-manufactured/https://ir.elekta.com/investors/press-releases/2019/elekta-named-one-of-the-worlds-most-ethical-companies-in-2019-by-ethisphere/https://ir.elekta.com/investors/press-releases/2019/interim-report-may-january-201819/https://ir.elekta.com/investors/press-releases/2019/change-in-elektas-nomination-committee-for-the-2019-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2019/conference-call-regarding-elektas-q3-report-for-201819/https://ir.elekta.com/investors/press-releases/2019/froedtert--the-medical-college-of-wisconsin-clinical-cancer-center-at-froedtert-hospital-begins-patient-treatments-with-elekta-unity-mr-linac/https://ir.elekta.com/investors/press-releases/2019/new-study-to-learn-from-every-cancer-patient-treated-with-magnetic-resonance-radiation-therapy/https://ir.elekta.com/investors/press-releases/2019/elektas-mosaiq-oncology-information-system-named-category-leader-for-oncology-in-2019-best-in-klas-software--services-report/https://ir.elekta.com/investors/press-releases/2019/elekta-to-showcase-precision-radiation-medicine-for-treating-cancer-at-arab-health-exhibition-and-congress/https://ir.elekta.com/investors/press-releases/2019/elekta-unity-elektas-transformative-radiation-therapy-delivery-system-receives-good-design-award-2018/https://ir.elekta.com/investors/press-releases/2018/elekta-and-equicare-health-establish-reseller-agreement-to-enhance-cancer-patient-engagement-care-and-management/https://ir.elekta.com/investors/press-releases/2018/elekta-to-demonstrate-advanced-solutions-for-quality-assurance-at-aapm-annual-meeting/https://ir.elekta.com/investors/press-releases/2018/elekta-unity-featured-in-41-abstracts-at-the-6th-mr-in-rt-symposium/https://ir.elekta.com/investors/press-releases/2018/allegheny-health-network-cancer-institute-invests-in-elektas-mr-linac-research-system/https://ir.elekta.com/investors/press-releases/2018/elekta-unity-worlds-first-high-field-mr-linac-receives-fda-510k-clearance/https://ir.elekta.com/investors/press-releases/2018/interim-report-may-october-201819-q2/https://ir.elekta.com/investors/press-releases/2018/conference-call-regarding-elektas-q2-report-for-201819/https://ir.elekta.com/investors/press-releases/2018/elektas-nomination-committee-for-the-2019-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2018/genesiscare-signs-mou-for-versa-hd-cancer-treatment-systems-and-research-agreement-with-elekta/https://ir.elekta.com/investors/press-releases/2018/elekta-unity-mr-linac-featured-in-11-abstracts-at-astro-2018/https://ir.elekta.com/investors/press-releases/2018/elekta-introduces-strategy-for-precision-radiation-medicine-at-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2018/elekta-wins-user-centered-product-design-award-for-its-mr-linac-elekta-unity/https://ir.elekta.com/investors/press-releases/2018/elekta-presents-long-term-strategy-and-financial-scenario-at-capital-markets-day/https://ir.elekta.com/investors/press-releases/2018/precision-cancer-therapy-with-elekta-unity-now-available-in-the-uk-at-the-royal-marsden-and-the-institute-of-cancer-research-london/https://ir.elekta.com/investors/press-releases/2018/uks-nhs-supply-chain-orders-elekta-brachytherapy-equipment-for-accurate-cancer-treatment/https://ir.elekta.com/investors/press-releases/2018/thailands-siriraj-hospital-to-improve-cancer-care-with-acquisition-of-advanced-elekta-radiotherapy-technology/https://ir.elekta.com/investors/press-releases/2018/magnetic-resonance-radiation-therapy-with-elekta-unity-is-now-in-clinical-use-at-the-netherlands-cancer-institute-antoni-van-leeuwenhoek-hospital/https://ir.elekta.com/investors/press-releases/2018/elekta-celebrates-inauguration-of-new-global-radiotherapy-innovation-center/https://ir.elekta.com/investors/press-releases/2018/bulletin-from-elektas-annual-general-meeting-2018/https://ir.elekta.com/investors/press-releases/2018/interim-report-may-july-201819/https://ir.elekta.com/investors/press-releases/2018/genesiscare-orders-elekta-unity-mr-linac-to-increase-access-to-cutting-edge-cancer-treatment/https://ir.elekta.com/investors/press-releases/2018/first-patient-treated-with-ce-marked-elekta-unity-at-university-medical-center-utrecht/https://ir.elekta.com/investors/press-releases/2018/reminder-welcome-to-elektas-capital-markets-day-in-stockholm-on-september-27-2018/https://ir.elekta.com/investors/press-releases/2018/elektas-annual-report-for-201718-available/https://ir.elekta.com/investors/press-releases/2018/conference-call-regarding-elektas-q1-report-for-201819/https://ir.elekta.com/investors/press-releases/2018/elekta-unity-is-pending-510k-with-the-fda-for-us-sales-and-clinical-use-clearance/https://ir.elekta.com/investors/press-releases/2018/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2018/elekta-digital-strategy-strengthened-through-acquisition-of-quality-assurance-expert-acumyn/https://ir.elekta.com/investors/press-releases/2018/elekta-to-sell-its-meg-business-to-york-instruments/https://ir.elekta.com/investors/press-releases/2018/elekta-to-donate-advanced-radiation-therapy-machine-to-jordans-al-bashir-hospital/https://ir.elekta.com/investors/press-releases/2018/welcome-to-elektas-capital-markets-day-in-stockholm-on-september-27-2018/https://ir.elekta.com/investors/press-releases/2018/elekta-unity-worlds-first-high-field-mr-linac-receives-ce-mark/https://ir.elekta.com/investors/press-releases/2018/elekta-nomination-committees-proposed-board-of-directors-for-the-2018-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2018/year-end-report-may-april-201718/https://ir.elekta.com/investors/press-releases/2018/elekta-cancer-treatment-solutions-to-have-significant-impact-on-patients-at-cork-university-hospital/https://ir.elekta.com/investors/press-releases/2018/pennsylvania-hospitals-acquire-advanced-cancer-management-systems-from-elekta/https://ir.elekta.com/investors/press-releases/2018/conference-call-regarding-elektas-q4-report-for-201718/https://ir.elekta.com/investors/press-releases/2018/apollo-hospitals-group-chooses-elektas-mosaiq-for-new-proton-center/https://ir.elekta.com/investors/press-releases/2018/elekta-mr-linac-featured-in-record-breaking-42-abstracts-at-estro-37/https://ir.elekta.com/investors/press-releases/2018/proton-partners-international-to-acquire-elekta-mr-linac-cancer-treatment-devices/https://ir.elekta.com/investors/press-releases/2018/elekta-and-rtsafe-sign-agreement-to-distribute-personalized-stereotactic-quality-assurance-solutions/https://ir.elekta.com/investors/press-releases/2018/at-estro-37-elekta-focuses-on-millimeter-precision-and-personalization-of-cancer-care/https://ir.elekta.com/investors/press-releases/2018/elekta-expands-the-mosaiq-ecosystem-of-complementary-applications-with-strategic-investment-in-palabraapps/https://ir.elekta.com/investors/press-releases/2018/elekta-strengthens-presence-in-mexico-with-government-tender-for-radiation-therapy-technology/https://ir.elekta.com/investors/press-releases/2018/egyptian-cancer-care-gets-boost-with-elekta-radiation-treatment-technology/https://ir.elekta.com/investors/press-releases/2018/11th-meeting-of-the-elekta-mr-linac-consortium-convenes-in-manchester-uk-with-impressive-momentum-on-breakthrough-technology/https://ir.elekta.com/investors/press-releases/2018/elekta-wins-if-design-award-2018-for-its-elekta-mr-linac/https://ir.elekta.com/investors/press-releases/2018/elekta-signs-agreement-with-frances-centre-de-radiotherapie-st-louis-to-supply-monaco-treatment-planning-systems/https://ir.elekta.com/investors/press-releases/2018/interim-report-may-january-201718/https://ir.elekta.com/investors/press-releases/2018/elekta-collaborates-with-leading-new-york-cancer-center-to-continue-development-of-clinical-protocols-for-mr-linac-technology/https://ir.elekta.com/investors/press-releases/2018/elekta-to-provide-stockholm-region-with-advanced-cancer-care/https://ir.elekta.com/investors/press-releases/2018/bolivian-government-invests-in-state-of-the-art-cancer-care-from-elekta/https://ir.elekta.com/investors/press-releases/2018/conference-call-regarding-elektas-q3-report-for-201718/https://ir.elekta.com/investors/press-releases/2018/elekta-fosters-innovation-through-nobel-center-partnership/https://ir.elekta.com/investors/press-releases/2018/elektas-leksell-gamma-knife-icon-radiosurgery-system-cleared-for-use-in-china/https://ir.elekta.com/investors/press-releases/2018/elekta-taps-ibm-watson-health-to-bring-ai-to-comprehensive-oncology-field/https://ir.elekta.com/investors/press-releases/2018/the-ottawa-hospital-acquires-several-elekta-versa-hd-devices-for-advanced-cancer-treatment/https://ir.elekta.com/investors/press-releases/2018/gamma-knife-radiosurgery-hits-half-century-mark-with-over-a-million-patients-treated/https://ir.elekta.com/investors/press-releases/2017/members-of-the-elekta-mr-linac-consortium-present-updates-on-magnetic-resonance-radiation-therapy-mrrt-at-the-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2017/elekta-to-highlight-mosaiq-oncology-analytics-a-game-changing-solution-for-managing-the-oncology-treatment-pathway-at-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2017/elekta-chooses-brainlab-to-distribute-stereotactic-neurosurgical-solutions-within-selected-markets-in-europe/https://ir.elekta.com/investors/press-releases/2017/elektas-mosaiq-is-once-again-category-leader-in-oncology-information-systems-receiving-top-score-in-best-in-klas-software--services-report/https://ir.elekta.com/investors/press-releases/2017/elekta-to-showcase-the-latest-in-stereotactic-solutions-at-estro-36/https://ir.elekta.com/investors/press-releases/2017/romanian-government-signs-deal-for-five-elekta-linear-accelerators/https://ir.elekta.com/investors/press-releases/2017/elekta-chooses-brainlab-as-exclusive-distributor-in-the-us-for-stereotactic-neurosurgery-solutions/https://ir.elekta.com/investors/press-releases/2017/new-data-in-the-journal-of-neurosurgery-reinforce-use-of-elektas-gamma-knife-in-hypofractionated-radiosurgery-to-treat-large-or-complex-brain-tumors/https://ir.elekta.com/investors/press-releases/2017/elekta-mr-linac-consortium-brings-founding-members-together-with-clinicians-from-five-new-centers-to-highlight-progress/https://ir.elekta.com/investors/press-releases/2017/neurosurgery-pioneer-prof-l-dade-lunsford-receives-swedish-award-for-radiosurgery-excellence/https://ir.elekta.com/investors/press-releases/2017/alliance-cancer-care-to-upgrade-cancer-care-in-southeastern-us-with-elekta-solutions/https://ir.elekta.com/investors/press-releases/2017/elekta-partners-with-estro-cancer-foundation-to-increase-radiation-therapy-awareness-and-access-in-europe/https://ir.elekta.com/investors/press-releases/2017/isala-and-elekta-sign-long-term-partnership-agreement-for-optimal-cancer-care/https://ir.elekta.com/investors/press-releases/2017/first-patient-in-canada-treated-with-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2017/parkinsons-disease-patients-are-first-to-be-treated-with-elektas-new-leksell-vantage-stereotactic-system/https://ir.elekta.com/investors/press-releases/2017/genesis-cancercare-queensland-is-first-in-asia-pacific-region-to-use-elektas-venezia-brachytherapy-applicator/https://ir.elekta.com/investors/press-releases/2017/elekta-unity-transformative-magnetic-resonance-radiation-therapy-mrrt-system-debuts-at-estro-36/https://ir.elekta.com/investors/press-releases/2017/elekta-collaborates-with-palabra-to-offer-the-industrys-only-voice-enabled-ehr/https://ir.elekta.com/investors/press-releases/2017/elekta-to-highlight-continued-innovation-in-stereotactic-neurosurgery-with-leksell-vantage-stereotactic-system-at-aans/https://ir.elekta.com/investors/press-releases/2017/elekta-introduces-advanced-cancer-treatment-to-kingdom-of-bhutan/https://ir.elekta.com/investors/press-releases/2017/spanish-hospitals-acquire-elekta-radiotherapy-equipment-to-support-positive-cancer-trends/https://ir.elekta.com/investors/press-releases/2017/elekta-and-brainlab-collaborate-to-streamline-treatment-workflows-for-stereotactic-radiation-therapy/https://ir.elekta.com/investors/press-releases/2017/elekta-to-support-uppsala-university-hospital-in-improvement-of-cancer-care/https://ir.elekta.com/investors/press-releases/2017/leaders-in-cancer-radiotherapy-recognize-world-cancer-day-through-elekta-brachytherapy-equipment-donation/https://ir.elekta.com/investors/press-releases/2017/elekta-radiosurgery-solutions-highlighted-at-international-stereotactic-radiosurgery-society-congress/https://ir.elekta.com/investors/press-releases/2017/patient-in-germany-is-worlds-first-to-receive-brachytherapy-with-elektas-new-venezia-gynecological-applicator/https://ir.elekta.com/investors/press-releases/2017/elektas-gamma-knife-icon-now-available-in-50-health-centers-globally-including-poliambulanza-foundation-hospital-in-italy/https://ir.elekta.com/investors/press-releases/2017/elekta-introduces-new-commercial-name-for-meg-business-and-reveals-new-system-for-studying-brain-activity-at-2017-american-epilepsy-society-meeting/https://ir.elekta.com/investors/press-releases/2017/bulovka-hospital-first-in-czech-republic-to-offer-advanced-cancer-treatment-using-elekta-versa-hd/https://ir.elekta.com/investors/press-releases/2017/university-hospitals-seidman-cancer-center-launches-use-of-elektas-venezia-gynecological-applicator-for-patients-with-advanced-cervical-cancer/https://ir.elekta.com/investors/press-releases/2017/elekta-monaco-users-win-top-ranking-in-global-contest-for-sbrt-lung-plans/https://ir.elekta.com/investors/press-releases/2017/elekta-to-highlight-high-definition-dynamic-radiosurgery-with-versa-hd-and-monaco-at-aapm-annual-meeting/https://ir.elekta.com/investors/press-releases/2017/first-in-human-data-validate-potential-of-elektas-mr-linac-to-revolutionize-radiation-oncology/https://ir.elekta.com/investors/press-releases/2017/elekta-receives-510k-clearance-for-venezia-an-image-guided-brachytherapy-applicator-for-treating-advanced-stage-gynecological-cancers/https://ir.elekta.com/investors/press-releases/2017/elekta-debuts-first-magnetic-resonance-radiation-therapy-system-to-enable-precision-oncology-therapy-at-radiological-society-of-north-america-annual-meeting/https://ir.elekta.com/investors/press-releases/2017/elektas-mr-linac-featured-in-21-abstracts-at-2017-aapm-annual-meeting/https://ir.elekta.com/investors/press-releases/2017/elektas-leksell-gamma-knife-icon-radiosurgery-system-receives-medical-device-license-from-health-canada/https://ir.elekta.com/investors/press-releases/2017/new-data-from-the-elekta-lung-research-group-support-the-use-of-stereotactic-body-radiation-therapy-in-elderly-patients-with-early-stage-lung-cancer/https://ir.elekta.com/investors/press-releases/2017/elekta-and-stockholm-county-council-agree-on-constructive-way-forward/https://ir.elekta.com/investors/press-releases/2017/interim-report-may-october-201718/https://ir.elekta.com/investors/press-releases/2017/uks-national-health-service-signs-gbp-22-million-agreement-for-elekta-cancer-treatment-systems/https://ir.elekta.com/investors/press-releases/2017/elektas-nomination-committee-for-the-2018-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2017/21st-century-oncology-chooses-elekta-for-replacement-of-radiation-therapy-devices/https://ir.elekta.com/investors/press-releases/2017/conference-call-regarding-elektas-q2-report-for-201718/https://ir.elekta.com/investors/press-releases/2017/elekta-mr-linac-functionality-and-ce-mark-update-correction/https://ir.elekta.com/investors/press-releases/2017/mclaren-health-care-and-elekta-mutually-terminate-long-term-agreement/https://ir.elekta.com/investors/press-releases/2017/elekta-and-the-alliance-for-cancer-care-partner-to-bring-leading-edge-radiation-therapy-and-radiosurgery-solutions-to-patients/https://ir.elekta.com/investors/press-releases/2017/elekta-and-iba-enter-an-mou-regarding-a-comprehensive-partnership-including-joint-software-development-and-sales-to-advance-proton-therapy-treatments/https://ir.elekta.com/investors/press-releases/2017/elekta-treatment-solutions-used-in-100-percent-of-americas-top-50-cancer-hospitals/https://ir.elekta.com/investors/press-releases/2017/bulletin-from-elektas-annual-general-meeting-2016/https://ir.elekta.com/investors/press-releases/2017/ioannis-panagiotelis-appointed-as-chief-marketing-and-sales-officer/https://ir.elekta.com/investors/press-releases/2017/interim-report-may-july-201718/https://ir.elekta.com/investors/press-releases/2017/welcome-to-elektas-investor-meeting-at-astro/https://ir.elekta.com/investors/press-releases/2017/conference-call-regarding-elektas-interim-report-for-may-july-201718/https://ir.elekta.com/investors/press-releases/2017/elektas-annual-report-for-201617-available/https://ir.elekta.com/investors/press-releases/2017/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2017/steven-wort-appointed-as-elektas-chief-operating-officer/https://ir.elekta.com/investors/press-releases/2017/installation-of-elekta-mr-linac-initiated-at-sunnybrook-health-sciences-centre/https://ir.elekta.com/investors/press-releases/2017/elekta-nomination-committees-proposed-board-of-directors-for-the-2017-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2017/peter-gaccione-joins-elektas-executive-management-as-head-of-north-america/https://ir.elekta.com/investors/press-releases/2017/year-end-report-may-april-201617/https://ir.elekta.com/investors/press-releases/2017/reminder-invitation-to-elektas-year-end-report-and-company-update-presentation/https://ir.elekta.com/investors/press-releases/2017/university-medical-centre-utrecht-treats-first-cancer-patient-with-elekta-unity/https://ir.elekta.com/investors/press-releases/2017/invitation-to-elektas-year-end-report-and-company-update-presentation/https://ir.elekta.com/investors/press-releases/2017/strategic-partnership-between-elekta-and-besa-to-improve-clinical-workflows/https://ir.elekta.com/investors/press-releases/2017/elekta-appoints-gustaf-salford-as-chief-financial-officer/https://ir.elekta.com/investors/press-releases/2017/clinical-data-on-elekta-unity-from-elektas-mr-linac-consortium-featured-in-20-abstracts-at-estro-36/https://ir.elekta.com/investors/press-releases/2017/number-of-outstanding-shares-in-elekta-ab/https://ir.elekta.com/investors/press-releases/2017/elekta-and-varian-settle-patent-litigation/https://ir.elekta.com/investors/press-releases/2017/elekta-convertible-bond-and-new-financing/https://ir.elekta.com/investors/press-releases/2017/laurent-leksell-acquires-shares-of-class-a-through-conversion-and-sells-some-shares-of-class-b/https://ir.elekta.com/investors/press-releases/2017/interim-report-may-january-201617/https://ir.elekta.com/investors/press-releases/2017/conference-call-regarding-elektas-interim-report-for-may-january-201617/https://ir.elekta.com/investors/press-releases/2017/number-of-outstanding-shares-in-elekta-ab-2017-01-31/https://ir.elekta.com/investors/press-releases/2016/elekta-to-demonstrate-market-leading-radiosurgery-solutions-and-innovations-at-estro-35/https://ir.elekta.com/investors/press-releases/2016/dutch-medical-center-begins-radiosurgery-treatments-with-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2016/elekta-signs-exclusive-us-distribution-agreement-with-kobold-medical-for-brachytherapy-applicators/https://ir.elekta.com/investors/press-releases/2016/elekta-expands-its-presence-in-north-africa-through-joint-venture/https://ir.elekta.com/investors/press-releases/2016/elekta-to-continue-to-help-bring-radiation-treatment-to-developing-countries-with-nonprofit-organization-radiating-hope/https://ir.elekta.com/investors/press-releases/2016/at-himss16-meeting-elekta-to-show-how-clinicians-can-better-harness-oncology-data-with-elekta-healthcare-analytics/https://ir.elekta.com/investors/press-releases/2016/radiation-oncology-centres-launches-australias-first-electronic-brachytherapy-system-for-treating-skin-cancer/https://ir.elekta.com/investors/press-releases/2016/elekta-surpasses-one-million-patients-treated-with-leksell-gamma-knife/https://ir.elekta.com/investors/press-releases/2016/new-published-data-show-elektas-gamma-knife-icon-enables-adaptive-fractionated-stereotactic-radiotherapy/https://ir.elekta.com/investors/press-releases/2016/new-data-presentations-reinforce-clinical-value-of-elektas-monaco-radiotherapy-treatment-planning-software/https://ir.elekta.com/investors/press-releases/2016/okan-university-hospital-to-treat-cancer-with-elekta-radiation-therapy-equipment/https://ir.elekta.com/investors/press-releases/2016/first-center-in-middle-east-with-elektas-versa-hd-radiotherapy-system-begins-treating-cancer-patients/https://ir.elekta.com/investors/press-releases/2016/first-patient-in-switzerland-treated-with-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2016/elektas-monaco-511-treatment-planning-system-takes-center-stage-at-2016-american-association-of-physicists-in-medicine-annual-meeting/https://ir.elekta.com/investors/press-releases/2016/elekta-introduces-venezia-a-new-option-for-treating-advanced-stage-cervical-cancer-at-world-congress-of-brachytherapy/https://ir.elekta.com/investors/press-releases/2016/chinas-peking-university-is-site-of-100th-elekta-magnetoencephalography-meg-system-installed-worldwide/https://ir.elekta.com/investors/press-releases/2016/russian-clinic-uses-gamma-knife-to-treat-record-number-of-patients-with-brain-cancer-and-other-cranial-disorders/https://ir.elekta.com/investors/press-releases/2016/first-patient-in-us-treated-with-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2016/the-netherlands-radiotherapy-group-is-countrys-first-to-use-elektas-esteya-electronic-brachytherapy-to-treat-skin-cancer-patients/https://ir.elekta.com/investors/press-releases/2016/new-data-presented-at-estro-35-show-positive-cosmesis-and-favorable-late-side-effects-after-accelerated-partial-breast-irradiation-apbi-with-multicatheter-interstitial-brachytherapy/https://ir.elekta.com/investors/press-releases/2016/new-standard-of-care-offers-lower-toxicity-shorter-treatment-times-and-improved-cosmetic-outcomes-for-women-with-early-stage-breast-cancer/https://ir.elekta.com/investors/press-releases/2016/us-rep-tom-price-joins-atlanta-medtech-and-veteran-communities-to-discuss-veterans-contributions-to-health-care-industry/https://ir.elekta.com/investors/press-releases/2016/the-netherlands-radiotherapy-group-treats-skin-cancer-patients-with-esteya-electronic-brachytherapy/https://ir.elekta.com/investors/press-releases/2016/elekta-to-highlight-high-definition-dynamic-radiosurgery-solutions-for-faster-more-precise-stereotactic-treatments-at-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2016/doctors-in-japan-begin-treating-patients-with-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2016/elekta-expands-in-greece-with-comprehensive-cancer-care-solutions/https://ir.elekta.com/investors/press-releases/2016/elektas-mosaiq-oncology-informatics-powers-continuous-learning-to-support-value-based-medicine/https://ir.elekta.com/investors/press-releases/2016/stockholm-county-council-new-karolinska-solna-and-elekta-sign-long-term-collaboration-agreement-to-advance-cancer-care/https://ir.elekta.com/investors/press-releases/2016/elekta-takes-orders-for-two-high-field-mr-linear-accelerators/https://ir.elekta.com/investors/press-releases/2016/elekta-interim-report-may-october-201617/https://ir.elekta.com/investors/press-releases/2016/conference-call-regarding-elektas-interim-report-for-may-october-201617/https://ir.elekta.com/investors/press-releases/2016/elektas-nomination-committee-for-the-2017-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2016/usitc-publishes-initial-determination-in-litigation-dispute/https://ir.elekta.com/investors/press-releases/2016/genesiscare-continues-to-expand-spanishcancer-services-with-elekta/https://ir.elekta.com/investors/press-releases/2016/all-india-institute-of-medical-science-expands-cancer-care-with-advanced-treatment-devices-from-elekta/https://ir.elekta.com/investors/press-releases/2016/installation-of-elektas-sixth-high-field-mr-adaptive-linear-accelerator-initiated-at-the-christie/https://ir.elekta.com/investors/press-releases/2016/data-presented-at-astro-underscore-the-promise-of-elektas-high-field-mr-adaptive-linear-accelerator-as-a-transformative-advance-in-radiation-therapy/https://ir.elekta.com/investors/press-releases/2016/elekta-and-brainlab-improve-interoperability-and-treatment-capabilities-in-stereotactic-neurosurgery-treatments/https://ir.elekta.com/investors/press-releases/2016/elektas-new-leksell-vantage-stereotactic-system-improves-imaging-and-workflow-for-neurosurgery-procedures/https://ir.elekta.com/investors/press-releases/2016/elekta-informs-investors-of-transformation-program-and-advanced-portfolio-development-at-astro-capital-markets-presentation/https://ir.elekta.com/investors/press-releases/2016/installation-initiated-for-elektas-high-field-mr-adaptive-linear-accelerator-at-froedtert--the-medical-college-of-wisconsin-clinical-cancer-center/https://ir.elekta.com/investors/press-releases/2016/reminder-welcome-to-elektas-capital-markets-presentation-at-astro/https://ir.elekta.com/investors/press-releases/2016/bulletin-from-elektas-annual-general-meeting-2016/https://ir.elekta.com/investors/press-releases/2016/interim-report-may--july-201617/https://ir.elekta.com/investors/press-releases/2016/welcome-to-elektas-capital-markets-presentation-at-astro/https://ir.elekta.com/investors/press-releases/2016/conference-call-regarding-elektas-interim-report-for-may-july-201617/https://ir.elekta.com/investors/press-releases/2016/elektas-annual-report-for-201516-available/https://ir.elekta.com/investors/press-releases/2016/data-presentations-at-aapm-2016-highlight-potential-of-elektas-high-field-mr-linac-to-enable-real-time-treatment-adaptation/https://ir.elekta.com/investors/press-releases/2016/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2016/viennese-hospitals-to-improve-cancer-treatment-with-elekta-equipment-and-software/https://ir.elekta.com/investors/press-releases/2016/scale-innovation-leadership-and-transformation-in-focus-at-elektas-capital-markets-day/https://ir.elekta.com/investors/press-releases/2016/installation-initiated-for-elektas-high-field-mr-linac-at-the-institute-of-cancer-research-london-and-the-royal-marsden/https://ir.elekta.com/investors/press-releases/2016/elektas-leksell-gamma-knife-icon-cleared-for-use-in-japan-and-united-states/https://ir.elekta.com/investors/press-releases/2016/year-end-report-may--april-201516/https://ir.elekta.com/investors/press-releases/2016/third-installation-of-elektas-high-field-mr-guided-linear-accelerator-underway-at-university-medical-centre-utrecht/https://ir.elekta.com/investors/press-releases/2016/elekta-wins-public-tender-to-deliver-advanced-cancer-care-solutions-to-new-karolinska-solna-nks/https://ir.elekta.com/investors/press-releases/2016/elekta-to-pay-humediq-eur-89-million-in-legal-dispute/https://ir.elekta.com/investors/press-releases/2016/conference-call-regarding-elektas-201516-year-end-report/https://ir.elekta.com/investors/press-releases/2016/leeds-st-james-acquires-eight-elekta-linear-accelerators-for-advanced-cancer-treatment/https://ir.elekta.com/investors/press-releases/2016/nhs-supply-chain-chooses-elekta-to-upgrade-uks-radiotherapy-resources/https://ir.elekta.com/investors/press-releases/2016/turkeys-medicana-health-group-invests-eur-10-million-in-elekta-cancer-treatment-equipment/https://ir.elekta.com/investors/press-releases/2016/welcome-to-elektas-capital-markets-day-in-stockholm-on-june-9-2016/https://ir.elekta.com/investors/press-releases/2016/number-of-outstanding-shares-in-elekta-ab/https://ir.elekta.com/investors/press-releases/2016/elektas-latest-monaco-release-features-up-to-four-times-faster-calculation-speed-for-reduced-radiotherapy-planning-times/https://ir.elekta.com/investors/press-releases/2016/transformative-potential-of-elektas-high-field-mr-guided-linear-accelerator-highlighted-in-seven-abstracts-at-estro-35/https://ir.elekta.com/investors/press-releases/2016/md-anderson-cancer-center-to-acquire-elekta-linear-accelerators-and-other-radiotherapy-solutions/https://ir.elekta.com/investors/press-releases/2016/john-lapre-to-fulfill-role-as-elektas-chief-technology-officer/https://ir.elekta.com/investors/press-releases/2016/elekta-and-philips-begin-installation-of-mr-guided-linear-accelerator-at-the-netherlands-cancer-institute/https://ir.elekta.com/investors/press-releases/2016/richard-hausmann-appointed-as-elektas-president-and-ceo/https://ir.elekta.com/investors/press-releases/2016/genesiscare-and-elekta-sign-strategic-partnership-for-more-than-usd-100-million/https://ir.elekta.com/investors/press-releases/2016/elekta-interim-report-may--january-201516/https://ir.elekta.com/investors/press-releases/2016/conference-call-regarding-elektas-interim-report-for-may-january-201516/https://ir.elekta.com/investors/press-releases/2016/number-of-outstanding-shares-in-elekta-ab-2016-01-29/https://ir.elekta.com/investors/press-releases/2015/internationally-renowned-netherlands-cancer-institute-antoni-van-leeuwenhoek-hospital-acquires-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2015/elekta-raises-more-than-28000-to-support-women-with-cancer/https://ir.elekta.com/investors/press-releases/2015/elekta-earns-top-rank-in-2015s-best-in-klas-for-radiation-therapy/https://ir.elekta.com/investors/press-releases/2015/phase-iii-data-published-in-the-lancet-show-accelerated-partial-breast-irradiation-with-multicatheter-brachytherapy-is-clinically-equivalent-to-whole-breast-irradiation-in-early-stage-cancer/https://ir.elekta.com/investors/press-releases/2015/new-data-demonstrate-accelerated-partial-breast-irradiation-with-multicatheter-brachytherapy-is-clinically-equivalent-to-whole-breast-irradiation-in-treating-early-stage-cancer/https://ir.elekta.com/investors/press-releases/2015/elekta-inaugurates-new-radiation-therapy-training-center-in-south-africa/https://ir.elekta.com/investors/press-releases/2015/bulgarian-cancer-patients-to-receive-modern-treatment-with-elekta-radiotherapy-equipment/https://ir.elekta.com/investors/press-releases/2015/elekta-to-showcase-new-leksell-gamma-knife-icon-at-congress-of-neurological-surgeons-annual-meeting/https://ir.elekta.com/investors/press-releases/2015/accelerated-partial-breast-irradiation-with-brachytherapy-achieves-excellent-tong-term-toxicity-and-cosmetic-outcomes/https://ir.elekta.com/investors/press-releases/2015/at-astro-annual-meeting-elekta-to-highlight-cancer-management-solutions-that-advance-and-simplify-patient-care/https://ir.elekta.com/investors/press-releases/2015/floridas-lynn-cancer-institute-begins-treating-skin-cancer-patients-with-elektas-esteya-electronic-brachytherapy-system/https://ir.elekta.com/investors/press-releases/2015/elekta---interim-report-may--october-201516/https://ir.elekta.com/investors/press-releases/2015/number-of-outstanding-shares-in-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2015/proton-partners-international-to-fight-cancer-with-elekta-radiotherapy-equipment/https://ir.elekta.com/investors/press-releases/2015/karolinska-university-hospital-to-purchase-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2015/amethyst-radiotherapy-orders-elekta-cancer-treatment-solutions-for-european-expansion/https://ir.elekta.com/investors/press-releases/2015/conference-call-regarding-elektas-interim-report-for-may-october-201516/https://ir.elekta.com/investors/press-releases/2015/elektas-operations-in-italy-under-investigation-for-suspected-antitrust-violations/https://ir.elekta.com/investors/press-releases/2015/elektas-nomination-committee-for-the-2016-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2015/elekta-highlights-leading-rd-program-and-reiterates-financial-ambitions/https://ir.elekta.com/investors/press-releases/2015/installation-completed-for-elekta-mri-guided-linear-accelerator-at-md-anderson-cancer-center/https://ir.elekta.com/investors/press-releases/2015/seven-us-medical-centers-to-acquire-elektas-new-leksell-gamma-knife-icon-brain-radiosurgery-system/https://ir.elekta.com/investors/press-releases/2015/reminder-welcome-to-elektas-capital-markets-presentation-at-astro/https://ir.elekta.com/investors/press-releases/2015/elekta-states-that-varian-claims-lack-merit/https://ir.elekta.com/investors/press-releases/2015/welcome-to-elektas-capital-markets-presentation-at-astro/https://ir.elekta.com/investors/press-releases/2015/bulletin-from-elektas-annual-general-meeting-2015/https://ir.elekta.com/investors/press-releases/2015/gustave-roussy-leading-european-comprehensive-cancer-center-chooses-elektas-versa-hd/https://ir.elekta.com/investors/press-releases/2015/interim-report-may--july-201516/https://ir.elekta.com/investors/press-releases/2015/university-hospital-la-timone-worlds-first-to-treat-patients-with-leksell-gamma-knife-icon-elektas-latest-generation-cranial-radiosurgery-system/https://ir.elekta.com/investors/press-releases/2015/conference-call-regarding-elektas-interim-report-for-may-july-201516/https://ir.elekta.com/investors/press-releases/2015/elektas-annual-report-for-201415-now-available/https://ir.elekta.com/investors/press-releases/2015/elekta-receives-us-510k-clearance-for-its-latest-generation-intracranial-radiosurgery-system-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2015/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2015/leading-european-health-centers-to-improve-cranial-radiosurgery-with-elektas-new-leksell-gamma-knife-icon/https://ir.elekta.com/investors/press-releases/2015/elekta-nomination-committees-proposed-board-of-directors-for-the-2015-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2015/william-beaumont-hospital-and-elekta-file-patent-lawsuit-against-varian-medical-systems/https://ir.elekta.com/investors/press-releases/2015/elekta-details-comprehensive-action-program-at-capital-markets-day/https://ir.elekta.com/investors/press-releases/2015/samsung-medical-center-acquires-asias-first-leksell-gamma-knife-icon-system/https://ir.elekta.com/investors/press-releases/2015/elekta-ce-marks-leksell-gamma-knife-icon-designed-to-treat-a-more-expansive-range-of-cranial-targets/https://ir.elekta.com/investors/press-releases/2015/elekta-announces-reorganization-and-changes-in-its-executive-management-team/https://ir.elekta.com/investors/press-releases/2015/year-end-report-may--april-201415/https://ir.elekta.com/investors/press-releases/2015/conference-call-regarding-elektas-201415-year-end-report/https://ir.elekta.com/investors/press-releases/2015/welcome-to-elektas-capital-markets-day-in-stockholm-on-june-11-2015/https://ir.elekta.com/investors/press-releases/2015/elekta-releases-preliminary-financial-results/https://ir.elekta.com/investors/press-releases/2015/new-leksell-gamma-knife-to-benefit-more-patients-with-brain-disease/https://ir.elekta.com/investors/press-releases/2015/elekta-ce-marks-for-monaco-v510-treatment-planning-system/https://ir.elekta.com/investors/press-releases/2015/elekta-to-highlight-elekta-radiosurgery-solutions-information-guided-cancer-care-at-3rd-estro-forum/https://ir.elekta.com/investors/press-releases/2015/elekta-to-deliver-advanced-cancer-management-solutions-to-providence-health--services/https://ir.elekta.com/investors/press-releases/2015/elekta-signs-agreement-to-acquire-assets-of-mexican-distributor-aeesa/https://ir.elekta.com/investors/press-releases/2015/number-of-outstanding-shares-in-elekta-ab-publ-2015-03-31/https://ir.elekta.com/investors/press-releases/2015/elekta-issues-a-sek-1-billion-bond-with-five-year-maturity/https://ir.elekta.com/investors/press-releases/2015/asa-hedin-evp-corporate-strategy-leaves-elekta/https://ir.elekta.com/investors/press-releases/2015/elekta-expands-in-poland-through-acquisition/https://ir.elekta.com/investors/press-releases/2015/elekta-establishes-bond-program/https://ir.elekta.com/investors/press-releases/2015/interim-report-may--january-201415/https://ir.elekta.com/investors/press-releases/2015/conference-call-regarding-elektas-interim-report-for-may-january-201415/https://ir.elekta.com/investors/press-releases/2015/elekta-takes-up-world-cancer-day-challenge-to-reduce-global-cancer-burden/https://ir.elekta.com/investors/press-releases/2015/elekta-plans-to-introduce-mri-guided-radiation-therapy-system-in-2017/https://ir.elekta.com/investors/press-releases/2015/turkish-republic-ministry-of-health-turkiye-hudut-ve-sahiller-genel-mudurlugu-to-acquire-advanced-cancer-treatment-systems-from-elekta/https://ir.elekta.com/investors/press-releases/2015/reminder-welcome-to-an-elekta-rd-update-at-university-medical-center-utrecht/https://ir.elekta.com/investors/press-releases/2015/revised-welcome-to-an-elekta-rd-update-at-university-medical-center-utrecht/https://ir.elekta.com/investors/press-releases/2014/welcome-to-an-elekta-rd-update-at-university-medical-center-utrecht/https://ir.elekta.com/investors/press-releases/2014/avera-health-partners-with-elekta-to-deliver-most-advanced-cancer-care/https://ir.elekta.com/investors/press-releases/2014/elekta-ltd-and-medical-intelligence-medizintechnik-gmbh-defend-claims-by-humediq-gmbh/https://ir.elekta.com/investors/press-releases/2014/number-of-outstanding-shares-in-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2014/interim-report-may--october-201415/https://ir.elekta.com/investors/press-releases/2014/conference-call-regarding-elektas-half-year-report-for-201415/https://ir.elekta.com/investors/press-releases/2014/elektas-nomination-committee-for-the-2015-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2014/elekta-recognized-by-cdp-for-environmental-commitment/https://ir.elekta.com/investors/press-releases/2014/elekta-included-in-ftse4good-index-series/https://ir.elekta.com/investors/press-releases/2014/tomas-puusepp-executive-director-of-the-board-acquires-shares/https://ir.elekta.com/investors/press-releases/2014/elekta-president-and-ceo-acquires-shares/https://ir.elekta.com/investors/press-releases/2014/chinese-clinics-and-cancer-patients-to-benefit-from-elektas-versa-hd-radiation-therapy-system/https://ir.elekta.com/investors/press-releases/2014/software-plays-key-role-as-elekta-presents-product-developments-at-astro-meeting/https://ir.elekta.com/investors/press-releases/2014/elekta-strengthens-its-internal-audit-and-compliance-functions/https://ir.elekta.com/investors/press-releases/2014/elektas-versa-hd-radiation-therapy-system-now-available-for-treatment-of-cancer-patients-in-japan/https://ir.elekta.com/investors/press-releases/2014/enhanced-collaboration-with-toshiba-strengthens-elektas-position-in-japan/https://ir.elekta.com/investors/press-releases/2014/bulletin-from-elektas-annual-general-meeting-2014/https://ir.elekta.com/investors/press-releases/2014/interim-report-may--july-201415/https://ir.elekta.com/investors/press-releases/2014/elekta-announces-intention-to-acquire-rta-a-leading-distributor-in-poland/https://ir.elekta.com/investors/press-releases/2014/welcome-to-elektas-capital-markets-day-at-astro/https://ir.elekta.com/investors/press-releases/2014/conference-call-regarding-elektas-interim-report-for-may-july-201415/https://ir.elekta.com/investors/press-releases/2014/elektas-annual-report-for-201314-is-now-available-on-the-companys-website/https://ir.elekta.com/investors/press-releases/2014/for-fourth-year-in-a-row-elektas-leksell-gamma-knife-perfexion-earns-top-rank-in-2014s-best-in-klas-for-radiation-therapy/https://ir.elekta.com/investors/press-releases/2014/number-of-outstanding-shares-in-elekta-ab-publ-2014-07-31/https://ir.elekta.com/investors/press-releases/2014/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2014/elekta-strengthens-its-position-in-turkey-with-acquisition-of-mesi-medikal/https://ir.elekta.com/investors/press-releases/2014/the-christie-hospital-joins-elekta-and-philips-research-consortium-to-develop-mri-guided-radiation-therapy-system-for-cancer-treatment/https://ir.elekta.com/investors/press-releases/2014/uppsala-university-hospital-and-elekta-to-further-cancer-research-in-sweden/https://ir.elekta.com/investors/press-releases/2014/elekta-presents-strategic-agenda-to-outgrow-the-market/https://ir.elekta.com/investors/press-releases/2014/the-institute-of-cancer-research-joins-the-elekta-and-philips-research-consortium-to-develop-mri-guided-therapy-system-for-cancer-treatment/https://ir.elekta.com/investors/press-releases/2014/year-end-report-may--april-201314/https://ir.elekta.com/investors/press-releases/2014/conference-call-regarding-elektas-201314-year-end-report/https://ir.elekta.com/investors/press-releases/2014/elekta-announces-changes-to-its-executive-management-team/https://ir.elekta.com/investors/press-releases/2014/elekta-announces-strategic-partnership-with-the-centre-hospitalier-de-luniversite-de-montreal/https://ir.elekta.com/investors/press-releases/2014/niklas-savander-assumes-role-as-elektas-new-president-and-ceo/https://ir.elekta.com/investors/press-releases/2014/number-of-outstanding-shares-in-elekta-ab-publ-2014-04-30/https://ir.elekta.com/investors/press-releases/2014/welcome-to-elektas-capital-markets-day-in-stockholm-on-june-17-2014/https://ir.elekta.com/investors/press-releases/2014/elekta-nomination-committees-proposed-board-of-directors-for-2014-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2014/dutch-medical-center-begins-installation-of-worlds-first-high-field-mri-guided-radiation-therapy-system/https://ir.elekta.com/investors/press-releases/2014/nhs-supply-chain-purchases-elekta-equipment-for-gbp-19-million/https://ir.elekta.com/investors/press-releases/2014/number-of-outstanding-shares-in-elekta-ab-publ-2014-02-28/https://ir.elekta.com/investors/press-releases/2014/interim-report-may--january-201314/https://ir.elekta.com/investors/press-releases/2014/elekta-announces-preliminary-results-for-third-quarter-and-revised-outlook-for-fiscal-year-201314/https://ir.elekta.com/investors/press-releases/2014/conference-call-regarding-elektas-interim-report-for-may-january-201314/https://ir.elekta.com/investors/press-releases/2014/number-of-outstanding-shares-in-elekta-ab-publ-2014-01-31/https://ir.elekta.com/investors/press-releases/2014/elekta-receives-significant-order-to-deliver-cancer-care-solutions-to-iraq/https://ir.elekta.com/investors/press-releases/2014/elekta-collaborates-with-algeria-to-bring-new-hope-to-cancer-patients/https://ir.elekta.com/investors/press-releases/2014/elekta-wins-public-tender-to-deliver-cancer-care-solutions-to-china/https://ir.elekta.com/investors/press-releases/2013/number-of-outstanding-shares-in-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2013/elekta-announces-strategic-partnership-with-mclaren-health-care-to-improve-cancer-care-in-michigan/https://ir.elekta.com/investors/press-releases/2013/interim-report-may--october-201314/https://ir.elekta.com/investors/press-releases/2013/elekta-receives-us-fda-510k-clearance-for-its-monaco-5-treatment-planning-system/https://ir.elekta.com/investors/press-releases/2013/conference-call-regarding-elektas-interim-report-for-may-october-201314/https://ir.elekta.com/investors/press-releases/2013/elekta-opens-state-of-the-art-radiotherapy-training-center-in-beijing/https://ir.elekta.com/investors/press-releases/2013/south-koreas-yonsei-university-health-system-orders-four-elekta-radiation-therapy-systems/https://ir.elekta.com/investors/press-releases/2013/number-of-outstanding-shares-in-elekta-ab-publ-2013-11-04/https://ir.elekta.com/investors/press-releases/2013/elektas-nomination-committee-for-the-2014-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2013/elekta-appoints-niklas-savander-as-its-next-president-and-chief-executive-officer/https://ir.elekta.com/investors/press-releases/2013/elekta-declines-to-continue-to-participate-in-linear-accelerator-bidding-process-in-brazil/https://ir.elekta.com/investors/press-releases/2013/nucletron-an-elekta-company-receives-us-fda-510k-clearance-for-esteya-electronic-brachytherapy-system-for-treating-skin-cancer/https://ir.elekta.com/investors/press-releases/2013/elekta-opens-global-education-center-for-oncology-and-neuroscience-professionals/https://ir.elekta.com/investors/press-releases/2013/elekta-leads-radiation-therapy-industry-through-innovation/https://ir.elekta.com/investors/press-releases/2013/nucletron-an-elekta-company-introduces-esteya-electronic-brachytherapy-for-treating-skin-cancer/https://ir.elekta.com/investors/press-releases/2013/elekta-announces-monaco-50--comprehensive-radiation-treatment-planning-capabilities-brought-together-in-one-system/https://ir.elekta.com/investors/press-releases/2013/elekta-included-in-dow-jones-sustainability-index/https://ir.elekta.com/investors/press-releases/2013/reminder-welcome-to-elekta-capital-markets-day-at-astro/https://ir.elekta.com/investors/press-releases/2013/elekta-receives-usd-25-million-order-from-china/https://ir.elekta.com/investors/press-releases/2013/bulletin-from-elektas-annual-general-meeting-2013/https://ir.elekta.com/investors/press-releases/2013/interim-report-may--july-201314/https://ir.elekta.com/investors/press-releases/2013/correction-in-the-annual-report-201213/https://ir.elekta.com/investors/press-releases/2013/elektas-versa-hd-system-now-features-automated-breath-hold-gating-for-improved-breast-and-lung-radiotherapy/https://ir.elekta.com/investors/press-releases/2013/welcome-to-elekta-capital-markets-day-at-astro/https://ir.elekta.com/investors/press-releases/2013/conference-call-regarding-elektas-interim-report-for-may-july-201314/https://ir.elekta.com/investors/press-releases/2013/lawsuit-with-varian-medical-systems-resolved/https://ir.elekta.com/investors/press-releases/2013/elektas-annual-report-for-201213-is-now-available-on-the-companys-website/https://ir.elekta.com/investors/press-releases/2013/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2013/number-of-outstanding-shares-in-elekta-ab-publ-2013-07-31/https://ir.elekta.com/investors/press-releases/2013/froedtert--the-medical-college-of-wisconsin-clinical-cancer-center-joins-elekta-and-philips-research-consortium-on-mri-guided-radiation-therapy/https://ir.elekta.com/investors/press-releases/2013/elektas-leksell-gamma-knife-perfexion-earns-top-rank-in-2013s-best-in-klas-for-radiation-therapy/https://ir.elekta.com/investors/press-releases/2013/elekta-to-focus-on-continued-strong-growth-and-rd-investments-in-coming-years/https://ir.elekta.com/investors/press-releases/2013/elekta-equra-health-partnership-to-increase-south-african-cancer-patients-access-to-radiation-therapy/https://ir.elekta.com/investors/press-releases/2013/year-end-report-may--april-201213/https://ir.elekta.com/investors/press-releases/2013/number-of-outstanding-shares-in-elekta-ab-publ-2013-05-31/https://ir.elekta.com/investors/press-releases/2013/reminder--elektas-capital-markets-day-in-stockholm-on-june-12-2013/https://ir.elekta.com/investors/press-releases/2013/leeds-st-jamess-institute-of-oncology-acquires-two-elekta-versa-hd-radiotherapy-systems/https://ir.elekta.com/investors/press-releases/2013/elekta-nomination-committees-proposals-for-the-2013-annual-general-meeting/https://ir.elekta.com/investors/press-releases/2013/conference-call-regarding-elektas-201213-full-year-report/https://ir.elekta.com/investors/press-releases/2013/canadas-sunnybrook-health-sciences-centre-joins-elekta-and-philips-research-consortium-on-mri-guided-radiation-therapy/https://ir.elekta.com/investors/press-releases/2013/number-of-outstanding-shares-in-elekta-ab-publ-2013-04-30/https://ir.elekta.com/investors/press-releases/2013/elekta-and-philips-research-consortium-on-mri-guided-radiation-therapy-adds-the-netherlands-cancer-institute-antoni-van-leeuwenhoek-hospital/https://ir.elekta.com/investors/press-releases/2013/md-anderson-cancer-center-acquires-two-elekta-versa-hd-systems/https://ir.elekta.com/investors/press-releases/2013/swedish-clinic-boosts-speed-and-precision-of-radiotherapy-for-cancer-patients-with-elekta-beam-shaping-technology/https://ir.elekta.com/investors/press-releases/2013/elekta-receives-us-fda-510k-clearance-following-launch-of-new-versa-hd-radiation-therapy-system-for-cancer-treatment/https://ir.elekta.com/investors/press-releases/2013/uk-clinic-anticipating-new-era-of-radiotherapy-speed-and-precision-with-elektas-new-versa-hd-system/https://ir.elekta.com/investors/press-releases/2013/japanese-approval-of-elektas-extend-system-allows-more-patients-to-be-treated/https://ir.elekta.com/investors/press-releases/2013/elektas-advanced-versa-hd-system-to-begin-treating-cancer-patients-at-new-swiss-radiotherapy-clinic/https://ir.elekta.com/investors/press-releases/2013/denmarks-odense-university-hospital-orders-elektas-new-versa-hd-linear-accelerator-for-radiotherapy-treatment-of-patients-with-cancer/https://ir.elekta.com/investors/press-releases/2013/kuopio-university-hospital-first-in-finland-with-elektas-new-beam-shaping-innovation-for-radiotherapy-of-cancer-patients/https://ir.elekta.com/investors/press-releases/2013/interim-report-may--january-201213/https://ir.elekta.com/investors/press-releases/2013/elekta-sets-new-benchmark-for-cancer-treatment-with-launch-of-versa-hd-system/https://ir.elekta.com/investors/press-releases/2013/conference-call-regarding-elektas-interim-report-for-may-january--201213/https://ir.elekta.com/investors/press-releases/2013/banner-md-anderson-cancer-center-acquires-multiple-elekta-cancer-management-systems/https://ir.elekta.com/investors/press-releases/2013/elektas-new-radiation-oncology-technology-to-shape-the-future-of-cancer-care/https://ir.elekta.com/investors/press-releases/2013/number-of-outstanding-shares-in-elekta-ab-publ-2013-01-31/https://ir.elekta.com/investors/press-releases/2013/elekta-and-philips-gain-md-anderson-cancer-center-as-collaborator-in-research-consortium-on-mri-guided-radiation-therapy/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2012/new-clarity-soft-tissue-visualization-software-neutralizes-organ-motion-challenges-during-prostate-cancer-radiotherapy/https://ir.elekta.com/investors/press-releases/2012/interim-report-may--october-201213/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-11-30/https://ir.elekta.com/investors/press-releases/2012/conference-call-regarding-elektas-interim-report-for-may-october-201213/https://ir.elekta.com/investors/press-releases/2012/elektas-growth-through-innovation-to-increase-use-of-radiation-therapy-and-improve-lives-of-cancer-patients/https://ir.elekta.com/investors/press-releases/2012/elekta-and-key-distributor-enter-agreement-to-increase-production-efforts-of-radiotherapy-technology-in-russia/https://ir.elekta.com/investors/press-releases/2012/elekta-and-philips-establish-research-consortium-to-leverage-a-breakthrough-in-cancer-care-with-integration-of-a-linear-accelerator-and-mr-imaging/https://ir.elekta.com/investors/press-releases/2012/elektas-nomination-committee-for-the-annual-general-meeting-2013/https://ir.elekta.com/investors/press-releases/2012/agility-elektas-innovative-beam-shaping-solution-for-cancer-treatment-ships-globally/https://ir.elekta.com/investors/press-releases/2012/dutch-clinic-is-first-in-country-to-treat-cancer-patients-with-elektas-agility-beam-shaping-solution-for-radiation-therapy/https://ir.elekta.com/investors/press-releases/2012/danish-clinics-anticipate-benefits-for-cancer-patients-with-elektas-innovative-beam-shaping-solution-for-radiotherapy/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-09-28/https://ir.elekta.com/investors/press-releases/2012/welcome-to-elekta-capital-markets-day-at-astro-boston-october-29-2012/https://ir.elekta.com/investors/press-releases/2012/recalculation-of-conversion-price-for-elektas-convertible-bond-due-to-resolution-to-implement-elekta-share-split/https://ir.elekta.com/investors/press-releases/2012/bulletin-from-elektas-annual-general-meeting-2012/https://ir.elekta.com/investors/press-releases/2012/interim-report-may--july-201213/https://ir.elekta.com/investors/press-releases/2012/elekta-wins-usd-35-million-tender-in-china/https://ir.elekta.com/investors/press-releases/2012/varian-medical-systems-files-a-lawsuit-in-the-united-states-against-elekta/https://ir.elekta.com/investors/press-releases/2012/conference-call-regarding-elektas-interim-report-for-may-july-201213/https://ir.elekta.com/investors/press-releases/2012/elektas-annual-report-for-201112-is-now-available-on-the-companys-website/https://ir.elekta.com/investors/press-releases/2012/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2012/elekta-appoints-ian-alexander-executive-vice-president-region-europe-africa-latin-america-and-middle-east/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-07-31/https://ir.elekta.com/investors/press-releases/2012/faster-more-accurate-cancer-treatments-on-horizon-in-japan-with-official-approval-of-elektas-agility-beam-shaping-innovation-for-radiation-therapy/https://ir.elekta.com/investors/press-releases/2012/elekta-to-incorporate-brainlab-patient-positioning-technology-in-therapy-systems-to-increase-comfort-for-patients-with-cancer/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-06-29/https://ir.elekta.com/investors/press-releases/2012/elekta-sees-several-opportunities-for-continued-strong-growth/https://ir.elekta.com/investors/press-releases/2012/elekta-strengthens-its-position-in-brazil-with-acquisition-of-radon-ltda/https://ir.elekta.com/investors/press-releases/2012/elektas-nomination-committee-proposal-for-the-election-of-board-of-directors-and-auditors-to-the-annual-general-meeting-2012/https://ir.elekta.com/investors/press-releases/2012/uks-nhs-supply-chain-signs-agreement-to-acquire-10-elekta-linear-accelerator-systems-for-cancer-treatment/https://ir.elekta.com/investors/press-releases/2012/us-patients-and-clinics-to-benefit-from-new-revolutionary-beam-shaping-device/https://ir.elekta.com/investors/press-releases/2012/elekta-announces-changes-to-its-executive-management/https://ir.elekta.com/investors/press-releases/2012/year-end-report-may--april-201112/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-05-31/https://ir.elekta.com/investors/press-releases/2012/the-us-oncology-network-to-standardize-on-elektas-mosaiq-oncology-information-system/https://ir.elekta.com/investors/press-releases/2012/invitation-to-elektas-full-year-report-conference-call/https://ir.elekta.com/investors/press-releases/2012/elekta-pioneers-modern-cancer-care-through-rd-leadership/https://ir.elekta.com/investors/press-releases/2012/invitation-to-elektas-capital-markets-day--june-19-2012-in-stockholm/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-04-30/https://ir.elekta.com/investors/press-releases/2012/elekta-announces-first-patients-treated-with-major-breakthrough-in-cancer-therapy/https://ir.elekta.com/investors/press-releases/2012/elektas-new-agility-mlc-solution-poised-to-revolutionize-beam-shaping-of-radiation-therapy-cancer-treatments/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-03-30/https://ir.elekta.com/investors/press-releases/2012/gamma-knife-radiosurgery-gets-nod-in-guinness-world-records-2012-edition-for-halting-growth-of-worlds-tallest-living-human/https://ir.elekta.com/investors/press-releases/2012/interim-report-may--january-201112/https://ir.elekta.com/investors/press-releases/2012/extraordinary-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-02-29/https://ir.elekta.com/investors/press-releases/2012/invitation-to-elektas-nine-month-interim-report-conference-call/https://ir.elekta.com/investors/press-releases/2012/number-of-outstanding-shares-in-elekta-ab-publ-2012-01-31/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2011/elekta-leading-in-emerging-markets/https://ir.elekta.com/investors/press-releases/2011/interim-report-may--october-201112/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-11-30/https://ir.elekta.com/investors/press-releases/2011/invitation-to-elektas-capital-markets-day-with-focus-on-emerging-markets-december-12-in-stockholm/https://ir.elekta.com/investors/press-releases/2011/invitation-to-elektas-six-month-interim-report-conference-call/https://ir.elekta.com/investors/press-releases/2011/elekta-high-resolution-quick-attachdetach-multi-leaf-collimator-will-facilitate-more-on-demand-stereotactic-treatments-in-the-clinic/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-10-31/https://ir.elekta.com/investors/press-releases/2011/elektas-board-member-vera-kallmeyer-has-passed-away/https://ir.elekta.com/investors/press-releases/2011/elektas-nomination-committee-for-the-annual-general-meeting-2012/https://ir.elekta.com/investors/press-releases/2011/growth-through-innovation-and-elektas-strategy-within-brachytherapy-solutions-highlighted-at-astro-investor-meeting/https://ir.elekta.com/investors/press-releases/2011/elekta-divests-its-anatomic-pathology-information-system/https://ir.elekta.com/investors/press-releases/2011/gilbert-wai-appointed-executive-vice-president-region-asia-pacific-and-member-of-elektas--executive-committee/https://ir.elekta.com/investors/press-releases/2011/nucletron-an-elekta-company-receives-fda-510k-clearance-for-precise-vaginal-ctmr-multi-channel-applicator/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-09-30/https://ir.elekta.com/investors/press-releases/2011/jos-lamers-appointed-member-of-elektas-executive-committee/https://ir.elekta.com/investors/press-releases/2011/elekta-completes-the-acquisition-of-nucletron/https://ir.elekta.com/investors/press-releases/2011/bulletin-from-elektas-annual-general-meeting-2011/https://ir.elekta.com/investors/press-releases/2011/regulatory-approval-for-elektas-acquisition-of-nucletron/https://ir.elekta.com/investors/press-releases/2011/interim-report-may--july-201112/https://ir.elekta.com/investors/press-releases/2011/invitation-elektas-interim-report-for-may-july-201112/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-08-31/https://ir.elekta.com/investors/press-releases/2011/elektas-annual-report-201011/https://ir.elekta.com/investors/press-releases/2011/invitation-elekta-capital-markets-day-at-astro-miami-october-3-2011/https://ir.elekta.com/investors/press-releases/2011/welcome-to-the-annual-general-meeting-of-shareholders-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-07-29/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-07-01/https://ir.elekta.com/investors/press-releases/2011/elektas-nomination-committees-proposal-to-the-annual-general-meeting-2011-regarding-composition-of-the-board-of-directors/https://ir.elekta.com/investors/press-releases/2011/elekta-to-acquire-nucletron-complementing-its-product-offering-with-world-leading-brachytherapy-technology/https://ir.elekta.com/investors/press-releases/2011/elekta-presents-priorities-for-continued-revenue-growth-and-profitability/https://ir.elekta.com/investors/press-releases/2011/elekta-to-accelerate-revenue-growth-and-sees-continued-strong-ebit-growth/https://ir.elekta.com/investors/press-releases/2011/year-end-report-may--april-201011/https://ir.elekta.com/investors/press-releases/2011/elekta-raises-debt-through-private-placement-of-200-million-usd/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-04-29/https://ir.elekta.com/investors/press-releases/2011/wake-forest-university-baptist-medical-center-chooses-elekta-for-major-oncology-upgrade/https://ir.elekta.com/investors/press-releases/2011/nine-month-interim-report-may--january-201011/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-02-28/https://ir.elekta.com/investors/press-releases/2011/number-of-outstanding-shares-in-elekta-ab-publ-2011-01-31/https://ir.elekta.com/investors/press-releases/2011/new-member-of-elektas-nomination-committee/https://ir.elekta.com/investors/press-releases/2010/number-of-outstanding-shares-in-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2010/elekta-signs-agreement-to-sell-stake-in-motala-verkstad-ab/https://ir.elekta.com/investors/press-releases/2010/elekta-signs-sales-and-marketing-agreement-with-toshiba-in-japan/https://ir.elekta.com/investors/press-releases/2010/six-month-interim-report-may--october-201011/https://ir.elekta.com/investors/press-releases/2010/number-of-outstanding-shares-in-elekta-ab-publ-2010-11-30/https://ir.elekta.com/investors/press-releases/2010/elektas-nomination-committee/https://ir.elekta.com/investors/press-releases/2010/china-expands-access-to-cancer-care-with-three-leksell-gamma-knife-systems/https://ir.elekta.com/investors/press-releases/2010/cancer-treatment-with-ultimate-precision-and-growth-drivers-highlighted-at-astro-investor-meeting/https://ir.elekta.com/investors/press-releases/2010/elekta-and-karolinska-university-hospital-to-collaborate-on-stereotactic-radiation-therapy-research/https://ir.elekta.com/investors/press-releases/2010/number-of-outstanding-shares-in-elekta-ab-publ-2010-11-01/https://ir.elekta.com/investors/press-releases/2010/number-of-shares-in-elekta/https://ir.elekta.com/investors/press-releases/2010/report-from-elektas-annual-general-meeting-2010/https://ir.elekta.com/investors/press-releases/2010/three-month-interim-report-may--july-201011/https://ir.elekta.com/investors/press-releases/2010/elektas-annual-report-200910/https://ir.elekta.com/investors/press-releases/2010/number-of-shares-in-elekta-2010-09-02/https://ir.elekta.com/investors/press-releases/2010/elekta-opens-south-korea-office-to-support-countrys-growing-cancer-management-needs/https://ir.elekta.com/investors/press-releases/2010/notice-of-annual-general-meeting-of-elekta-ab-publ/https://ir.elekta.com/investors/press-releases/2010/jan-secher-proposed-as-new-member-of-elekta-board-of-directors/https://ir.elekta.com/investors/press-releases/2010/repurchase-of-elekta-shares/https://ir.elekta.com/investors/press-releases/2010/year-end-report-may--april-200910/https://ir.elekta.com/investors/press-releases/2010/year-end-report-may--april-200910-2010-06-09/https://ir.elekta.com/investors/press-releases/2010/elektas-capital-markets-day-june-9/https://ir.elekta.com/investors/press-releases/2010/elekta-introduces-next-generation-meg-system-for-monitoring-the-brain-in-action/https://ir.elekta.com/investors/press-releases/2010/elekta-acquires-resonant-medical-inc-adding-new-solutions-for--image-guided-radiation-therapy-for-treating-cancer/https://ir.elekta.com/investors/press-releases/2010/invitation-elektas-year-end-report-and-capital-markets-day-june-9/https://ir.elekta.com/investors/press-releases/2010/swedish-cancer-institute-and-elekta-launch-renewed-partnership-agreement/https://ir.elekta.com/investors/press-releases/2010/todd-powell-new-executive-vice-president-of-elekta-software/https://ir.elekta.com/investors/press-releases/2010/karolinska-university-hospital-acquires-leksell-gamma-knife-perfexion-to-expand-radiosurgery-versatility-efficiency-in-brain-cancer-therapy/https://ir.elekta.com/investors/press-releases/2010/elekta-names-new-head-of-asia-pacific-organization/https://ir.elekta.com/investors/press-releases/2010/nine-month-interim-report-may--january-200910/https://ir.elekta.com/investors/press-releases/2010/nine-month-interim-report-may--january-200910-2010-03-10/https://ir.elekta.com/investors/press-releases/2010/invitation-elektas-interim-report-may-january-200910/https://ir.elekta.com/investors/press-releases/2009/elekta-wins-world-class-manufacturing-award/https://ir.elekta.com/investors/press-releases/2009/six-month-interim-report-may--october-200910/https://ir.elekta.com/investors/press-releases/2009/invitation-elektas-interim-report-may-october-200910/https://ir.elekta.com/investors/press-releases/2009/elektas-election-committee/https://ir.elekta.com/investors/press-releases/2009/elekta-presents-new-image-guidance-solutions-at-capital-markets-day-in-chicago-usa/https://ir.elekta.com/investors/press-releases/2009/elekta-continues-to-grow-in-key-emerging-markets-delivers-clinical-solutions-to-nine-cancer-clinics-in-russia/https://ir.elekta.com/investors/press-releases/2009/elekta-investor-meeting-at-astro-on-november-2-2009/https://ir.elekta.com/investors/press-releases/2009/elektas-radiosurgery-solutions-on-center-stage-at-2009-congress-of-neurological-surgeons-annual-meeting-extend-receives-fda-510k-clearance/https://ir.elekta.com/investors/press-releases/2009/elekta-investor-meeting-at-astro-on-november-2-2009-2009-10-14/https://ir.elekta.com/investors/press-releases/2009/massachusetts-general-hospital-selects-elekta-as-new-vendor-for-complete-cancer-treatment-solution/https://ir.elekta.com/investors/press-releases/2009/report-from-elektas-annual-meeting-2009/https://ir.elekta.com/investors/press-releases/2009/interim-report-may--july-200910/https://ir.elekta.com/investors/press-releases/2009/invitation-elektas-interim-report-may-july-200910/https://ir.elekta.com/investors/press-releases/2009/elektas-annual-report-200809/https://ir.elekta.com/investors/press-releases/2009/iba-selects-elekta-software-for-key-proton-therapy-site-in-prague/https://ir.elekta.com/investors/press-releases/2009/elekta-names-new-ceo-for-north-american-organization/https://ir.elekta.com/investors/press-releases/2009/notice-of-annual-general-meeting-of-elekta-ab/https://ir.elekta.com/investors/press-releases/2009/elekta-wins-multiple-order-of-elekta-systems-from-icesp-in-brasil-creates-center-for-training-and-product-development/https://ir.elekta.com/investors/press-releases/2009/procure-and-integris-choose-elekta-software-solutions/https://ir.elekta.com/investors/press-releases/2009/elekta-receives-fda-510-k-clearance-for-monaco-vmat-treatment-planning-solution/https://ir.elekta.com/investors/press-releases/2009/c-rad-sentinel-selected-as-elekta-preferred-solution-for-intra-fraction-motion-detection/https://ir.elekta.com/investors/press-releases/2009/elekta-and-swedfund-invest-in-cancer-care-in-developing-countries/https://ir.elekta.com/investors/press-releases/2009/elekta-provides-vmat-and-radiosurgery-solutions-for-new-jersey-health-system/https://ir.elekta.com/investors/press-releases/2009/elekta-signs-cooperative-agreement-with-swedish-export-credit-corporation/https://ir.elekta.com/investors/press-releases/2009/updated--elektas-capital-markets-day/https://ir.elekta.com/investors/press-releases/2009/year-end-report-may--april-200809/https://ir.elekta.com/investors/press-releases/2009/reminder-invitation-to-elektas-capital-markets-day/https://ir.elekta.com/investors/press-releases/2009/elekta-and-the-ottawa-hospital-forge-long-term-strategic-partnership-agreement/https://ir.elekta.com/investors/press-releases/2009/procure-treatment-centers-to-equip-chicago-facility-with-software-solutions-from-elekta/https://ir.elekta.com/investors/press-releases/2009/elekta-and-nucletron-combine-forces-to-market-leading-software/https://ir.elekta.com/investors/press-releases/2009/invitation-elektas-full-year-report-and-capital-markets-day/https://ir.elekta.com/investors/press-releases/2009/uk-cancer-centre-begins-innovative-radiotherapy-treatment-with-four-elekta-systems/https://ir.elekta.com/investors/press-releases/2009/elekta-chosen-to-deliver-sophisticated-brain-mapping-technology-to-the-mind-research-network/https://ir.elekta.com/investors/press-releases/2009/number-of-shares-in-elekta-as-of-march-31-2009/https://ir.elekta.com/investors/press-releases/2009/taiwan-treats-patient-with-new-cancer-fighting-radiotherapy-system-from-elekta/https://ir.elekta.com/investors/press-releases/2009/interim-report-may---january-200809/https://ir.elekta.com/investors/press-releases/2009/new-treatment-with-leksell-gamma-knife-perfexion-introduced-in-japan/https://ir.elekta.com/investors/press-releases/2009/m-d-anderson-cancer-center-acquires-leksell-gamma-knife-perfexion-for-targeted-brain-lesion-treatments/https://ir.elekta.com/investors/press-releases/2009/elekta-invitation-to-telephone-conference/https://ir.elekta.com/investors/press-releases/2009/revolutionary-treatment-option-offers-new-hope-to-russian-cancer-patients/https://ir.elekta.com/investors/press-releases/2009/cancer-patients-in-sweden-and-estonia-receive-faster-more-precise-radiation-therapy-treatments/https://ir.elekta.com/investors/press-releases/2009/elekta-has-received-approval-for-elekta-compact-in-china/https://ir.elekta.com/investors/press-releases/2008/leading-european-universities-choose-elekta-to-deliver-advanced-3d-brain-mapping-tool-for-research/https://ir.elekta.com/investors/press-releases/2008/elektas-head-of-region-asia-dead-in-plane-crash/https://ir.elekta.com/investors/press-releases/2008/interim-report-may--october-200809/https://ir.elekta.com/investors/press-releases/2008/elektas-election-committee/https://ir.elekta.com/investors/press-releases/2008/elekta-invitation-to-telephone-conference/https://ir.elekta.com/investors/press-releases/2008/invitation-to-telephone-conference/https://ir.elekta.com/investors/press-releases/2008/elekta-announces-installation-of-leksell-gamma-knife-perfexion-at-haukeland-university-hospital-in-norway/https://ir.elekta.com/investors/press-releases/2008/wake-forest-university-baptist-medical-center-ramps-up-cancer-treatment-capabilities-with-stereotactic-systems-from-elekta/https://ir.elekta.com/investors/press-releases/2008/elekta-commits-to-supporting-the-further-development-of-advanced-health-care-in-ukraine---donation-of-brain-surgery-system-in-the-presence-of-her-majesty-queen-silvia-of-sweden/https://ir.elekta.com/investors/press-releases/2008/clinicians-in-odense-denmark-first-in-scandinavia-to-offer-new-innovative-technology-from-elekta-for-faster-and-more-accurate-cancer-treatment/https://ir.elekta.com/investors/press-releases/2008/elekta-announces-availability-of-elekta-infinity-with-vmat-technology-for-fast-more-precise-treatment-of-cancer/https://ir.elekta.com/investors/press-releases/2008/report-from-elektas-annual-meeting-2008/https://ir.elekta.com/investors/press-releases/2008/thompson-cancer-survival-center-to-take-cancer-program-to-the-next-level-with-purchase-of-elekta-infinity-treatment-system/https://ir.elekta.com/investors/press-releases/2008/elekta-extends-its-line-of-stereotactic-treatment-solutions-at-2008-congress-of-neurological-surgeons-annual-meeting/https://ir.elekta.com/investors/press-releases/2008/interim-report-may--july-200809/https://ir.elekta.com/investors/press-releases/2008/elekta-announces-next-generation-radiation-treatment-technologies-at-estro-27/https://ir.elekta.com/investors/press-releases/2008/elektas-annual-report-200708/https://ir.elekta.com/investors/press-releases/2008/notice-of-annual-general-meeting-of-elekta-ab/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-august-29-2008/https://ir.elekta.com/investors/press-releases/2008/cms-inc-an-elekta-company-announces-first-cancer-patients-treated-with-monaco-radiation-treatment-planning-system/https://ir.elekta.com/investors/press-releases/2008/invitation-to-investor-meeting/https://ir.elekta.com/investors/press-releases/2008/invitation-to-telephone-conference-2008-08-22/https://ir.elekta.com/investors/press-releases/2008/skagit-valley-hospital-regional-cancer-care-center-enhances-patient-care-with-elekta-axesse/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-july-31-2008/https://ir.elekta.com/investors/press-releases/2008/seattles-swedish-cancer-institute-first-in-us-to-treat-cancer-patient-with-elekta-vmat/https://ir.elekta.com/investors/press-releases/2008/elekta-investor-meeting-22-september-2008/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-june-30-2008/https://ir.elekta.com/investors/press-releases/2008/elekta-vmat-510k-clearance-welcomed-by-us-radiation-oncologists/https://ir.elekta.com/investors/press-releases/2008/year-end-report-may--april-200708/https://ir.elekta.com/investors/press-releases/2008/elekta-and-mary-bird-perkins-cancer-center-sign-strategic-multi-center-radiation-therapy-systems-agreement/https://ir.elekta.com/investors/press-releases/2008/reminder-elekta-full-year-report-and-investor-meeting/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-may-30-2008/https://ir.elekta.com/investors/press-releases/2008/leksell-gamma-knife-perfexion-receives-regulatory-approval-in-japan/https://ir.elekta.com/investors/press-releases/2008/elekta-sees-record-attendance-and-record-number-of-submitted-abstracts-at-international-leksell-gamma-knife-society-meeting-in-quebec-canada/https://ir.elekta.com/investors/press-releases/2008/australian-safety-agency-orders-elekta-synergy-as-gold-standard-for-calibration-and-dosimetry/https://ir.elekta.com/investors/press-releases/2008/invitation-elekta-full-year-report-and-investor-meeting/https://ir.elekta.com/investors/press-releases/2008/elekta-receives-an-order-to-deliver-comprehensive-suite-of-advanced-cancer-treatment-technologies-to-new-center-in-sydney-including-the-first-leksell-gamma-knife-to-be-installed-in-australia/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-april-30-2008/https://ir.elekta.com/investors/press-releases/2008/elekta-announces-first-linear-accelerator-order-in-new-zealand/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-march-31-2008/https://ir.elekta.com/investors/press-releases/2008/nine-month-interim-report-may--january-200708/https://ir.elekta.com/investors/press-releases/2008/elekta-completes-the-acquisition-of-cms/https://ir.elekta.com/investors/press-releases/2008/number-of-shares-in-elekta-as-of-february-29-2008/https://ir.elekta.com/investors/press-releases/2008/elekta-chosen-to-deliver-advanced-3-d-brain-mapping-technology-as-part-of-collaboration-with-leading-french-brain-imaging-facility/https://ir.elekta.com/investors/press-releases/2008/elekta-9-months-report-and-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2008/elekta-signs-agreement-to-acquire-cms/https://ir.elekta.com/investors/press-releases/2008/elekta-chosen-to-deliver-sophisticated-brain-mapping-technology-to-the-nebraska-medical-center/https://ir.elekta.com/investors/press-releases/2008/elekta-has-repurchased-own-shares-for-sek-100-m/https://ir.elekta.com/investors/press-releases/2008/elekta-users-first-to-treat-patients-with-volumetric-intensity-modulated-arc-therapy-vmat/https://ir.elekta.com/investors/press-releases/2008/webcast-of-presentation-by-elektas-ceo-tomas-puusepp-on-february-6/https://ir.elekta.com/investors/press-releases/2008/invitation-to-investor-day-in-crawley-uk-march-12/https://ir.elekta.com/investors/press-releases/2008/elekta-initiates-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2008/procure-selects-impac-as-provider-of-oncology-information-systems/https://ir.elekta.com/investors/press-releases/2008/elektas-board-decides-to-repurchase-own-shares-and-adjust-net-debtequity-objective/https://ir.elekta.com/investors/press-releases/2008/elekta-to-supply-chu-de-poitiers-hospital-center-in-france-with-advanced-technology-for-image-guided-radiation-therapy/https://ir.elekta.com/investors/press-releases/2008/elekta-announces-first-two-clinical-sites-using-vmat-cancer-treatment-capability/https://ir.elekta.com/investors/press-releases/2008/elekta-negotiates-to-acquire-cms/https://ir.elekta.com/investors/press-releases/2007/elekta-ab---six-month-interim-report-may--october-200708/https://ir.elekta.com/investors/press-releases/2007/number-of-shares-in-elekta-as-of-november-30-2007/https://ir.elekta.com/investors/press-releases/2007/elektas-founder-and-executive-director-laurent-leksell-awarded-entrepreneur-of-the-year--will-represent-sweden-in-the-world-final/https://ir.elekta.com/investors/press-releases/2007/elekta-6-months-report-and-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2007/belgian-cancer-patients-to-receive-state-of-the-art-radiation-therapy-treatments-with-new-technology-from-elekta/https://ir.elekta.com/investors/press-releases/2007/number-of-shares-in-elekta-as-of-october-31-2007/https://ir.elekta.com/investors/press-releases/2007/beaumont-hospital-royal-oak-treats-its-first-patients-with-elekta-axesse/https://ir.elekta.com/investors/press-releases/2007/elekta-announces-elekta-infinity--a-new-system-for-faster-and-more-precise-treatment-of-cancer-tumors/https://ir.elekta.com/investors/press-releases/2007/iba-and-elekta-initiate-global-particle-therapy-program-at-astro/https://ir.elekta.com/investors/press-releases/2007/elekta-announces-clinical-start-up-of-new-leksell-gamma-knife-perfexion-at-upmc/https://ir.elekta.com/investors/press-releases/2007/elekta-announces-new-cancer-care-solutions-and-highlights-personalized-efficiency-at-astro-2007/https://ir.elekta.com/investors/press-releases/2007/elektas-election-committee-appointed/https://ir.elekta.com/investors/press-releases/2007/finding-hope-for-autism--new-brain-research-technology-centre-opened-by-hrh-princess-anne/https://ir.elekta.com/investors/press-releases/2007/niguarda-hospital-in-milan-italy-will-commence-stereotactic-radiosurgery-treatments-with-leksell-gamma-knife-perfexion-from-elekta/https://ir.elekta.com/investors/press-releases/2007/number-of-shares-in-elekta-as-of-september-28-2007/https://ir.elekta.com/investors/press-releases/2007/elekta-wins-tender-to-supply-new-hospital-in-austria-a-with-comprehensive-solution-for-advanced-radiation-therapy/https://ir.elekta.com/investors/press-releases/2007/save-the-dates--elekta-investor-events-autumn-and-winter-2007-08/https://ir.elekta.com/investors/press-releases/2007/elekta-selected-to-supply-advanced-radiation-therapy-capability-to-greeces-largest-private-hospital/https://ir.elekta.com/investors/press-releases/2007/elekta-annual-general-meeting-2007/https://ir.elekta.com/investors/press-releases/2007/two-new-italian-cancer-centers-select-advanced-radiation-treatment-technology-from-elekta/https://ir.elekta.com/investors/press-releases/2007/elekta-ab---three-month-interim-report-may--july-200708/https://ir.elekta.com/investors/press-releases/2007/elekta-q1-report-and-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2007/elekta-annual-report-200607-published/https://ir.elekta.com/investors/press-releases/2007/elekta-ab-publ---annual-report-200607/https://ir.elekta.com/investors/press-releases/2007/elekta-launches-new-linear-accelerator-at-2007-estro-to-expand-cancer-treatment-availability/https://ir.elekta.com/investors/press-releases/2007/number-of-shares-in-elekta-as-of-august-31-2007/https://ir.elekta.com/investors/press-releases/2007/correction-to-notice-to-attend-annual-general-meeting-in-elekta/https://ir.elekta.com/investors/press-releases/2007/elekta-investor-event--save-the-date/https://ir.elekta.com/investors/press-releases/2007/notice-to-attend-annual-general-meeting-in-elekta/https://ir.elekta.com/investors/press-releases/2007/johns-hopkins-to-add-elekta-synergy-s-to-cancer-treatment-lineup/https://ir.elekta.com/investors/press-releases/2007/barnes-jewish-hospital-upgrades-radiosurgery-capabilities-with-leksell-gamma-knife-perfexion/https://ir.elekta.com/investors/press-releases/2007/elekta-to-deliver-leksell-gamma-knife-to-st-petersburg-russia/https://ir.elekta.com/investors/press-releases/2007/elekta-q1-report-teleconference-and-quiet-period/https://ir.elekta.com/investors/press-releases/2007/number-of-shares-in-elekta-as-of-july-31-2007/https://ir.elekta.com/investors/press-releases/2007/gamma-knife-surgery-best-choice-says-cancer-patient/https://ir.elekta.com/investors/press-releases/2007/elekta-has-repurchased-own-shares-for-sek-100-m/https://ir.elekta.com/investors/press-releases/2007/cancer-patients-in-new-south-wales-australia-to-receive-advanced-image-guided-radiation-therapy-treatments-with-arrival-of-new-elekta-linear-accelerators/https://ir.elekta.com/investors/press-releases/2007/elekta-initiates-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2007/elektas-board-decides-on-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2007/elekta-selected-to-supply-the-royal-marsden-hospital-in-london-uk-with-additional-advanced-radiation-therapy-systems/https://ir.elekta.com/investors/press-releases/2007/as-medical-radiation-exposure-rises-lowering-peripheral-dose-from-radiosurgery-takes-on-new-importance/https://ir.elekta.com/investors/press-releases/2007/leksell-gamma-knife-perfexion-setting-new-standards-for-fast-effective-precise-radiosurgery-treatments/https://ir.elekta.com/investors/press-releases/2007/year-end-report-1-may--30-april-200607/https://ir.elekta.com/investors/press-releases/2007/reminder-elekta-capital-markets-day-in-stockholm-on-june-14-2007/https://ir.elekta.com/investors/press-releases/2007/elekta-year-end-report-and-capital-markets-day-on-june-14/https://ir.elekta.com/investors/press-releases/2007/new-gamma-knife-center-in-lisbon-portugal-orders-leksell-gamma-knife-perfexion-from-elekta/https://ir.elekta.com/investors/press-releases/2007/elekta-neuromag-and-innokas-medical-in-agreement-on-production-outsourcing/https://ir.elekta.com/investors/press-releases/2007/elekta-to-supply-leading-igrt-solution-to-vejle-hospital-in-denmark/https://ir.elekta.com/investors/press-releases/2007/elekta-finalizes-the-acquisition-of-3d-line-medical-systems/https://ir.elekta.com/investors/press-releases/2007/elekta-finalizes-the-acquisition-of-3d-line-medical-systems-2007-05-03/https://ir.elekta.com/investors/press-releases/2007/elekta-receives-order-to-deliver-the-first-leksell-gamma-knifer-perfexion-to-india/https://ir.elekta.com/investors/press-releases/2007/elekta-initiatives-will-increase-access-to-gamma-knife-surgery-the-gold-standard-in-radiosurgery/https://ir.elekta.com/investors/press-releases/2007/elekta-refinances-5-year-credit-facility/https://ir.elekta.com/investors/press-releases/2007/elekta-acquires-3d-line-medical-systems/https://ir.elekta.com/investors/press-releases/2007/elekta-has-repurchased-own-shares-for-sek-100-m-2007-03-19/https://ir.elekta.com/investors/press-releases/2007/elekta-initiates-repurchase-of-own-shares-2007-03-13/https://ir.elekta.com/investors/press-releases/2007/university-of-tokyo-hospital-commence-treatment-with-japans-first-system-for-advanced-image-guided-radiation-therapy/https://ir.elekta.com/investors/press-releases/2007/elektas-board-decides-on-repurchase-of-own-shares-2007-03-09/https://ir.elekta.com/investors/press-releases/2007/elekta-ab---nine-month-interim-report-may--january-200607/https://ir.elekta.com/investors/press-releases/2007/elekta-chosen-to-deliver-sophisticated-brain-mapping-technology-to-university-clinic-in-jena-germany/https://ir.elekta.com/investors/press-releases/2007/elekta-q3-report-and-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2007/the-london-gamma-knife-centre-to-install-leksell-gamma-knife-perfexion--more-patients-to-benefit-from-radiosurgery/https://ir.elekta.com/investors/press-releases/2007/landeskrankenhaus-feldkirch-will-bring-new-hope-to-cancer-patients-in-western-austria-with-the-help-of-elekta-technology-and-software-solutions/https://ir.elekta.com/investors/press-releases/2007/velindre-cancer-centre-will-improve-cancer-care-for-patients-in-wales-using-elekta-synergy-image-guided-radiation-therapy-systems/https://ir.elekta.com/investors/press-releases/2007/elekta-to-deliver-leksell-gamma-knife-perfexion-to-upmc/https://ir.elekta.com/investors/press-releases/2006/arden-cancer-center-to-benefit-from-clinical-decision-support-systems-from-impac-medical-systems-and-first-databank-europe/https://ir.elekta.com/investors/press-releases/2006/elektas-nomination-committee-appointed/https://ir.elekta.com/investors/press-releases/2006/six-month-interim-report-may--october-200607/https://ir.elekta.com/investors/press-releases/2006/nih-funded-study-harnesses-elekta-technologies-to-explore-lung-tumor-motion/https://ir.elekta.com/investors/press-releases/2006/leading-toronto-cancer-center-to-streamline-radiation-therapy-with-elekta-synergy-and-impac-oncology-pacs/https://ir.elekta.com/investors/press-releases/2006/elektas-chairman-akbar-seddigh-awarded-the-golden-gavel-for-meritorious-chairmanship/https://ir.elekta.com/investors/press-releases/2006/elekta-6-months-report-to-be-published-on-dec-12---invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2006/elekta-selected-to-equip-new-uk-cancer-center-in-30-year-pfi-contract/https://ir.elekta.com/investors/press-releases/2006/elekta-to-deliver-four-leksell-gamma-knife-perfexion-to-customers-of-american-shared-hospital-services-gamma-knife-financing-unit/https://ir.elekta.com/investors/press-releases/2006/elekta-and-impac-users-at-astro-discuss-how-technology-advancements-for-cancer-management-are-shaping-clinical-practice/https://ir.elekta.com/investors/press-releases/2006/reminder/https://ir.elekta.com/investors/press-releases/2006/elekta-to-install-the-first-leksell-gamma-knife-in-kuwait/https://ir.elekta.com/investors/press-releases/2006/elekta-wins-tender-to-deliver-sophisticated-3-d-brain-mapping-technology-to-leading-german-institution/https://ir.elekta.com/investors/press-releases/2006/elekta-selected-to-deliver-four-advanced-radiation-therapy-systems-to-ireland/https://ir.elekta.com/investors/press-releases/2006/elekta-investor-meeting-at-astro-on-november-6-2006/https://ir.elekta.com/investors/press-releases/2006/alexian-brothers-purchase-elekta-neuromag-the-world-leading-technology-for-real-time-mapping-of-brain-activities/https://ir.elekta.com/investors/press-releases/2006/community-clinic-uses-imaging-equipped-elekta-treatment-system-to-zero-in-on-cancer/https://ir.elekta.com/investors/press-releases/2006/elekta-annual-general-meeting-2006/https://ir.elekta.com/investors/press-releases/2006/three-month-interim-report-may--july-200607/https://ir.elekta.com/investors/press-releases/2006/elekta-annual-report-200506-published/https://ir.elekta.com/investors/press-releases/2006/elekta-ab-publ---annual-report-200506/https://ir.elekta.com/investors/press-releases/2006/elekta-to-deliver-leksell-gamma-knife-perfexion-to-university-of-virginia/https://ir.elekta.com/investors/press-releases/2006/elekta-q1-report-and-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2006/elekta-signs-agreement-with-us-oncology/https://ir.elekta.com/investors/press-releases/2006/elekta-finalizes-the-acquisition-of-80-percent-of-bmei/https://ir.elekta.com/investors/press-releases/2006/elekta-receives-fda-clearance-for-leksell-gamma-knife-perfexion/https://ir.elekta.com/investors/press-releases/2006/notice-to-attend-annual-general-meeting-in-elekta/https://ir.elekta.com/investors/press-releases/2006/elekta-to-deliver-leksell-gamma-knife-perfexion-to-cromwell-hospital-in-london-uk/https://ir.elekta.com/investors/press-releases/2006/elekta-receives-us-regulatory-approval-for-treatment-planning-on-leksell-gamma-knife-perfexion/https://ir.elekta.com/investors/press-releases/2006/first-patient-treated-with-new-leksell-gamma-knife-perfexion/https://ir.elekta.com/investors/press-releases/2006/elekta-have-repurchased-own-shares-for-sek-100-m/https://ir.elekta.com/investors/press-releases/2006/elekta-selected-to-upgrade-and-expand-the-cancer-treatment-facilities-at-odense-university-hospital-in-denmark/https://ir.elekta.com/investors/press-releases/2006/elekta-initiates-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2006/elektas-board-decides-on-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2006/elekta-synergy-receives-regulatory-approval-in-japan-and-first-deliveries-to-be-effected-immediately/https://ir.elekta.com/investors/press-releases/2006/year-end-report-1-may---30-april-200506/https://ir.elekta.com/investors/press-releases/2006/elekta-year-end-report-and-capital-markets-day/https://ir.elekta.com/investors/press-releases/2006/elekta-sets-new-standard-in-stereotactic-radiosurgery-by-introducing-leksell-gamma-knifer-perfexion/https://ir.elekta.com/investors/press-releases/2006/elekta-convenes-300-neurosurgeons-radiation-oncologists-and-leksell-gamma-knife-users-in-seoul-korea/https://ir.elekta.com/investors/press-releases/2006/elekta-investor-events--save-the-dates/https://ir.elekta.com/investors/press-releases/2006/elekta-chosen-by-five-uk-hospitals-in-nhs-investment-wave/https://ir.elekta.com/investors/press-releases/2006/elekta-extends-long-standing-development-relationship-with-upmc-through-elekta-axesse/https://ir.elekta.com/investors/press-releases/2006/elekta-to-deliver-multiple-elekta-synergy-systems-to-providence-health-system-in-the-us/https://ir.elekta.com/investors/press-releases/2006/change-of-guard-at-elekta-ir-in-north-america/https://ir.elekta.com/investors/press-releases/2006/elekta-receives-multiple-elekta-synergy-orders-from-australia/https://ir.elekta.com/investors/press-releases/2006/elekta-introduces-new-image-guided-stereotactic-solution-to-expand-product-range-for-treating-cancers-in-the-brain-spine-and-body/https://ir.elekta.com/investors/press-releases/2006/elekta-chosen-to-deliver-complete-oncology-it-solution-to-top-london-hospitals/https://ir.elekta.com/investors/press-releases/2006/elekta-to-deliver-sophisticated-3-d-brain-mapping-technology-to-leading-uk-institution/https://ir.elekta.com/investors/press-releases/2006/elekta-strengthens-stereotactic-planning-portfolio/https://ir.elekta.com/investors/press-releases/2006/elekta-acquires-bmei-the-leading-domestic-chinese-supplier-of-radiation-therapy-equipment/https://ir.elekta.com/investors/press-releases/2006/elekta-demonstrates-excellence-in-service-according-to-study-among-us-radiation-oncology-centers/https://ir.elekta.com/investors/press-releases/2006/elekta-and-warsaw-cancer-center-secure-advanced-cancer-treatments-for-patients-in-poland/https://ir.elekta.com/investors/press-releases/2006/interim-report-for-the-nine-month-period-may-1---january-31-200506/https://ir.elekta.com/investors/press-releases/2006/elekta-capital-markets-day-in-new-york-on-march-15-2006/https://ir.elekta.com/investors/press-releases/2006/elekta-reports-an-operating-margin-of-9-percent-for-the-third-quarter--operating-margin-of-about-10-percent-expected-for-full-year/https://ir.elekta.com/investors/press-releases/2006/elekta---invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2006/elekta-contracts-give-medassets-supply-chain-systems-customers-access-to-leading-radiation-oncology-and-oncology-it-solutions/https://ir.elekta.com/investors/press-releases/2006/elekta-investor-events--save-the-dates-2006-02-03/https://ir.elekta.com/investors/press-releases/2006/elekta-receive-order-for-complete-impac-it-solution-to-university-hospitals-coventry--warwickshire-nhs-trust/https://ir.elekta.com/investors/press-releases/2006/elektas-advanced-solutions-for-radiation-therapy-now-available-for-cancer-patients-in-hong-kong/https://ir.elekta.com/investors/press-releases/2006/elektas-nomination-committee-appointed-2006-01-16/https://ir.elekta.com/investors/press-releases/2006/university-of-florida-shands-cancer-center-gives-new-hope-to-spine-tumor-patients/https://ir.elekta.com/investors/press-releases/2005/elekta-to-deliver-leksell-gamma-knife-to-vietnam/https://ir.elekta.com/investors/press-releases/2005/interim-report-for-the-six-month-period-may-1---october-31-2005/https://ir.elekta.com/investors/press-releases/2005/elekta-receive-order-for-complete-impac-it-solution-throughout-generidis-network-of-private-radiation-oncology-centers/https://ir.elekta.com/investors/press-releases/2005/elekta-acquires-medical-intelligence/https://ir.elekta.com/investors/press-releases/2005/invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2005/invitation-to-teleconference-2005-11-24/https://ir.elekta.com/investors/press-releases/2005/elekta-receives-orders-for-the-latest-generation-leksell-gamma-knife--in-india/https://ir.elekta.com/investors/press-releases/2005/elekta-receives-regulatory-approval-in-japan-for-leksell-gamma-knife-4c/https://ir.elekta.com/investors/press-releases/2005/elekta-and-impac-users-demonstrate-clinical-advancements-at-astro--new-integrated-workflow-environment-for-igrt-introduced/https://ir.elekta.com/investors/press-releases/2005/elekta-carries-outs-31-share-split/https://ir.elekta.com/investors/press-releases/2005/elektas-image-guided-treatment-solutions-receive-regulatory-approval-in-canada/https://ir.elekta.com/investors/press-releases/2005/reminder-elekta-capital-markets-day-at-astro-on-october-17-2005/https://ir.elekta.com/investors/press-releases/2005/elekta-solutions-dominate-igrt-presentations-at-major-european-radiation-therapy-meeting/https://ir.elekta.com/investors/press-releases/2005/elekta-announces-new-chief-executive-officer-for-impac---former-ceo-and-founder-appointed-executive-vice-president-product-creation-for-the-entire-elekta-group/https://ir.elekta.com/investors/press-releases/2005/elekta-signs-exclusive-five-year-contract-with-providence-health-system/https://ir.elekta.com/investors/press-releases/2005/elekta-annual-general-meeting-2005/https://ir.elekta.com/investors/press-releases/2005/interim-report-for-the-three-month-period-may-1july-31-2005/https://ir.elekta.com/investors/press-releases/2005/elekta-capital-markets-day-at-astro-on-october-17-2005/https://ir.elekta.com/investors/press-releases/2005/elekta-annual-report-200405-published/https://ir.elekta.com/investors/press-releases/2005/elekta-ab-publ---annual-report-200405/https://ir.elekta.com/investors/press-releases/2005/elekta-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2005/elekta-signs-a-private-placement-agreement-with-us-institutional-investors/https://ir.elekta.com/investors/press-releases/2005/notice-to-attend-annual-general-meeting-in-elekta/https://ir.elekta.com/investors/press-releases/2005/elekta-announces-the-next-generation-of-elekta-synergy-with-510k-clearance-of-enhanced-workflow-tools-for-4d-adaptive-igrt/https://ir.elekta.com/investors/press-releases/2005/elekta-demonstrates-superior-quality-in-igrt-at-physicist-meeting/https://ir.elekta.com/investors/press-releases/2005/elekta-and-medical-intelligence-form-international-distribution-partnership-creating-complete-solutions-for-stereotactic-radiation-treatments/https://ir.elekta.com/investors/press-releases/2005/elekta-establishes-new-financial-objectives-and-proposes-dividend-of-sek-660/https://ir.elekta.com/investors/press-releases/2005/report-on-operations-in-the-year-ended-april-30-2005/https://ir.elekta.com/investors/press-releases/2005/elekta-to-deliver-10-linear-accelerators-within-program-to-multiply-public-radiation-therapy-capacity-in-venezuela/https://ir.elekta.com/investors/press-releases/2005/elekta-and-impac-selected-by-french-hospital-to-deliver-comprehensive-treatment-management-solution/https://ir.elekta.com/investors/press-releases/2005/elekta-year-end-report-and-capital-markets-day/https://ir.elekta.com/investors/press-releases/2005/elekta-selected-by-canadian-world-leader-in-cancer-treatment/https://ir.elekta.com/investors/press-releases/2005/tomas-puusepp-assumes-position-as-president--ceo-of-elekta--new-managers-appointed-for-global-sales-and-for-market-region-europe/https://ir.elekta.com/investors/press-releases/2005/elekta-reinforces-leadership-position-in-neurosurgery-at-aans/https://ir.elekta.com/investors/press-releases/2005/elekta-invites-you-to-a-capital-markets-day-in-stockholm-on-june-16/https://ir.elekta.com/investors/press-releases/2005/elektas-nomination-committee-appointed/https://ir.elekta.com/investors/press-releases/2005/elekta-invites-you-to-aans-in-new-orleans/https://ir.elekta.com/investors/press-releases/2005/elekta-ab-acquires-impac-medical-systems-inc/https://ir.elekta.com/investors/press-releases/2005/elekta--impac-announce-expiration-of-hart-scott-rodino-waiting-period/https://ir.elekta.com/investors/press-releases/2005/elekta-neuromag-receives-regulatory-approval-in-canada/https://ir.elekta.com/investors/press-releases/2005/elekta-synergy-to-enhance-treatment-at-leading-dutch-cancer-institute/https://ir.elekta.com/investors/press-releases/2005/elekta---interim-report-for-the-nine-month-period-may-1-2004---january-31-200405/https://ir.elekta.com/investors/press-releases/2005/elekta--impac-provide-update-on-proposed-merger/https://ir.elekta.com/investors/press-releases/2005/elekta-invitation-to-teleconference-2005-03-01/https://ir.elekta.com/investors/press-releases/2005/elekta-neuromag-to-enhance-brain-research-at-ucsd/https://ir.elekta.com/investors/press-releases/2005/elekta-chosen-as-supplier-of-meg-systems-to-leading-institutions-in-united-kingdom-japan-and-china/https://ir.elekta.com/investors/press-releases/2005/elekta-have-repurchased-own-shares-for-sek-50-m/https://ir.elekta.com/investors/press-releases/2005/elekta-initiates-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2005/elekta-invitation-to-investor-events/https://ir.elekta.com/investors/press-releases/2005/elekta-ab-to-acquire-impac-medical-systems-inc/https://ir.elekta.com/investors/press-releases/2005/elekta-investor-teleconference-2005-01-18-at-1000-am-swedish-time/https://ir.elekta.com/investors/press-releases/2004/elektas-board-decides-on-repurchase-of-own-shares/https://ir.elekta.com/investors/press-releases/2004/elekta---interim-report-for-the-six-month-period-may-1--october-31-200405/https://ir.elekta.com/investors/press-releases/2004/elekta-invitation-to-teleconference/https://ir.elekta.com/investors/press-releases/2004/elekta-to-deliver-advanced-brain-research-equipment-to-seoul-national-university-hospital/https://ir.elekta.com/investors/press-releases/2004/elekta-chosen-as-solution-partner-in-uks-largest-ever-cancer-centre-pfi/https://ir.elekta.com/investors/press-releases/2004/elekta-emerges-as-clear-leader-in-igrt-at-astro-annual-meeting/https://ir.elekta.com/investors/press-releases/2004/elekta-and-impac-medical-systems-announce-sales-consulting-agreement/https://ir.elekta.com/investors/press-releases/2004/elekta-introduces-disease-focused-solutions-to-improve-cancer-treatment/https://ir.elekta.com/investors/press-releases/2004/elekta-capital-established-to-provide-financing-solutions-for-advanced-clinical-solutions/https://ir.elekta.com/investors/press-releases/2004/elektas-annual-general-meeting-2004/https://ir.elekta.com/investors/press-releases/2004/elektas-president--ceo-dr-laurent-leksell-assumes-new-role-as-executive-director---tomas-puusepp-appointed-new-preside/https://ir.elekta.com/investors/press-releases/2004/interim-report-for-the-three-month-period-may-1-july-31-2004/https://ir.elekta.com/investors/press-releases/2004/elekta-invitation-to-capital-markets-day-at-astro-5-october-2004/https://ir.elekta.com/investors/press-releases/2004/elekta-annual-report-200304-published/https://ir.elekta.com/investors/press-releases/2004/annual-report-2003-2004/https://ir.elekta.com/investors/press-releases/2004/elekta-invitation-to-investor-events/https://ir.elekta.com/investors/press-releases/2004/elektas-board-of-directors-proposes-share-unit-option-plan/https://ir.elekta.com/investors/press-releases/2004/notice-to-attend-annual-general-meeting-in-elekta---proposals-for-share-repurchase-and-share-unit-plan/https://ir.elekta.com/investors/press-releases/2004/elekta-to-enhance-cancer-treatment-accuracy-with-addition-of--ultrasound-targeting-from-north-american-scientific/https://ir.elekta.com/investors/press-releases/2004/upmc-expands-neurosurgery-leadership-by-acquiring-elekta-neuromag-meg-system/https://ir.elekta.com/investors/press-releases/2004/clinic-set-to-maximize-clinical-availability-and-performance-with-elekta-intellimax/https://ir.elekta.com/investors/press-releases/2004/elekta-wins-major-oncology-contract-with-leading-gpo/https://ir.elekta.com/investors/press-releases/2004/us-top-group-purchasing-organizations-trust-elekta-for-life-saving-solutions/https://ir.elekta.com/investors/press-releases/2004/elekta-establish-new-subsidiary-in-australia/https://ir.elekta.com/investors/press-releases/2004/elekta-signs-preferred-provider-contract-with-consorta/https://ir.elekta.com/investors/press-releases/2004/elekta-will-establish-international-research-centers-for-elekta-neuromag-magnetoencephalography-systems/https://ir.elekta.com/investors/press-releases/2004/elekta-will-establish-international-research-centers-for-elekta-neuromag-magnetoencephalography-systems-2004-06-22/https://ir.elekta.com/investors/press-releases/2004/us-district-court-declares-case-closed-in-elekta-patent-case/https://ir.elekta.com/investors/press-releases/2004/report-on-operations-in-the-year-ended-april-30-2004/https://ir.elekta.com/investors/press-releases/2004/new-hope-in-the-increasing-battle-against-glaucoma/https://ir.elekta.com/investors/press-releases/2004/new-hope-in-the-increasing-battle-against-glaucoma-2004-06-15/https://ir.elekta.com/investors/press-releases/2004/report-on-operations-in-the-year-ended-april-30-2004-2004-06-15/https://ir.elekta.com/investors/press-releases/2004/year-end-report-on-operations-may-1---april-30-200304/https://ir.elekta.com/investors/press-releases/2004/reminder-elekta-releases-full-year-report-may---april-200304-and-conduct-capital-markets-day-on-june-15-2004/https://ir.elekta.com/investors/press-releases/2004/elektas-nomination-committee-appointed/https://ir.elekta.com/investors/press-releases/2004/elekta-receives-award-for-export-achievements/https://ir.elekta.com/investors/press-releases/2004/invitation-elekta-releases-full-year-report-may---april-200304-and-conduct-capital-markets-day-on-june-15-2004/https://ir.elekta.com/investors/press-releases/2004/elekta-unveils-new-treatment-solutions-at-aans/https://ir.elekta.com/investors/press-releases/2004/elekta-unveils-new-treatment-solutions-at-aans-2004-04-30/https://ir.elekta.com/investors/press-releases/2004/elekta-invites-you-to-aans-in-orlando/https://ir.elekta.com/investors/press-releases/2004/elekta-appoints-new-head-of-north-american-operations/https://ir.elekta.com/investors/press-releases/2004/we-are-updating-our-contact-lists-for-press-releases-and-reports/https://ir.elekta.com/investors/press-releases/2004/elekta-receives-regulatory-approval-in-japan-for-latest-model-of-leksell-gamma-knife/https://ir.elekta.com/investors/press-releases/2004/elekta-receives-notification-that-the-us-supreme-court-denies-opponents-petition-in-patent-dispute/https://ir.elekta.com/investors/press-releases/2004/elekta-to-deliver-first-leksell-gamma-knife-unit-to-russia/https://ir.elekta.com/investors/press-releases/2004/elekta-will-supply-uc-davis-cancer-center-radiation-oncology-with-the-next-generation-radiation-treatment-system/https://ir.elekta.com/investors/press-releases/2004/elekta-receives-achievement-award-for-corporate-excellence/https://ir.elekta.com/investors/press-releases/2004/interim-report-for-the-nine-month-period-may-1---january-31-200304/https://ir.elekta.com/investors/press-releases/2004/elekta---payment-for-share-redemption/https://ir.elekta.com/investors/press-releases/2004/elektas-opponent-in-patent-dispute-files-petition-to-us-supreme-court/https://ir.elekta.com/investors/press-releases/2003/elekta-helps-build-advanced-healthcare-in-iraq/https://ir.elekta.com/investors/press-releases/2003/interim-report-for-the-six-month-period-may-1---october-31-2003-2003-12-08/https://ir.elekta.com/investors/press-releases/2003/elekta-and-impac-medical-systems-agree-to-jointly-develop-dicom-rt-linear-accelerator-interface/https://ir.elekta.com/investors/press-releases/2003/elektas-share-redemption-program-concluded/https://ir.elekta.com/investors/press-releases/2003/elekta-signs-provider-contract-with-catholic-health-east/https://ir.elekta.com/investors/press-releases/2003/elektas-opponent-in-us-patent-dispute-denied-reconsideration/https://ir.elekta.com/investors/press-releases/2003/elekta-receives-fda-clearance-for-elekta-synergy-tm/https://ir.elekta.com/investors/press-releases/2003/elektas-revolution-encourages-radiotherapy-evolution/https://ir.elekta.com/investors/press-releases/2003/elekta-installs-breakthrough-treatment-platform-at-thomas-jefferson-university-in-philadelphia-usa/https://ir.elekta.com/investors/press-releases/2003/elekta-invites-you-to-astro/https://ir.elekta.com/investors/press-releases/2003/elekta-recieves-favorable-ruling-in-us-patent-dispute/https://ir.elekta.com/investors/press-releases/2003/elektas-annual-general-meeting-2003/https://ir.elekta.com/investors/press-releases/2003/interim-report-for-the-three-month-period-may-1-through-july-31-2003-2003-09-22/https://ir.elekta.com/investors/press-releases/2003/elekta-announce-first-order-for-elekta-synergytm-in-germany/https://ir.elekta.com/investors/press-releases/2003/boards-proposal-for-redemption-of-shares-in-elekta/https://ir.elekta.com/investors/press-releases/2003/annual-report-2002-2003/https://ir.elekta.com/investors/press-releases/2003/report-on-operations-for-the-fiscal-year-ended-april-30-2003/https://ir.elekta.com/investors/press-releases/2003/bokslutskommunike-1-maj---30-april-200203/https://ir.elekta.com/investors/press-releases/2003/elekta-recruits-to-its-corporate-communications-department/https://ir.elekta.com/investors/press-releases/2003/nine-months-report-ended-january-2003/https://ir.elekta.com/investors/press-releases/2003/elekta-expands-its-neurosurgery-leadership-position-through-acquisition-of-brain-monitoring-company/https://ir.elekta.com/investors/press-releases/2003/elekta-comments-on-decision-by-stockholmsborsens-disciplinary-committee/https://ir.elekta.com/investors/press-releases/2003/elekta-receives-orders-for-leksell-gamma-knife-valued-at-sek-123-million/https://ir.elekta.com/investors/press-releases/2002/elekta-financing-investments-in-rd-with-long-term-loans/https://ir.elekta.com/investors/press-releases/2002/interim-report-for-the-six-month-period-may-1-through-october-31-2002/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-order-for-radiotherapy-equipment-for-treatment-of-cancer-in-the-netherlands-valued-at-sek-160-m/https://ir.elekta.com/investors/press-releases/2002/elekta-and-mds-nordion-announce-a-global-marketing-agreement-for-the-oncentra-suite-of-integrated-oncology-management-so/https://ir.elekta.com/investors/press-releases/2002/elektas-annual-general-meeting-2002/https://ir.elekta.com/investors/press-releases/2002/interim-report-for-the-three-months-ended-july-31-2002/https://ir.elekta.com/investors/press-releases/2002/elektas-patent-dispute-in-the-us/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-judgment-from-first-instance-in-patent-dispute/https://ir.elekta.com/investors/press-releases/2002/annual-report-2002-2003/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-orders-for-leksell-gamma-knife-in-the-us-japan-and-italy-valued-at-sek-160-million/https://ir.elekta.com/investors/press-releases/2002/elektas-warrants-program/https://ir.elekta.com/investors/press-releases/2002/elekta-invests-in-swedish-oncology-start-up/https://ir.elekta.com/investors/press-releases/2002/elekta-implements-new-organization-and-expands-group-management/https://ir.elekta.com/investors/press-releases/2002/report-on-operations-for-the-fiscal-year-ended-april-30-2002/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-orders-for-leksell-gamma-knife-in-the-us-and-europe-valued-at-sek-110-million/https://ir.elekta.com/investors/press-releases/2002/interim-report-for-the-nine-months-ended-january-31-2002/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-orders-for-leksell-gamma-knifer--in-greece-and-italy-valued-at-sek-70-million/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-order-for-leksell-gamma-knifer-in-canada/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-court-ruling-in-us-patent-dispute/https://ir.elekta.com/investors/press-releases/2002/elekta-and-4-d-neuroimaging-announce-a-strategic-agreement-to-distribute-meg-systems-in-the-us/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-orders-for-leksell-gamma-knife-in-the-us-valued-at-sek-97-million/https://ir.elekta.com/investors/press-releases/2002/elekta-installs-equipment-for-radiation-treatment-of-cancer-with-imrt-at-the-university-hospital-in-uppsala-sweden/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-orders-valued-at-sek-80m-for-radiotherapy-equipment-for-treatment-of-cancer-in-france-and-australia/https://ir.elekta.com/investors/press-releases/2002/elekta-receives-orders-valued-at-sek-120-m-for-radiotherapy-equipment-for-treatment-of-cancer-in-north-america/https://ir.elekta.com/investors/press-releases/2001/interim-report-for-the-six-months-ended-october-31-2001/https://ir.elekta.com/investors/press-releases/2001/elekta-delivers-leksell-gamma-knife-to-hm-queen-sophia-hospital-in-stockholm/https://ir.elekta.com/investors/press-releases/2001/elekta-receives-orders-for-leksell-gamma-knife-valued-at-sek-155-million/https://ir.elekta.com/investors/press-releases/2001/elektas-annual-general-meeting-2001/https://ir.elekta.com/investors/press-releases/2001/interim-report-for-the-three-months-ended-july-31-2001/https://ir.elekta.com/investors/press-releases/2001/iviewgt-portal-imaging-system-from-elekta-gains-510k-clearance-from-us-food-and-drug-administration/https://ir.elekta.com/investors/press-releases/2001/annual-report-2000-2001/https://ir.elekta.com/investors/press-releases/2001/elekta-receives-orders-for-radiotherapy-equipment-for-treatment-of-cancer-valued-at-sek-250-million/https://ir.elekta.com/investors/press-releases/2001/elekta-receives-orders-for-leksell-gamma-knife-valued-at-sek-95-million/https://ir.elekta.com/investors/press-releases/2001/elekta-and-adac-announce-strategic-alliance-for-complete-imrt-planning-and-delivery-solution/https://ir.elekta.com/investors/press-releases/2001/elektas-debenture-loan-converted/https://ir.elekta.com/investors/press-releases/2001/elekta-receives-repeat-order-in-uk-for-linear-accelerators-announces-expansion-of-production-at-crawley-plant/https://ir.elekta.com/investors/press-releases/2001/elekta-sell-leksell-gamma-knife-c-to-the-us/https://ir.elekta.com/investors/press-releases/2001/report-on-operations-for-the-fiscal-year-ended-april-30-2001/https://ir.elekta.com/investors/press-releases/2001/elektas-convertible-debenture-loan-98-01/https://ir.elekta.com/investors/press-releases/2001/elekta-receives-orders-for-leksell-gamma-knife-valued-at-sek-280-million/https://ir.elekta.com/investors/press-releases/2001/interim-report-may-1---january-31-200001/https://ir.elekta.com/investors/press-releases/2000/interim-report-may-1---october-31-2000/https://ir.elekta.com/investors/press-releases/2000/interim-report-may-1---july-31-20002001/https://ir.elekta.com/investors/press-releases/2000/annual-report-1999-2000/https://ir.elekta.com/investors/press-releases/2000/preliminary-report-on-operations-for-the-fiscal-year-ended-april-30-2000/https://ir.elekta.com/investors/press-releases/2000/interim-report-nine-months-ended-january-31-2000/https://ir.elekta.com/investors/press-releases/1999/interim-report-may-1---october-3119992000/https://ir.elekta.com/investors/press-releases/1999/interim-report-may-1--1999---july-31-1999/https://ir.elekta.com/investors/press-releases/1999/annual-report-1998-1999/https://ir.elekta.com/investors/press-releases/1999/preliminary-report-may-1-1998---april-30-1999/https://ir.elekta.com/investors/press-releases/1999/interim-report-nine-months-ended-january-31-1999/https://ir.elekta.com/investors/ir-calendar/https://ir.elekta.com/investors/ir-calendar/2023/jefferies-pan-european-mid-cap-conference/https://ir.elekta.com/investors/ir-calendar/2023/bofa-global-healthcare-conference-london/https://ir.elekta.com/investors/ir-calendar/2026/https://ir.elekta.com/investors/ir-contacts/https://ir.elekta.com/investors/subscriptions/https://ir.elekta.com/investors/subscriptions/subscription-conditions/https://ir.elekta.com/corporate-governance/https://ir.elekta.com/corporate-governance/shareholders-meeting/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2024/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/agm-2021/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/agm-2020/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2019/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2018/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2017/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2016/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2015/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2014/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2013/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2011/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2010/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2009/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2007/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2006/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2005/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2004/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/egm-2021/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/extraordinary-general-meeting-2012/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2022/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2022/presentation/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2022/interview/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2023/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2025/https://ir.elekta.com/corporate-governance/shareholders-meeting/meetings/annual-general-meeting-2026/https://ir.elekta.com/corporate-governance/shareholders-meeting/nomination-committee/https://ir.elekta.com/corporate-governance/shareholders-meeting/nomination-committee/ncagm2023/https://ir.elekta.com/corporate-governance/shareholders-meeting/nomination-committee/nomination-committee-ahead-of-the-annual-general-meeting-2024/https://ir.elekta.com/corporate-governance/shareholders-meeting/nomination-committee/nomination-committee-ahead-of-the-annual-general-meeting-2025/https://ir.elekta.com/corporate-governance/shareholders-meeting/nomination-committee/nomination-committee-ahead-of-the-annual-general-meeting-2026/https://ir.elekta.com/corporate-governance/board-of-directors/https://ir.elekta.com/corporate-governance/board-of-directors/members/https://ir.elekta.com/corporate-governance/board-of-directors/insider-transactions-2/https://ir.elekta.com/corporate-governance/board-of-directors/remuneration/https://ir.elekta.com/corporate-governance/board-of-directors/audit-committee/https://ir.elekta.com/corporate-governance/board-of-directors/compensation-and-sustainability-committee/https://ir.elekta.com/corporate-governance/executive-committee/https://ir.elekta.com/corporate-governance/executive-committee/members/https://ir.elekta.com/corporate-governance/executive-committee/insider-transactions/https://ir.elekta.com/corporate-governance/executive-committee/remuneration/https://ir.elekta.com/corporate-governance/auditors/https://ir.elekta.com/corporate-governance/reports/https://ir.elekta.com/corporate-governance/reports/report-archive/https://ir.elekta.com/corporate-governance/glossary/https://ir.elekta.com/side-navigation/https://ir.elekta.com/tmp2/https://ir.elekta.com/navigation-ping/https://ir.elekta.com/sv/investerare/https://ir.elekta.com/sv/investerare/elekta-som-investering/https://ir.elekta.com/sv/investerare/elekta-som-investering/stark-efterfragan/https://ir.elekta.com/sv/investerare/elekta-som-investering/attraktiv-verksamhet/https://ir.elekta.com/sv/investerare/elekta-som-investering/strategiskt-fokus/https://ir.elekta.com/sv/investerare/elekta-som-investering/ledande-innovationer/https://ir.elekta.com/sv/investerare/prognos/https://ir.elekta.com/sv/investerare/marknad-och-trender/https://ir.elekta.com/sv/investerare/marknad-och-trender/drivkrafter-for-stralbehandling/https://ir.elekta.com/sv/investerare/marknad-och-trender/halso-och-sjukvardstrender/https://ir.elekta.com/sv/investerare/marknad-och-trender/marknadsegenskaper/https://ir.elekta.com/sv/investerare/the-share/https://ir.elekta.com/sv/investerare/the-share/totalavkastning/https://ir.elekta.com/sv/investerare/the-share/aktiepris-kalkylator/https://ir.elekta.com/sv/investerare/the-share/marknadsestimat/https://ir.elekta.com/sv/investerare/the-share/analytiker/https://ir.elekta.com/sv/investerare/the-share/agarstruktur/https://ir.elekta.com/sv/investerare/the-share/aktiekapitalets-utveckling/https://ir.elekta.com/sv/investerare/finansiell-information/https://ir.elekta.com/sv/investerare/finansiell-information/definitioner/https://ir.elekta.com/sv/investerare/finansiering/https://ir.elekta.com/sv/investerare/finansiering/mtn-program/https://ir.elekta.com/sv/investerare/finansiering/nyckeltal/https://ir.elekta.com/sv/investerare/finansiering/nyckeltal/cp-program/https://ir.elekta.com/sv/investerare/finansiering/mtn-program-2/https://ir.elekta.com/sv/investerare/rapporter-presentationer/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majjuli-202324/https://ir.elekta.com/sv/investerare/rapporter-presentationer/andra-kvartalet-augustioktober-202526/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-forsta-kvartalet-majjuli-202526/https://ir.elekta.com/sv/investerare/rapporter-presentationer/elektas-arsredovisning-for-202324-tillganglig/https://ir.elekta.com/sv/investerare/rapporter-presentationer/bokslutskommunike-majapril-202324/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-kv-3-novemberjanuari-202425/https://ir.elekta.com/sv/investerare/rapporter-presentationer/tredje-kvartalet-novemberjanuari-202526/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majjanuari-202324-/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majoktober-202324/https://ir.elekta.com/sv/investerare/rapporter-presentationer/bokslutskommunike-majapril-202425/https://ir.elekta.com/sv/investerare/rapporter-presentationer/elektas-arsredovisning-for-202425-tillganglig/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-kv-2-augustioktober-202425/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majjuli-202425/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majoktober-202122/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majjuli-202122/https://ir.elekta.com/sv/investerare/rapporter-presentationer/elektas-arsredovisning-for-202021-tillganglig/https://ir.elekta.com/sv/investerare/rapporter-presentationer/bokslutskommunike-majapril-202021/https://ir.elekta.com/sv/investerare/rapporter-presentationer/cmd-2023/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majjanuari-202122/https://ir.elekta.com/sv/investerare/rapporter-presentationer/220214-preliminara-resultat-q3-202122/https://ir.elekta.com/sv/investerare/rapporter-presentationer/210607-elekta-capital-markets-day-2021-presentation/https://ir.elekta.com/sv/investerare/rapporter-presentationer/bokslutskommunike-majapril-202122/https://ir.elekta.com/sv/investerare/rapporter-presentationer/arsredovisning-202122-i-ixbrl/https://ir.elekta.com/sv/investerare/rapporter-presentationer/elektas-arsredovisning-for-202122-tillganglig/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majjuli-202223/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-majoktober-202223/https://ir.elekta.com/sv/investerare/rapporter-presentationer/delarsrapport-maj-januari-202223/https://ir.elekta.com/sv/investerare/rapporter-presentationer/bokslutskommunike-majapril-202223/https://ir.elekta.com/sv/investerare/rapporter-presentationer/elektas-arsredovisning-for-202223-tillganglig/https://ir.elekta.com/sv/investerare/rapporter-presentationer/arsredovisning-202223-i-ixbrl/https://ir.elekta.com/sv/investerare/rapporter-presentationer/arsredovisning-202324-i-ixbrl-2/https://ir.elekta.com/sv/investerare/rapporter-presentationer/arsredovisning-202425-i-ixbrl/https://ir.elekta.com/sv/investerare/pressmeddelanden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/inbjudan-till-elektas-strategiska-uppdatering-den-30-januari/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/elekta-utser-tomas-eliasson-till-vice-ordforande-i-styrelsen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/elekta-far-fda-510k-godkannande-for-linjaracceleratorn-elekta-evo/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/tredje-kvartalet-novemberjanuari-202526/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/forandring-i-elektas-valberedning-infor-arsstamman-2026/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/inbjudan-till-elektas-q3-202526-presentation-kl-9-00-cet-den-5-mars/https://ir.elekta.com/sv/investerare/pressmeddelanden/2026/elekta-presenterar-strategisk-uppdatering-tillvaxt-innovation-och-operativ-excellens/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/andra-kvartalet-augustioktober-202526/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/inbjudan-till-presentation-av-elektas-andra-kvartal-202526/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/kommunike-fran-elektas-arsstamma-2025/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-tillkannager-forandringar-i-koncernledningen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-uppmarksammar-den-tvamiljonte-patienten-som-behandlats-med-leksell-gamma-knife-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/studie-visar-att-mri-styrd-adaptiv-stralbehandling-med-elekta-unity-forbattrar-patientrapporterade-urinvagssymtom-hos-man-med-prostatacancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/ny-paverkansrapport-belyser-stralbehandlingens-roll-inom-cancervarden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elektas-valberedning-infor-arsstamman-2026/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-starker-cancerbehandlingen-i-kroatien-med-strategiskt-forvarv/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-ledare-presenterar-tillbakablick-och-framtida-utveckling-for-marknaden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-utser-jakob-just-bomholt-till-ny-vd-och-koncernchef/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/valberednings-forslag-till-styrelse-infor-elektas-arsstamma-2025/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/bokslutskommunike-majapril-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/inbjudan-till-presentation-av-elektas-rakenskapsar-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/mer-precis-stralbehandling-med-elektas-mr-linac-elekta-unity-bevarar-den-sexuella-funktionen-hos-man-med-prostatacancer-visar-en-ny-klinisk-provning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/inbjudan-till-elektas-investerarevenemang-den-10-juni-2025/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/inbjudan-till-presentation-av-elektas-forsta-kvartal-202526/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-far-amerikanskt-fda-510k-godkannande-for-sitt-gamma-knife-stralkirurgisystem-for-behandling-av-patienter-med-refraktar-lakemedelsresistent-mesial-temporallobsepilepsi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elektas-arsredovisning-for-202425-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/delarsrapport-forsta-kvartalet-majjuli-202526/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-unity-blir-en-hornsten-i-moffitt-cancer-centers-mrgrt-program/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-far-stororder-fran-imss-atta-linjaracceleratorer-som-revolutionerar-den-mexikanska-cancervarden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/inbjudan-till-presentation-av-elektas-tredje-kvartal-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-one-ois-ledande-i-2025-best-in-klas-software-and-services-report/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/delarsrapport-kv-3-novemberjanuari-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/gustaf-salford-lamnar-sin-position-som-vd-och-koncernchef-for-elekta-den-6-mars/https://ir.elekta.com/sv/investerare/pressmeddelanden/2025/elekta-och-azra-ai-inleder-ett-partnersamarbete-inom-ai-driven-automatisering-som-forbattrar-inrapporteringen-till-cancerregister-/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-lanserar-ai-driven-adaptiv-ct-linac-som-tar-cancervarden-till-nasta-niva/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-blir-ny-emittent-pa-den-svenska-foretagscertifikatmarknaden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-starker-sin-mjukvarusvit-elekta-one-ytterligare-med-forvarvet-av-philips-patentportfolj-for-behandlingsplanering/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-och-ge-healthcares-mim-software-inleder-ett-betydande-samarbete-for-att-leverera-ledande-losningar-for-cancerbehandlingsplanering/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/inbjudan-till-investerarmote-vid-estro-2024-i-glasgow/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-inleder-samarbete-med-msd-for-battre-njurcancervard-med-hjalp-av-digitala-losningar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-ansoker-om-fda-marknadsgodkannande-i-usa-for-evo--kommer-att-presenteras-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/caroline-leksell-cooke-tar-over-ledningen-av-elekta-neuro-solutions/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elektas-ai-drivna-adaptiva-ct-linac-elekta-evo-far-ce-markning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/kommunike-fran-elektas-arsstamma-2024/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/delarsrapport-majjuli-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-ingar-ett-joint-venture-med-sin-programvarupartner-ansheng-for-att-starka-marknadspositionen-i-kina/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/inbjudan-till-presentation-av-elektas-forsta-kvartal-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-far-en-order-pa-64-miljoner-usd-for-toppmoderna-linacs-och-gamma-knife-i-mexiko/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2024/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elektas-arsredovisning-for-202324-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-emitterar-en-obligation-pa-1-5-miljarder-kronor-och-tecknar-en-revolverande-kreditfacilitet-pa-1-miljard-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/bokslutskommunike-majapril-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/inbjudan-till-presentation-av-elektas-rakenskapsar-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/delarsrapport-kv-2-augustioktober-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/cancercentrum-i-tyskland-behandlar-den-forsta-patienten-i-varlden-med-den-nya-ct-linjaracceleratorn-elekta-evo/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/inbjudan-till-elektas-deep-dive-seminarium-den-19-december/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/inbjudan-till-presentation-av-elektas-andra-kvartal-202425/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/caroline-leksell-cooke-avgar-fran-elektas-styrelse/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elektas-valberedning-infor-arsstamman-2025/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/det-forsta-stora-framsteget-inom-stralbehandling-av-hoggradiga-gliom-pa-mer-an-25-ar-presenterades-pa-astro-2024/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elektas-mosaiq-ledande-i-2024-best-in-klas-software-and-services-report/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/inbjudan-till-presentation-av-elektas-tredje-kvartal-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/delarsrapport-majjanuari-202324-/https://ir.elekta.com/sv/investerare/pressmeddelanden/2024/elekta-meddelar-att-styrelseledamoten-kelly-londy-avgar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-expanderar-marknaden-och-anvandningsomraden-for-brakyterapi-genom-att-forvarva-icad-incs-xoft-verksamhet/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/mojligheten-till-omfattande-rorelsehantering-med-elekta-unity-mr-linac-i-fokus-pa-astro-2023/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-foundation-samlar-in-50-000-dollar-till-kvinnor-med-langt-framskriden-livmoderhalscancer-med-cykelutmaningen-ride4rwanda/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elektas-arsredovisning-for-202223-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2023/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-far-fda-510k-godkannande-for-avancerad-rorelsestyrning-vid-stralbehandling-med-elekta-unity-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-foundations-cancervardsframgangar-i-rwanda-kommer-att-utokas-i-andra-laginkomstlander/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/forsta-esprit-gamma-knife-patienten-aterupptar-livet-som-vanligt-bara-dagar-efter-sin-hjarnoperation/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/delarsrapport-maj-januari-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elektas-klimatmal-godkanda-av-sbti--science-based-targets-initiative/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-starker-sin-marknadsposition-i-asien-genom-forvarv-av-distributor-i-thailand/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/inbjudan-till-presentation-av-elektas-tredje-kvartal-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/inbjudan-till-presentation-av-elektas-andra-kvartal-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/krishna-institute-of-medical-sciences-hyderabad-i-indien-bestaller-stralbehandlingssystem-for-usd-40-miljoner-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elektas-valberedning-infor-arsstamman-2024/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-fortsatter-stodja-cancerpatienter-i-ukraina-med-den-senaste-utrustningen-for-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/delarsrapport-majoktober-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-och-det-internationella-atomenergiorganet-iaea-sluter-partnerskap-for-okad-tillgang-till-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/kommunike-fran-elektas-arsstamma-2023/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elektas-flexitron-har-gynnat-cancerpatienter-med-flera-miljoner-brakyterapibehandlingar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-och-bristol-myers-squibb-i-partnerskap-for-att-hjalpa-patienter-med-melanom/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/vardpersonal-inom-canceromradet-kan-nu-planera-och-styra-arbetsflodet-pa-ett-mer-effektivt-satt-med-ny-programvara-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-fokuserar-pa-innovation-mjukvara-och-vardeskapande-pa-kapitalmarknadsdagen-2023/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-esprit-far-designutmarkelsen-red-dot-award-for-patient--och-lakarfokus/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-undertecknar-den-forsta-hallbarhetskopplade-revolverande-kreditfaciliteten-varderad-till-250-miljoner-euro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/bokslutskommunike-majapril-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/kliniska-anvandare-pa-european-radiation-oncology-conference-rapporterar-med-elekta-unity-gar-det-att-se-och-behandla-cancer-battre-an-nagonsin-tidigare/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/delarsrapport-majjuli-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/mercurius-health-utrustar-robert-janker-klinik-med-en-integrerad-onkologilosning-fran-elekta-och-philips/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/inbjudan-till-presentation-av-elektas-rakenskapsar-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/inbjudan-till-elektas-kapitalmarknadsdag-2023/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/inbjudan-till-presentation-av-elektas-forsta-kvartal-202324/https://ir.elekta.com/sv/investerare/pressmeddelanden/2023/elekta-och-sinopharm-samarbetar-for-att-forbattra-tillgang-och-kvalitet-pa-cancervarden-i-kina/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-och-karkinos-healthcare-okar-tillgangen-till-modern-cancervard-over-hela-indien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/delarsrapport-majjuli-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elektas-valberednings-forslag-till-styrelse-infor-arsstamman/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-oppnar-upp-for-cancervard-till-ytterligare-123-miljoner-manniskor-och-exekverar-det-strategiska-malet-for-vardtillganglighet/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-esprit-den-senaste-versionen-av-leksell-gamma-knife-far-fda-510k-godkannande/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-visar-lovande-livskvalitetsutfall-bade-vid-pankreas--och-prostatacancer-pa-arets-astro-kongress/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-utokar-sitt-utbud-av-tjanster-med-mervarde-och-starker-sin-position-som-langsiktig-partner/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elektas-valberedning-infor-arsstamman-2023/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/inbjudan-till-presentation-av-elektas-andra-kvartal-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/svenska-och-jordanska-kungligheter-inviger-stralbehandlingsteknik-fran-elekta-for-cancer-och-hjarnsjukdomar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/delarsrapport-majoktober-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/forsta-patienten-nagonsin-med-cancer-i-bukspottkorteln-har-fatt-avancerad-stralbehandling-med-rorelsestyrning-med-elekta-unity-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/bokslutskommunike-majapril-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/kaiku-health-forbattrar-cancervarden-genom-partnerskap-med-lakemedelsforetag/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/kommunike-fran-elektas-arsstamma-2022/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elektas-nya-system-for-stralkirurgi-elekta-esprit-far-ce-markning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-och-healthcare-global-enterprises-ltd-startar-ett-gemensamt-utbildningscenter-i-mumbai/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/inbjudan-till-presentation-av-elektas-forsta-kvartal-202223/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/aapm-2022-motet-lyfter-fram-allt-starkare-bevis-for-stralbehandling-med-elekta-unity/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elektas-arsredovisning-for-202122-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/formagan-att-se-vad-man-behandlar-med-elekta-unity-redovisas-i-71-referat-vid-estro-2022/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-unitys-rorelsehanteringsfunktioner-forebadar-en-ny-era-inom-precisionsstralterapi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/kaiku-health-ingar-ett-strategiskt-partnerskap-for-att-ytterligare-forbattra-resultaten-for-patienter-via-digital-patientovervakning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-vinner-majoriteten-av-en-italiensk-offentlig-upphandling-av-avancerad-cancervard-2022-10-18/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-och-netherlands-cancer-institute-samarbetar-om-att-utveckla-nasta-generations-losningar-inom-stralonkologi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-utser-tobias-hagglov-till-finansdirektor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-lanserar-ny-gamma-knife-elekta-esprit/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/inbjudan-till-presentation-av-elektas-rakenskapsar-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-harmony-tilldelas-utmarkelsen-red-dot-for-produktdesign/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-och-ge-healthcare-samarbetar-for-att-utoka-tillgangen-till-precisionsstralningslosningar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/englands-sjukvardssystem-nhs-forbattrar-cancerbehandlingar-med-hjalp-av-elektas-losning-proknow/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/inbjudan-till-investerarmote-vid-estro-i-kopenhamn/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-och-iba-samarbetar-for-att-optimera-kvalitetssakring-inom-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-delarsrapport-maj-januari-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/elekta-offentliggor-preliminara-resultat-for-tredje-kvartalet-2022-02-14/https://ir.elekta.com/sv/investerare/pressmeddelanden/2022/inbjudan-till-presentation-av-elektas-tredje-kvartal-202122-2022-02-04/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elektas-nya-hallbarhetslankade-obligationer-overtecknade/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/delarsrapport-majoktober-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/inbjudan-till-presentation-av-elektas-andra-kvartal-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elekta-upprattar-ramverk-for-hallbarhetslankade-obligationer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elektas-valberedning-infor-arsstamman-2022/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elekta-inleder-med-investment-grade-rating-fran-sp-global-ratings/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/kommunike-fran-elektas-arsstamma-2021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/delarsrapport-majjuli-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/inbjudan-till-presentation-av-elektas-forsta-kvartal-202122/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elektas-arsredovisning-for-202021-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/bokslutskommunike-majapril-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/inbjudan-till-presentation-av-elektas-rakenskapsar-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/kommunike-fran-elektas-extra-bolagsstamma-2021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/kallelse-till-extra-bolagsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elektas-styrelse-foreslar-en-extra-utdelning-om-090-kr-per-aktie/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/delarsrapport-majjanuari-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elekta-utser-johan-adeback-till-finansdirektor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/inbjudan-till-presentation-av-elektas-tredje-kvartal-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2021/elekta-avyttrar-sitt-innehav-i-viewray/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/delarsrapport-majoktober-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/gustaf-salford-utsedd-till-ny-vd-for-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/inbjudan-till-presentation-av-elektas-andra-kvartal-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elektas-valberedning-infor-arsstamman-2021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elekta-introducerar-ny-stralbehandlingslosning-som-bidrar-till-att-bekampa-cancer-globalt/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/kommunike-fran-elektas-arsstamma-2020/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/delarsrapport-majjuli-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/inbjudan-till-presentation-av-elektas-forsta-kvartal-202021/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elekta-unity-mr-linac-far-godkannande-av-kinas-national-medical-products-administration/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elektas-arsredovisning-for-201920-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/foreslagen-utdelning-for-elekta-for-rakenskapsaret-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/dr-richard-hausmann-slutar-som-vd-och-koncernchef-for-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2020/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/bokslutskommunike-majapril-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/inbjudan-till-presentation-av-elektas-rakenskapsar-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/genesiscare-investerar-stort-i-elektas-teknik-for-cancerbehandling-vid-sin-entre-pa-den-amerikanska-marknaden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elekta-andrar-utsikterna-for-201920-och-adresserar-utmaningar-relaterade-till-covid-19/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/elekta-lanserar-brachyterapi-applikatorn-geneva-for-precisionsbehandling-av-olika-gynekologiska-cancertyper/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/delarsrapport-majjanuari-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/korrigering-av-pressmeddelande-avseende-quebec-forvarvar-avancerade-linjaracceleratorer-for-att-tillgodose-det-okande-behovet-av-avancerad-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/inbjudan-till-presentation-av-elektas-tredje-kvartal-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/quebec-forvarvar-12-linjaracceleratorer-elekta-versa-hd-for-att-tillgodose-det-okande-behovet-av-avancerad-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2020/institut-jules-bordet-i-belgien-investerar-i-elektas-senaste-cancerbehandlingsteknik/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/elekta-slutfor-sin-investering-i-viewray/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/elekta-tillkannager-samarbete-med-viewray-for-att-framja-mr-styrd-stralterapi-och-investering-i-en-minoritetsandel-genom-en-nyemission/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/delarsrapport-majoktober-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/inbjudan-till-presentation-av-elektas-andra-kvartal-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/elekta-publicerar-preliminara-resultat-for-andra-kvartalet-och-uppdaterade-utsikter-for-rakenskapsaret-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/akademiska-sjukhuset-i-uppsala-forst-i-sverige-att-behandla-patient-med-cancerbehandlingssystemet-elekta-unity/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/elektas-valberedning-infor-arsstamman-2020/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/kommunike-fran-elektas-arsstamma-2019/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/delarsrapport-majjuli-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/inbjudan-till-presentation-av-elektas-forsta-kvartal-201920/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/genesiscare-forvarvar-nio-elekta-unity-system-for-avancerad-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/rattelse-av-pressmeddelande-om-kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/elektas-arsredovisning-for-201819-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2019/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/bokslutskommunike-majapril-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/telefonkonferens-avseende-elektas-bokslutskommunike-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/delarsrapport-maj--januari-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/forandring-i-elektas-valberedning-infor-arsstamman-2019/https://ir.elekta.com/sv/investerare/pressmeddelanden/2019/telefonkonferens-avseende-elektas-q3-rapport-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-unity-har-fatt-godkannande-av-amerikanska-fda/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/delarsrapport-maj--oktober-201819-q2/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/telefonkonferens-avseende-elektas-q2-rapport-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elektas-valberedning-infor-arsstamman-2019/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/genesiscare-tecknar-avsiktsforklaring-for-kop-av-versa-hd-cancerbehandlingssystem-och-forskningsavtal-med-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-presenterar-langsiktig-strategi-och-finansiellt-scenario-pa-kapitalmarknadsdag/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/kommunike-fran-elektas-arsstamma-2018/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/delarsrapport-maj--juli-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/forsta-patienten-behandlad-med-ce-markta-elekta-unity-vid-university-medical-center-i-utrecht/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/paminnelse-inbjudan-till-elektas-kapitalmarknadsdag-i-stockholm-den-27-september-2018/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elektas-arsredovisning-for-201718-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/telefonkonferens-avseende-elektas-q1-rapport-201819/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-unity-har-en-pagaende-510k-ansokan-hos-den-amerikanska-lakemedelsmyndigheten-fda-for-godkannande-av-klinisk-anvandning-och-forsaljning-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/inbjudan-till-elektas-kapitalmarknadsdag-i-stockholm-den-27-september-2018/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-unity-varldens-forsta-15t-baserade-mr-stralkanon-far-ce-markning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2018/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/bokslutskommunike-maj-april-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/telefonkonferens-avseende-elektas-q4-rapport-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/proton-partners-international-forvarvar-elekta-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/delarsrapport-maj-januari-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-samarbetar-med-ledande-cancercenter-i-new-york-for-att-fortsatta-utvecklingen-av-kliniska-protokoll-for-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-levererar-avanceradcancervard-till-stockholmsregionen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/telefonkonferens-avseende-elektas-q3-rapport-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/elekta-valjer-ibm-watson-health-for-att-ta-ai-till-onkologiomradet/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/ottawa-hospital-koper-elekta-versa-hd-for-avancerad-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2018/stralkirurgi-med-gamma-knife-firar-femtio-ar-med-over-en-miljon-behandlade-patienter/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elekta-och-stockholms-lans-landsting-enas-om-en-konstruktiv-vag-framat/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/delarsrapport-maj-oktober-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/nhs-i-storbritannien-tecknar-avtal-om-22-miljoner-gbp-for-cancerbehandlingssystem-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elektas-valberedning-infor-arsstamman-2018/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/21st-century-oncology-valjer-elekta-vid-byte-till-ny-stralbehandlingsutrustning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/telefonkonferens-avseende-elektas-q2-rapport-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/uppdatering-avseende-funktionalitet-och-ce-markning-for-elektas-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/mclaren-health-care-och-elekta-sager-omsesidigt-upp-langsiktigt-avtal/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elekta-och-the-alliance-for-cancer-care-samarbetar-om-att-erbjuda-patienterna-toppmoderna-losningar-inom-stralterapi-och-stralkirurgi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/kommunike-fran-elektas-arsstamma-2017/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/ioannis-panagiotelis-utsedd-till-chief-marketing-and-sales-officer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/delarsrapport-maj--juli-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/valkommen-till-elektas-investerarmote-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/telefonkonferens-avseende-elektas-delarsrapport-for-maj-juli-201718/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elektas-arsredovisning-for-201617-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/steven-wort-utsedd-till-elektas-chief-operating-officer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/installationen-av-elekta-mr-linac-paborjad-vid-sunnybrook-health-sciences-centre/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/valberedningens-forslag-till-styrelse-i-elekta-infor-arsstamman-2017/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/peter-gaccione-tar-plats-i-elektas-koncernledning-som-chef-for-nordamerika/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/bokslutskommunike-maj--april-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/paminnelse-inbjudan-till-elektas-bokslutskommunike-och-en-uppdatering-av-bolaget/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/university-medical-centre-utrecht-behandlar-den-forsta-patienten-med-elekta-unity/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/inbjudan-till-elektas-bokslutskommunike-och-en-uppdatering-av-bolaget/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elekta-utser-gustaf-salford-till-ekonomi--och-finansdirektor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/kliniska-data-avseende-elekta-unity-fran-mr-linac-konsortiet-lyfts-fram-i-20-abstracts-pa-estro-36/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elekta-unity-visas-for-forsta-gangen---ett-stralbehandlingssystem-med-transformativ-mri/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/antalet-utestaende-aktier-i-elekta-ab/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/elekta-och-varian-forlikas-i-patenttvister/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/laurent-leksell-koper-a-aktier-genom-konvertering-och-saljer-ett-lagre-antal-b-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/delarsrapport-maj--januari-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/telefonkonferens-avseende-elektas-delarsrapport-for-maj-januari-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2017/antalet-utestaende-aktier-i-elekta-ab-2017-01-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/stockholm-lans-landsting-nya-karolinska-solna-och-elekta-i-langsiktigt-samarbetsavtal-for-battre-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-vinner-tva-order-pa-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-delarsrapport-maj--oktober-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/telefonkonferens-avseende-elektas-delarsrapport-for-maj-oktober-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elektas-valberedning-infor-arsstamman-2017/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/usitc-publicerar-preliminart-beslut-irattsprocess/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/genesiscare-starker-spansk-cancervard-ytterligare-genom-linjaracceleratorer-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/all-india-institute-of-medical-science-starker-cancervarden-genom-avancerade-behandlingslosningar-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/installation-av-elektas-sjatte-mr-adaptiva-hogfalts-linjaraccelerator-paborjad-hos-the-christie/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/data-som-presenterades-pa-astro-starker-bilden-av-att-elektas-mr-adaptiva-hogfalts-linjaraccelerator-har-potential-att-forandra-stralterapin/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-och-brainlab-forbattrar-interoperabilitet-och-behandlingskapacitet-for-stereotaktisk-neurokirurgi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elektas-nya-leksell-vantage-stereotactic-system-forbattrar-visualiseringsteknik-och-arbetsfloden-inom-neurokirurgi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-redogor-for-forandringsprogrammetoch-visar-det-senaste-inom-utvecklingsportfoljen-vidkapitalmarknadspresentationen-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elektas-mr-linac-installeras-pa-froedtert--the-medical-college-of-wisconsin-clinical-cancer-center/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/paminnelse-valkommen-till-elektas-kapitalmarknadspresentationpa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/kommunike-fran-elektas-arsstamma-2016/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/delarsrapport-maj--juli-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/valkommen-till-elektas-kapitalmarknadspresentation-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/telefonkonferens-avseende-elektas-delarsrapport-for-maj-juli-201617/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elektas-arsredovisning-for-201516-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/presentationer-pa-aapm-2016-visar-pa-potentialen-hos-elektas-mr-linac/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/sjukhus-i-wien-forbattrar-behandlingen-av-cancer-med-hardvara-och-mjukvara-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/skalfordelar-forandring-och-ledarskap-inom-innovation-i-fokus-pa-elektas-kapitalmarknadsdag/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/mr-linac-installeras-for-the-institute-of-cancer-research-london-och-the-royal-marsden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elektas-leksell-gamma-knife-icon-har-fatt-klartecken-for-anvandning-i-japan-och-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/bokslutskommunike-maj--april-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/mr-linac-nummer-3-installeras-vid-university-medical-centre-utrecht/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-vinner-upphandling-att-leverera-avancerade-cancerbehandlingslosningar-till-nya-karolinska-solna/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-betalar-humediq-89-meur-efter-rattstvist/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/telefonkonferens-avseende-elektas-bokslutskommunike-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/leeds-st-james-forvarvar-atta-linjaracceleratorer-for-avancerad-cancerbehandling-av-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/nhs-supply-chain-valjer-elekta-for-att-uppgradera-stralbehandlingen-i-storbritannien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/turkiets-medicana-health-group-investerar-10-meur-i-cancerbehandlingsutrustning-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/inbjudan-till-elektas-kapitalmarknadsdag-i-stockholm-den-9-juni/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/antalet-utestaende-aktier-i-elekta-ab/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elektas-senaste-version-av-monaco-ger-upp-till-fyra-ganger-snabbare-berakningar-av-behandlingsplaner/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/den-transformativa-potentialen-for-elektas-mr-linac-lyfts-fram-i-sju-abstracts-pa-estro-35/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/md-anderson-cancer-center-forvarvar-elektas-linjaracceleratorer-och-ovriga-stralbehandlingslosningar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/john-lapre-utnamns-till-elektas-chief-technology-officer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-och-philips-installerar-mri-styrd-linjaraccelerator-vid-netherlands-cancer-institute/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/richard-hausmann-utsedd-till-vd-och-koncernchef-for-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/genesiscare-och-elekta-tecknar-strategiskt-samarbetsavtal-till-ett-varde-om-mer-an-100-musd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/elekta-delarsrapport-maj--januari-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/telefonkonferens-avseende-elektas-delarsrapport-for-maj-januari-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2016/antalet-utestaende-aktier-i-elekta-ab-2016-01-29/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta---delarsrapport-maj--oktober-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/antalet-utestaende-aktier-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/proton-partners-international-koper-elektas-stralbehandlingsutrustning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/karolinska-universitetssjukhuset-forvarvar-elektas-leksell-gamma-knife-icon/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/amethyst-radiotherapy-valjer-elektas-cancerbehandlingslosningar-for-expansion-i-europa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/telefonkonferens-avseende-elektas-delarsrapport-for-maj-oktober-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elektas-verksamhet-i-italien-ar-under-utredning-angaende-mojliga-konkurrensovertradelser/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elektas-valberedning-infor-arsstamman-2016/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-framhaller-ledande-fou-program-och-upprepar-finansiella-ambitioner/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elektas-mri-styrda-linjaraccelerator-installerad-pa-md-anderson-cancer-center/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elektas-nya-leksell-gamma-knife-icon-till-forsta-sju-sjukhusen-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/paminnelse-valkommen-till-elektas-kapitalmarknadspresentation-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-uppger-att-varians-krav-saknar-grund/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/valkommen-till-elektas-kapitalmarknadspresentation-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/kommunike-fran-elektas-arsstamma-2015/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/gustave-roussy-ett-ledande-europeiskt-cancercenter-valjer-elektas-versa-hd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/delarsrapport-maj--juli-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/universitetssjukhuset-la-timone-forst-i-varlden-med-att-behandla-patienter-med-leksell-gamma-knife-icon/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/telefonkonferens-avseende-elektas-delarsrapport-for-maj-juli-201516/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elektas-arsredovisning-for-201415-nu-tillganglig/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-far-510k-klartecken-fran-fda-for-leksell-gamma-knife-icon--den-senaste-generations-stralkirurgisystem-for-hjarnan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/ledande-europeiska-sjukhus-forbattrar-kraniell-stralkirurgi-med-elektas-nya-leksell-gamma-knife-icon/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/valberedningens-forslag-till-styrelse-i-elekta-ab-publ-infor-arsstamman-2015/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/william-beaumont-hospital-och-elekta-lamnar-in-patentstamningsansokan-mot-varian-medical-systems/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-presenterar-omfattande-atgardsprogram-under-kapitalmarknadsdagen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/samsung-medical-center-koper-asiens-forsta-leksell-gamma-knife-icon/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-ce-marker-leksell-gamma-knife-icon-utformad-for-att-behandla-fler-typer-av-hjarnsjukdomar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-meddelar-omorganisation-och-forandringar-i-koncernledningen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/bokslutskommunike-maj--april-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/telefonkonferens-avseende-elektas-bokslutskommunike-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/inbjudan-till-elektas-kapitalmarknadsdag-i-stockholm-den-11-juni-2015/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-meddelar-preliminart-finansiellt-resultat/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/nya-leksell-gamma-knife-hjalper-fler-patienter-med-hjarnsjukdomar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elektas-behandlingsplaneringssystem-monaco-v510-ce-marks/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-satter-fokus-pa-stralkirurgilosningar-och-informationsstyrd-cancervard-pa-estro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-levererar-avancerade-cancervardslosningar-till-amerikanska-providence-health--services/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-undertecknar-avtal-om-forvarv-av-tillgangar-fran-mexikansk-distributor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/antalet-utestaende-aktier-i-elekta-ab-publ-2015-03-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-emitterar-en-5-arig-obligation-om-1-miljarder-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/asa-hedin-evp-corporate-strategy-lamnar-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-utokar-i-polen-genom-forvarv/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-etablerar-obligationsprogram/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/delarsrapport-maj--januari-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/telefonkonferens-avseende-elektas-delarsrapport-for-maj-januari-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-antar-utmaningen-fran-varldscancerdagen-2015-for-att-minska-cancern-globalt/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/elekta-planerar-att-lansera-mri-styrt-stralbehandlingssystem-2017/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/halsovardsministeriet-i-turkiet-koper-avancerade-cancerbehandlingssystem-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2015/uppdaterad-valkommen-till-elektas-fou-uppdatering-vid-university-medical-center-utrecht/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/valkommen-till-elektas-fou-uppdatering-vid-university-medical-center-utrecht/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/avera-health-samarbetar-med-elekta-for-avancerad-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-ltd-och-medical-intelligence-medizintechnik-gmbh-bestrider-krav-fran-humediq-gmbh/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/antalet-utestaende-aktier-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/delarsrapport-maj--oktober-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/telefonkonferens-avseende-elektas-halvarsrapport-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-valberedning-infor-arsstamman-2015/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-uppmarksammas-av-cdp-for-miljoengagemang/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-ingar-i-ftse4good-index-series/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/tomas-puusepp-arbetande-styrelseledamot-koper-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-vd-och-koncernchef-koper-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-stralterapisystem-versa-hd-tillgangligt-i-kina/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/mjukvara-i-fokus-nar-elekta-presenterade-senaste-produktutvecklingen-under-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-utvecklar-sin-internrevision--och-compliance-funktion/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-stralbehandlingssystem-versa-hd-tillgangligt-i-japan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/utokat-samarbete-med-toshiba-starker-elektas-position-i-japan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/kommunike-fran-elektas-arsstamma-2014/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/delarsrapport-maj--juli-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-meddelar-avsiktsforklaring-om-forvarv-av-rta-en-ledande-distributor-i-polen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/valkommen-till-elektas-kapitalmarknadsdag-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/telefonkonferens-avseende-elektas-delarsrapport-for-maj-juli-201415/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-arsredovisning-for-201314-finns-nu-tillganglig-pa-elektas-webbplats/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-leksell-gamma-knife-perfexion-rankas-som-nummer-ett-av-amerikanska-klas-for-fjarde-aret-i-rad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/antalet-utestaende-aktier-i-elekta-ab-publ-2014-07-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-starker-position-i-turkiet-genom-forvarv-av-mesi-medikal/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/christie-hospital-ansluter-sig-till-elektas-och-philips-forskningskonsortium-for-mri-styrd-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/akademiska-sjukhuset-och-elekta-ska-framja-cancerforskning-i-sverige/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-presenterar-strategisk-agenda-for-hogre-tillvaxt-an-marknaden-som-helhet/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/institute-of-cancer-research-ansluter-sig-till-elektas-och-philips-forskningskonsortium-for-mri-styrd-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/bokslutskommunike-maj--april-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/telefonkonferens-avseende-elektas-bokslutskommunike-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/forandringar-i-elektas-koncernledning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-ingar-strategiskt-samarbete-med-centre-hospitalier-de-luniversite-de-montreal/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/niklas-savander-tilltrader-som-vd-och-koncernchef-for-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/antalet-utestaende-aktier-i-elekta-ab-publ-2014-04-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/inbjudan-till-elektas-kapitalmarknadsdag-i-stockholm-den-17-juni-2014/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-valberednings-forslag-till-styrelse-infor-arsstamman-2014/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/installationen-av-varldens-forsta-hogfalts-mri-styrda-stralbehandlingssystem-paborjad-vid-university-medical-center-i-nederlanderna/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/nhs-supply-chain-koper-utrustning-av-elekta-for-19-miljoner-pund/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/antalet-utestaende-aktier-i-elekta-ab-publ-2014-02-28/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/delarsrapport-maj--januari-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-meddelar-preliminara-resultat-for-det-tredje-kvartalet-och-justerade-utsikter-for-rakenskapsaret-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/telefonkonferens-avseende-elektas-delarsrapport-for-maj-januari-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/antalet-utestaende-aktier-i-elekta-ab-publ-2014-01-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-tar-betydande-order-pa-cancervardslosningar-till-irak/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elektas-samarbete-med-algeriet-ger-cancerpatienter-nytt-hopp/https://ir.elekta.com/sv/investerare/pressmeddelanden/2014/elekta-vinner-kinesisk-upphandling-av-cancervardslosningar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/antalet-utestaende-aktier-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-i-strategiskt-samarbete-med-mclaren-health-care-for-forbattrad-cancervard-i-michigan-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/delarsrapport-maj--oktober-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-far-510k-klartecken-fran-fda-for-behandlingsplaneringssystemet-monaco-5/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/telefonkonferens-avseende-elektas-delarsrapport-for-maj-oktober-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-oppnar-ultramodernt-utbildningscenter-i-beijing/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/yonsei-university-health-system-i-sydkorea-koper-fyra-stralterapisystem-av-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/antalet-utestaende-aktier-i-elekta-ab-publ-2013-10-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elektas-valberedning-infor-arsstamman-2014/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/niklas-savander-utsedd-till-elektas-nasta-vd-och-koncernchef/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-avbojer-fortsatt-deltagande-i-brasiliansk-anbudsprocess-pa-linjaracceleratorer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/klartecken-i-usa-for-esteya---elektas-nya-system-for-hudcancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-oppnar-utbildningscenter-inom-onkologi-och-neurovetenskap/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/innovation-gor-elekta-till-ledare-inom-stralterapi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-lanserar-esteya--elektronisk-brachyterapi-for-behandling-av-hudcancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-lanserar-monaco-50--ett-heltackande-behandlingsplaneringssystem-for-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-inkluderas-i-dow-jones-sustainability-index/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/paminnelse-valkommen-till-elektas-kapitalmarknadsdag-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-tar-kinesisk-order-pa-25-miljoner-usd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/kommunike-fran-elektas-arsstamma-2013/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/delarsrapport-maj--juli-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/korrigering-i-arsredovisningen-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-versa-hd-mojliggor-nu-stralbehandling-anpassad-efter-patientens-andningsrorelser/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/valkommen-till-elektas-kapitalmarknadsdag-pa-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/telefonkonferens-avseende-elektas-delarsrapport-for-maj-juli-201314/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elektas-arsredovisning-for-201213-finns-nu-tillganglig-pa-elektas-webbplats/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/forlikning-traffad-avseende-stamningen-fran-varian-medical-systems/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/antalet-utestaende-aktier-i-elekta-ab-publ-2013-07-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/froedtert--medical-college-of-wisconsin-clinical-cancer-center-ansluter-till-elektas-och-philips-forskningskonsortium-for-mri-styrd-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elektas-leksell-gamma-knife-perfexion-rankas-som-nummer-ett-av-amerikanska-klas/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-fokuserar-pa-fortsatt-stark-tillvaxt-och-okar-satsningarna-pa-forskning-och-utveckling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-och-equra-health-i-samarbete-for-att-oka-tillgangen-pa-stralterapi-i-sydafrika/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/bokslutskommunike-maj--april-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/antalet-utestaende-aktier-i-elekta-ab-publ-2013-05-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/paminnelse-inbjudan-till-elektas-kapitalmarknadsdag-i-stockholm-den-12-juni-2013/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/st-jamess-institute-of-oncology-i-storbritannien-koper-tva-versa-hd-system/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elektas-valberednings-forslag-infor-arsstamman-2013/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/inbjudan-till-telefonkonferens-avseende-elektas-bokslutskommunike-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/kanadensiska-sunnybrook-health-sciences-centre-ny-medlem-i-elektas-och-philips-forskningskonsortium-for-mri-styrd-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/antalet-utestaende-aktier-i-elekta-ab-publ-2013-04-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elektas-och-philips-forskningskonsortium-for-mri-styrd-stralbehandling-utokas-med-nederlandska-cancerinstitutet-vid-antoni-van-leeuwenhoek-sjukhuset/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/md-anderson-cancer-center-i-houston-forvarvar-tva-versa-hd-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/akademiska-sjukhuset-i-uppsala-forbattrar-hastighet-och-precision-vid-stralterapibehandling-genom-elektas-stralformeringsteknik/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/klartecken-for-elektas-nya-stralterapisystem-versa-hd-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/christie-nhs-foundation-trust-lyfter-stralbehandlingen-till-ny-niva-med-versa-hd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/hopital-rivieras-i-schweiz-forvarvar-versa-hd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/odense-universitetssjukhus-i-danmark-bestaller-elektas-nya-stralterapissystem-versa-hd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/kuopio-universitetssjukhus-forst-i-finland-med-elektas-nya-stralformeringslosning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/delarsrapport-maj--januari-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-satter-ny-niva-for-cancerbehandlingar-med-lanseringen-av-versa-hd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/telefonkonferens-avseende-elektas-delarsrapport-for-maj-januari-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/banner-md-anderson-cancer-center-forvarvar-cancerbehandlingssystem-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/ny-stralbehandlingsteknik-fran-elekta-formar-framtidens-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/antalet-utestaende-aktier-i-elekta-ab-publ-2013-01-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2013/elekta-och-philips-i-samarbete-med-university-of-texas-md-anderson-cancer-center-kring-mri-styrd-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/programvaran-clarity-for-visualisering-av-mjukvavnad-neutraliserar-organrorelser-vid-stralbehandling-av-prostatacancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/delarsrapport-maj--oktober-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-11-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/telefonkonferens-avseende-elektas-delarsrapport-for-maj-oktober-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-vaxer-genom-innovation-for-att-oka-anvandningen-av-stralbehandling-och-gora-livet-battre-for-cancerpatienter/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-och-dess-distributor-tecknar-avtal-om-tillverkning-av-stralbehandlings-utrustning-i-ryssland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-och-philips-i-forskningssamarbete-for-att-skapa-banbrytande-cancervard-genom-integrering-av-linjaraccelerator-och-magnetresonansavbildning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elektas-valberedning-infor-arsstamman-2013/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/global-rackvidd-for-agility--elektas-innovativa-stralformningslosning-vid-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/nederlandsk-klinik-forst-i-landet-med-att-behandla-cancerpatienter-med-elektas-stralformningslosning-agility-vid-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/danska-kliniker-ser-fordelar-for-cancerpatienter-med-elektas-innovativa-stralformningslosning-vid-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-09-28/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/valkommen-till-kapitalmarknadsdag-pa-astro-boston-29-oktober-2012/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/omrakning-av-konverteringskurs-i-elektas-konvertibel-med-anledning-av-beslut-om-uppdelning-av-elektas-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/kommunike-fran-elektas-arsstamma-2012/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/delarsrapport-maj--juli-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-vinner-upphandling-i-kina-vard-35-miljoner-usd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/varian-medical-systems-stammer-elekta-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/telefonkonferens-avseende-elektas-delarsrapport-for-maj-juli-201213/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elektas-arsredovisning-for-201112-finns-nu-tillganglig-pa-elektas-webbplats/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-utser-ian-alexander-till-executive-vice-president-region-europa-och-afrika-latinamerika-och-mellanostern/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-07-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/snabbare-och-tillforlitligare-cancerbehandling-i-japan-efter-godkannandet-av-agility--elektas-innovation-for-stralformning-vid-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-integrerar-patientpositioneringsteknik-fran-brainlab-i-sina-behandlingssystem-for-okad-bekvamlighet-for-cancerpatienter/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-06-29/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-ser-flera-mojligheter-till-fortsatt-stark-tillvaxt/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-forvarvar-radon-ltda-och-starker-sin-position-i-brasilien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elektas-valberednings-forslag-till-styrelse-och-revisor-infor-arsstamman-2012/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/brittiska-nhs-supply-chain-forvarvar-tio-linjaracceleratorer-for-behandling-av-cancer-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/patienter-och-kliniker-i-usa-kommer-fa-del-av-ny-revolutionerande-stralformning-vid-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/bokslutskommunike-maj--april-201112/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/forandringar-i-elektas-koncernledning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-05-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/us-oncology-network-valjer-elektas-onkologiinformationssystem-mosaiq-som-standard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/inbjudan-till-telefonkonferens-avseende-elektas-bokslutskommunike/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elekta-pionjar-inom-modern-cancervard-genom-ledande-forskning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/inbjudan-till-elektas-kapitalmarknadsdag---stockholm-den-19-juni-2012/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-04-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/forsta-cancerpatienterna-har-behandlats-med-banbrytande-teknik-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/elektas-nya-flerbladskollimator-agility-revolutionerar-stralformning-vid-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-03-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/svensk-uppfinning-fick-varldens-langsta-man-att-sluta-vaxa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/delarsrapport-maj--januari-201112/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/extra-bolagsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-02-29/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/inbjudan-till-telefonkonferens-avseende-elektas-niomanadersrapport/https://ir.elekta.com/sv/investerare/pressmeddelanden/2012/antalet-utestaende-aktier-i-elekta-ab-publ-2012-01-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-ledande-pa-tillvaxtmarknader/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/halvarsrapport-maj--oktober-201112/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-11-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/inbjudan-till-elektas-kapitalmarknadsdag-med-fokus-pa-tillvaxtmarknader---stockholm-den-12-december/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/inbjudan-till-telefonkonferens-avseende-elektas-halvarsrapport/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-far-klartecken-510k-fran-fda-for-apex-dynamisk-flerbladskollimator/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-10-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elektas-styrelseledamot-vera-kallmeyer-avliden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elektas-valberedning-infor-arsstamman-2012/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/tillvaxt-genom-innovation-och-elektas-strategi-inom-brachyterapi-stod-i-fokus-pa-kapitalmarknadsdagen-i-samband-med-astros-arsmote/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-avyttrar-informationssystem-for-anatomisk-patologi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/gilbert-wai-utsedd-till-executive-vice-president-asien-och-stillahavsregionen-och-medlem-i-elektas-koncernledning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/nucletron-som-ingar-i-elektakoncernen-far-klartecken-510-k-fran-fda-for-precise-vaginal-ctmr-multi-channel-applicator/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-09-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/jos-lamers-ny-medlem-i-elektas-koncernledning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-slutfor-forvarvet-av-nucletron/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/kommunike-fran-elektas-arsstamma-2011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elektas-forvarv-av-nucletron-far-konkurrensmyndigheters-godkannande/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/delarsrapport-maj--juli-201112/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-08-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elektas-arsredovisning-201011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/valkommen-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-07-29/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-07-01/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elektas-valberednings-forslag-till-ny-styrelse-infor-arsstamman-2011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-tecknar-avtal-om-forvarv-av-nucletron--kompletterar-produktsortimentet-med-varldsledande-brachy-teknologi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-presenterar-prioriteringar-for-fortsatt-forsaljningstillvaxt-och-lonsamhet/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-raknar-med-accelererad-omsattningstillvaxt-och-fortsatt-stark-ebit-tillvaxt/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/bokslutskommunike-maj--april-201011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/elekta-tar-upp-nya-lan-genom-private-placement-om-200-miljoner-usd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-04-29/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/wake-forest-university-baptist-medical-center-valjer-elekta-som-leverantor-for-omfattande-uppgradering-av-onkologikliniker/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/niomanadersrapport-maj--januari-201011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-02-28/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/antalet-utestaende-aktier-i-elekta-ab-publ-2011-01-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2011/ny-ledamot-i-elektas-valberedning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/antalet-utestaende-aktier-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-saljer-andel-i-motala-verkstad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-tecknar-forsaljnings--och-marknadsforingsavtal-med-toshiba-i-japan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/halvarsrapport-maj--oktober-201011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/antalet-utestaende-aktier-i-elekta-ab-publ-2010-11-30/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elektas-valberedning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-och-karolinska-universitetssjukhuset-i-forskningssamarbete-om-stereotaktisk-stralterapi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/kina-okar-tillgang-till-cancervard-med-tre-leksell-gamma-knife/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/cancerbehandling-med-hogsta-precision-och-tillvaxtfaktorer-i-fokus-vid-kapitalmarknadsdag-pa-astro-mote/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/antalet-utestaende-aktier-i-elekta-ab-publ-2010-11-01/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/antal-utestaende-aktier-i-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/kommunike-fran-elektas-arsstamma-2010/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/tremanadersrapport-maj--juli-201011/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elektas-arsredovisning-200910/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/antal-utestaende-aktier-i-elekta-2010-09-02/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-oppnar-kontor-i-sydkorea-for-att-stodja-landets-okande-behov-av-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/jan-secher-foreslas-som-ny-medlem-i-elektas-styrelse/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/aterkop-av-aktier-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/bokslutskommunike-maj--april-200910/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/bokslutskommunike-maj--april-200910-2010-06-09/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-lanserar-nasta-generations-meg-system/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-forvarvar-resonant-medical-inc-och-far-tillgang-till-nya--losningar-for-bildstyrd-stralbehandling-mot-cancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/swedish-cancer-institute-och-elekta-i-mangarigt-omfattande-strategiskt-samarbete-for-battre-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/todd-powell-ny-chef-for-elekta-software/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/karolinska-universitetssjukhuset-koper-leksell-gamma-knife-perfexion/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/elekta-utser-ny-chef-for-verksamheten-i-asien-och-stillahavsregionen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/niomanadersrapport-maj--januari-200910/https://ir.elekta.com/sv/investerare/pressmeddelanden/2010/niomanadersrapport-maj--januari-200910-2010-03-10/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-vinner-pris-for-basta-tillverkning-i-storbritannien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/halvarsrapport-maj--oktober-200910/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elektas-valberedning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-presenterar-nya-losningar-for-bildstyrning-vid-kapitalmarknadsdag-i-chigaco-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-fortatter-vaxa-pa-betydande-tillvaxtmarknader-levererar-kliniska-losningar-till-9-cancerkliniker-i-ryssland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elektas-behandlingsprogram-extend-far-fda-510-k-godkannande/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/massachusetts-general-hospital-valjer-elekta-till-ny-leverantor-av-kompletta-losningar-for-behandling-av-cancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/kommunike-fran-elektas-arsstamma-2009/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/tremanadersrapport-maj--juli-200910/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elektas-arsredovisning-200809/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/iba-valjer-elektas-mjukvara-till-protonterapicenter-i-prag/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-utser-ny-chef-for-nordamerikanska-verksamheten/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/kallelse-till-arsstamma-i-elekta-ab/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-far-order-pa-flera-elekta-system-fran-icesp-i-brasilien-och-skapar-center-for-utbildning-och-produktutveckling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/procure-och-integris-valjer-mjukvarulosningar-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-far-fda-510-k-godkannande-for-monaco-med-vmat-for-behandlingsplanering/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-valjer-c-rad-sentinel-for-overvakning-av-intrafraktionell-rorelse/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-och-swedfund-investerar-i-cancervard-i-utvecklingslander/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-levererar-vmat--och-stralkirurgilosningar-till-centrastate-medical-center/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-och-svensk-exportkredit-tecknar-samarbetsavtal/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/bokslutskommunike-maj--april-200809/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-tecknar-ett-langsiktigt-strategiskt-samarbetsavtal-med-ottawa-hospital/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/procure-treatment-centers-utrustar-anlaggning-i-chicago-med-mjukvarusystem-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-och-nucletron-i-samarbete-for-att-marknadsfora-ledande-mjukvara/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/cancerklinik-i-storbritannien-inleder-innovativ-stralbehandling-med-fyra-system-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-utvalt-att-leverera-sofistikerad-utrustning-for-kartlaggning-av-hjarnaktivitet-till-the-mind-research-network/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/antal-utestaende-aktier-i-elekta-per-den-31-mars-2009/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/niomanadersrapport-maj--januari-200809/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/forsta-japanska-patienterna-behandlade-med-leksell-gamma-knife-perfexion/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/m-d-andersson-cancer-center-valjer-leksell-gamma-knife-perfexion-for-hogprecisionsbehandling-av-hjarnsjukdomar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/ny-behandlingsmetod-ger-hopp-till-ryska-cancerpatienter/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/cancerpatienter-i-sverige-och-estland-far-snabbare-och-mer-precis-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2009/elekta-har-fatt-godkannande-for-elekta-compact-i-kina/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/ledande-universitet-i-europa-valjer-elektas-avancerade-forskningsutrustning-for-kartlaggning-av-hjarnan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elektas-chef-for-region-asien-har-omkommit-i-flygolycka/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/halvarsrapport-maj--oktober-200809/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elektas-valberedning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-installerar-leksell-gamma-knife-perfexion-vid-hauklands-universitetssjukhus-i-norge/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/wake-forest-university-baptist-medical-center-forbattrar-cancerbehandlingen-med-stralkirurgisystem-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-samarbetar-for-att-stodja-utvecklingen-av-avancerad-sjukvard-i-ukraina---donation-av-system-for-hjarnkirurgi-overlamnad-i-narvaro-av-hennes-majestat-drottning-silvia/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/odense-sjukhus-i-danmark-forst-i-skandinavien-att-erbjuda-ny-och-innovativ-teknologi-fran-elekta-for-snabbare-och-mer-precis-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/kommunike-fran-elektas-arsstamma-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/thompson-cancer-survival-center-i-tennessee-forstarker-sitt-vardprogram-med-elekta-infinity/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/delarsrapport-maj--juli-200809/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elektas-arsredovisning-200708/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/kallelse-till-bolagsstamma-i-elekta-ab/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-29-august-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/skagit-valley-hospital-skapar-nya-mojligheter-till-avancerad-cancerbehandling-med-elekta-axesse/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-31-juli-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-30-juni-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-vmat-far-fda-godkannande/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/bokslutskommunike-maj--april-200708/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-tecknar-strategiskt-multi-centeravtal-med-mary-bird-perkins-cancer-center-for-leverans-av-stralbehandlingssystem/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-30-maj-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/leksell-gamma-knife-perfexion-far-myndighetsgodkannande-i-japan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/institut-for-stralsakerhet-i-australien-valjer-elekta-synergy-som-sitt-referenssystem-for-kalibrering-och-dosimetri/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-far-order-att-leverera-ett-omfattande-paket-med-avancerad-teknologi-for-cancerbehandling-till-ett-nytt-sjukhus-i-sydney-inklusive-den-forsta-gammakniven-till-australien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-30-april-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-tecknar-sin-forsta-order-fran-nya-zeeland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-31-mars-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/niomanadersrapport-maj--januari-200708/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-slutfor-forvarvet-av-cms/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/antal-utestaende-aktier-i-elekta-per-den-29-februari-2008/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-tecknar-avtal-om-att-forvarva-cms/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-har-aterkopt-egna-aktier-for-100-mkr/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-inleder-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elektas-styrelse-beslutar-om-aterkop-av-egna-aktier-samt-reviderar-finansiellt-mal-avseende-skuldsattningsgrad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-far-order-att-leverera-avancerad-utrustning-for-bildstyrd-stralterapi-till-universitetssjukhuset-i-poitiers-frankrike/https://ir.elekta.com/sv/investerare/pressmeddelanden/2008/elekta-forhandlar-om-forvarv-av-cms/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-ab---halvarsrapport-maj--oktober-200708/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/antal-utestaende-aktier-i-elekta-per-den-30-november-2007/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elektas-grundare-och-styrelseledamot-laurent-leksell-utsedd-till-arets-entreprenor--representerar-sverige-i-varldsfinalen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/cancerpatienter-i-belgien-far-tillgang-till-avancerad-stralbehandling-tack-vare-teknologi-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/antal-utestaende-aktier-i-elekta-per-den-31-oktober-2007/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/iba-och-elekta-inleder-ett-globalt-samarbete-kring-partikelterapi-i-samband-med-astro/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elektas-valberedning-utsedd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/milanos-ledande-sjukhus-ospedale-niguarda-valjer-leksell-gamma-knife-perfexion-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/antal-utestaende-aktier-i-elekta-per-28-september-2007/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-vinner-upphandling-att-utrusta-ett-nytt-sjukhus-i-osterrike-med-en-heltackande-losning-for-avancerad-stralbehandling-av-cancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-utvalt-att-leverera-avancerade-stralterapisystem-till-greklands-storsta-privata-sjukhus/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elektas-arsstamma-2007/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/tva-nya-italienska-cancerkliniker-valjer-avancerad-stralterapiutrustning-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-ab---tremanadersrapport-maj--juli-200708/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elektas-arsredovisning-200607-publicerad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-ab-publ---arsredovisning-200607/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-presenterar-nytt-stralterapisystem-vid-estro-2007--underlattar-utbyggnad-av-kapacitet-for-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/antal-utestaende-aktier-i-elekta-per-31-augusti-2007/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/rattelse-av-kallelse-till-arsstamma-i-elekta-ab-publ/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/kallelse-till-elektas-bolagsstamma/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/johns-hopkins-utokar-kapaciteten-for-cancerbehandling-med-elekta-synergy-s/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/barnes-jewish-hospital-i-illinois-usa-uppgraderar-sitt-stralkirurgiprogram-med-leksell-gamma-knife-perfexion/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-far-order-att-leverera-leksell-gamma-knife-till-st-petersburg-ryssland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/antal-utestaende-aktier-i-elekta-per-31-juli-2007/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-har-aterkopt-egna-aktier-for-100-mkr/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-inleder-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elektas-styrelse-beslutar-om-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-far-order-att-leverera-ytterligare-system-for-avancerad-stralbehandling-till-royal-marsden-hospital-i-london/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/leksell-gamma-knife-perfexion-satter-ny-standard-for-snabb-effektiv-och-exakt-stralkirurgisk-behandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/bokslutskommunike-maj--april-200607/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/ny-gammaknivsklinik-i-lissabon-portugal-valjer-leksell-gamma-knife-perfexion-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-neuromag-tecknar-produktionsavtal-med-innokas-medical/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-far-order-att-leverera-avancerad-teknologi-for-bildstyrd-stralterapi-till-vejle-sjukhus-i-danmark/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-slutfor-forvarvet-av-3d-line-medical-systems/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-slutfor-forvarvet-av-3d-line-medical-systems-2007-05-03/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-far-order-att-leverera-den-forsta-leksell-gamma-knifer-perfexion-till-indien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-har-refinansierat-sin-femariga-bankkredit/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-forvarvar-3d-line-medical-systems/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-har-aterkopt-egna-aktier-for-100-mkr-2007-03-19/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-inleder-aterkop-av-egna-aktier-2007-03-13/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elektas-styrelse-beslutar-om-aterkop-av-egna-aktier-2007-03-09/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-ab---niomanadersrapport-maj--januari-200607/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-utvalt-att-leverera-avancerad-teknologi-for-kartlaggning-av-hjarnan-till-universitetsklinik-i-jena-tyskland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/the-london-gamma-knife-centre-valjer-leksell-gamma-knife-perfexion--fler-patienter-kan-dra-nytta-av-stralkirurgi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/landeskrankenhaus-feldkirch-forbattrar-varden-for-cancerpatienter-i-vastra-osterrike-med-hjalp-av-teknologi-och-mjukvara-fran-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/velindre-cancer-center-valjer-elekta-synergy-for-bildstyrd-stralbehandling-av-cancer-inom-ramen-for-ett-regionalt-program-for-forbattrad-cancervard-i-wales/https://ir.elekta.com/sv/investerare/pressmeddelanden/2007/elekta-kommer-att-leverera-leksell-gamma-knife-perfexion-till-upmc/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-valberedning-utsedd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/halvarsrapport-maj--oktober-200607/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/nih-finansierar-cancerstudie-dar-teknologi-fran-elekta-anvands-for-att-forbattra-behandlingen-av-lungtumorer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/ledande-cancerklinik-i-kanada-effektiviserar-och-forbattrar-stralbehandlingen-med-hjalp-av-elekta-synergy-och-impacs-mosaiq-oncology-pacs/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-ordforande-akbar-seddigh-tilldelas-guldklubban-for-fortjanstfullt-ordforandeskap/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-uppdrag-att-under-30-ar-leverera-utrustning-och-service-till-ny-cancerklinik-i-storbritannien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-order-att-leverera-fyra-leksell-gamma-knife-perfexion-till-kunder-till-american-shared-hospital-services--gamma-knife-financing/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-uppdrag-att-leverera-den-forsta-gammakniven-till-kuwait/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-vinner-upphandling-att-leverera-avancerad-teknologi-for-kartlaggning-av-hjarnan-till-ledande-institut-i-tyskland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-order-att-leverera-fyra-avancerade-stralbehandlingsystem-till-irland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/alexian-brothers-koper-elekta-neuromag-den-varldsledande-teknologin-for-kartlaggning-av-hjarnan-i-realtid/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/cancerklinik-i-kentucky-forbattrar-varden-med-hjalp-av-elektas-teknologi-for-bildstyrd-stralterapi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-arsstamma-2006/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/tremanadersrapport-maj--juli-200607/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-arsredovisning-200506-publicerad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-ab-publ---arsredovisning-200506/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-order-att-leverera-leksell-gamma-knife-perfexion-till-university-of-virginia/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-tecknar-avtal-med-us-oncology/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-slutfor-forvarvet-av-80-procent-av-bmei/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-fda-godkannande-for-leksell-gamma-knife-perfexion/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/kallelse-till-elektas-bolagsstamma/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-order-pa-leksell-gamma-knife-perfexion-fran-cromwell-hospital-i-london/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-behandlingssystem-for-leksell-gamma-knife-perfexion-erhaller-amerikanskt-myndighetsgodkannande/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/forsta-patienten-behandlad-med-leksell-gamma-knife-perfexion/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-har-aterkopt-egna-aktier-for-100-mkr/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-utvalt-att-leverera-nya-behandlingssystem-till-cancerkliniken-pa-odense-universitetssjukhus/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-inleder-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-styrelse-beslutar-om-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-synergy-erhaller-myndighetsgodkannande-i-japan-och-leveranser-paborjas-omgaende/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/bokslutskommunike-1-maj---30-april-200506/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-satter-ny-standard-for-stereotaktisk-stralkirurgi-genom-lanseringen-av-leksell-gamma-knife-perfexiontm/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-samlar-300-neurokirurger-stralterapeuter-och-gammaknivsanvandare-i-seoul-korea/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-utvalt-att-leverera-till-fem-brittiska-sjukhus-inom-ramen-for-nhs-investeringsprogram/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-forstarker-sitt-langsiktiga-samarbete-med-upmc-genom-elekta-axesse/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-ett-flertal-order-pa-elekta-synergy-fran-providence-health-system-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-ett-flertal-order-pa-elekta-synergy-fran-australien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-lanserar-ny-bildstyrd-och-stereotaktisk-losning-som-forstarker-produktportfoljen-for-behandling-av-cancer-i-hjarnan-ryggraden-och-ovriga-kroppen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-ar-utvalt-att-leverera-heltackande-it-system-for-cancervarden-till-ledande-sjukhus-i-london/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-utvalt-att-leverera-sofistikerad-utrustning-for-tredimensionell-kartlaggning-av-hjarnan-till-ledande-brittiskt-forskningscentrum/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-starker-produktportfoljen-inom-stereotaktisk-planering/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-forvarvar-bmei-den-ledande-kinesiska-leverantoren-av-utrustning-for-stralbehandling-av-cancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-serviceverksamhet-far-hoga-betyg-i-studie-bland-amerikanska-radioterapikliniker/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-avancerade-losningar-for-stralbehandling-av-cancer-blir-nu-tillgangliga-for-patienter-i-polen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/niomanadersrapport-1-maj---31-januari-200506/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-redovisar-en-rorelsemarginal-pa-9-procent-for-tredje-kvartalet--for-helaret-forvantas-en-rorelsemarginal-pa-cirka-10-procent/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-tecknar-ramavtal-med-medassets-en-amerikansk-inkopsorganisation-omfattande-stralbehandling-av-cancer-och-it-losningar-for-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-far-order-att-leverera-heltackande-impac-system-till-university-hospitals-coventry--warwickshire-nhs-trust/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-avancerade-losningar-for-stralbehandling-av-cancer-blir-nu-tillgangliga-for-patienter-i-hong-kong/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elekta-och-mejan-labs-inleder-ny-form-av-samarbete-mellan-foretagsamhet-och-konstvarlden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/elektas-valberedning-utsedd-2006-01-16/https://ir.elekta.com/sv/investerare/pressmeddelanden/2006/university-of-florida-shands-cancer-center-ger-nytt-hopp-till-patienter-med-ryggradstumorer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-far-leverera-leksell-gamma-knife-till-vietnam/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/halvarsrapport-1-maj---31-oktober-200506/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-erhaller-order-att-leverera-impacs-kompletta-it-losningar-till-generidis-natverk-av-privata-stralbehandlingskliniker/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-forvarvar-medical-intelligence/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-far-order-pa-att-leverera-den-senaste-versionen-av-leksell-gamma-knife-till-indien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-erhaller-myndighetsgodkannande-i-japan-for-leksell-gamma-knife-4c/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elektas-och-impacs-anvandare-visar-kliniska-resultat-pa-astro--ny-mjukvara-presenterad-for-integrerat-arbetsflode-vid-bildstyrd-stralterapi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-verkstaller-aktiesplit-31/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elektas-losningar-for-bildstyrd-stralterapi-far-myndighetsgodkannande-i-kanada/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elektas-losningar-dominerade-de-kliniska-presentationerna-kring-bildstyrd-stralterapi-vid-stor-europeisk-konferens/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-utser-ny-verkstallande-direktor-for-impac-den-tidigare-vdn-utsedd-till-global-chef-for-produktutveckling-for-hela-elektakoncernen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-tecknar-ett-exklusivt-femarigt-avtal-med-providence-health-system/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elektas-ordinarie-bolagsstamma-2005/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/tremanadersrapport-1-maj---31-juli-200506/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elektas-arsredovisning-200405-publicerad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-ab-publ---arsredovisning-200405/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-starker-sin-langsiktiga-finansieringsstruktur-och-genomfor-en-sk-private-placement-med-amerikanska-institutionella-investerare/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/kallelse-till-elektas-bolagsstamma/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-fortsatter-utvecklingen-av-bildstyrd-stralterapi-genom-lansering-och-fda-godkannade-av-en-ny-generation-mjukvara-for-elekta-synergy/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-visar-upp-overlagsen-kvalitet-inom-igrt-vid-fysikermote/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-och-medical-intelligence-tecknar-internationellt-distributionsavtal-kring-kompletta-losningar-for-stereotaktisk-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-faststaller-nya-finansiella-mal-och-foreslar-utdelning-pa-660-kr/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/bokslutskommunike-1-maj---30-april-200405/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-far-order-att-leverera-10-linjaracceleratorer-till-venezuela-inom-ramen-for-en-satsning-pa-att-mangfaldiga-landets-kapacitet-for-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-och-impac-far-order-att-leverera-heltackande-behandlings--och-it-system-till-franskt-sjukhus/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-far-order-av-varldsledande-kanadensiskt-cancercentrum/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/tomas-puusepp-tilltrader-som-vd-for-elekta--nya-chefer-utsedda-for-global-forsaljning-och-for-marknadsregion-europa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-forstarker-sitt-ledarskap-inom-neurokirurgi-vid-aans/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elektas-nomineringskommitte-utsedd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-ab-slutfor-forvarvet-av-impac-medical-systems-inc/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta--impac-meddelar-att-tidsperioden-nu-har-lopt-ut-for-granskning-under-amerikansk-konkurrenslagstiftning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-neuromag-far-myndighetsgodkannande-i-kanada/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-synergy-forbattrar-behandlingen-vid-ledande-cancerinstitut-i-holland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta---niomanadersrapport-1-maj---31-januari-200405/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta--impac-informerar-ang-planerat-forvarv/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-neuromag-forstarker-hjarnforskningen-pa-ucsd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-far-order-pa-meg-system-fran-ledande-institutioner-i-storbritannien-japan-och-kina/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-har-aterkopt-egna-aktier-for-50-mkr/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-inleder-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2005/elekta-ab-forvarvar-impac-medical-systems-inc/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-styrelse-beslutar-om-aterkop-av-egna-aktier/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta---halvarsrapport-1-maj---31-oktober-200405/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-far-leverera-avancerad-utrustning-for-hjarnforskning-till-universitetssjukhuset-i-seoul/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-utsedd-till-leverantor-i-den-storsta-privatfinansierade-cancersatsningen-i-storbritanniens-historia/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-befaster-sin-ledande-position-inom-bildstyrd-stralterapi-vid-den-arliga-astro-kongressen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-och-impac-medical-systems-tecknar-avtal-om-forsaljningssamarbete/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-lanserar-sjukdomsspecifika-losningar-for-forbattrad-cancerbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-introducerar-elekta-capital-for-finansiering-av-avancerade-kliniska-losningar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-ordinarie-bolagsstamma-2004/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-verkstallande-direktor-dr-laurent-leksell-axlar-ny-roll-som-arbetande-styrelseledamot---tomas-puusepp-utsedd-ti/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/tremanadersrapport-1-maj---31-juli-200405/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-arsredovisning-200304-publicerad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/arsredovisning-2003-2004/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-styrelse-foreslar-nytt-incitamentsprogram/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/kallelse-till-elektas-bolagsstamma---forslag-kring-aterkop-av-aktier-samt-incitamentsprogram/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-forbattrar-noggrannheten-vid-behandling-av-cancer-med-hjalp-av-ultraljud-fran-north-american-scientific/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/upmc-starker-sin-position-inom-neurokirurgi-med-hjalp-av-elekta-neuromag-meg/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/cancerklinik-installerar-elekta-intellimax-for-maximal-tillganglighet-och-prestanda/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-tecknar-viktigt-stralterapiavtal-med-ledande-amerikansk-inkopsorganisation/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/ledande-amerikanska-inkopsorganisationer-forlitar-sig-pa-elekta-for-avancerade-kliniska-losningar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-etablerar-nytt-dotterbolag-i-australien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-skriver-avtal-med-consorta-om-att-bli-prioriterad-leverantor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-etablerar-internationella-forskningscentra-for-elekta-neuromag-elektas-system-for-magnetencefalografi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/amerikansk-domstol-forklarar-patenttvist-avgjord/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/nytt-hopp-i-den-intensifierade-kampen-mot-glaukom-gron-starr/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/bokslutskommunike-1-maj---30-april-200304/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-nomineringskommitte-utsedd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-far-pris-for-exportframgangar/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-visar-upp-nya-losningar-for-stralbehandling-pa-aans/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-utser-ny-chef-for-sin-verksamhet-i-nordamerika/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-uppdaterar-sitt-mottagarregister-for-pressmeddelanden/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-erhaller-myndighetsgodkannande-i-japan-for-den-senaste-modellen-av-leksell-gamma-knife/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-motpart-i-patenttvist-nekas-provning-i-usas-hogsta-domstol/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-levererar-den-forsta-stralkniven-till-ryssland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-levererar-nasta-generations-utrustning-for-bildstyrd-stralterapi-till-uc-davis-i-kalifornien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta-i-usa-far-exportpriset-achievement-award-2004-for-corporate-excellence/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/niomanadersrapport-1-maj---31-januari-200304/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elekta---utbetalning-av-inlosen/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/niomanadersrapport-1-maj---31-januari-200304-2004-03-10/https://ir.elekta.com/sv/investerare/pressmeddelanden/2004/elektas-motpart-i-patenttvist-ansoker-om-provning-i-usas-hogsta-domstol/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-bidrar-till-uppbyggnaden-av-avancerad-sjukvard-i-irak/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/halvarsrapport-1-maj---31-oktober-200304/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/halvarsrapport-1-maj---31-oktober-200304-2003-12-08/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-och-impac-medical-systems-traffar-avtal-om-gemensam-utveckling-av-nytt-granssnitt-for-linjaracceleratorer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elektas-inlosenprogram-avslutat/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-tecknar-leverantortsavtal-med-catholic-health-east/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elektas-motpart-i-amerikansk-patenttvist-nekas-omprovning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-far-fda-godkannande-for-elekta-synergy-tm/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elektas-revolutionerande-system-mojliggor-framsteg-inom-stralterapi/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-installerar-dagens-modernaste-utrustning-for-stralbehandling-av-cancer-pa-thomas-jefferson-universitetet-i-philad/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-invites-you-to-a-capital-markets-day-in-crawley-uk-on-november-14/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-vinner-overklagande-i-amerikansk-patenttvist/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elektas-ordinarie-bolagsstamma-2003/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/tremanadersrapport-1-maj---31-juli-200304/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/tremanadersrapport-1-maj---31-juli-200304-2003-09-22/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-far-forsta-order-pa-elekta-synergytm-i-tyskland/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/styrelsens-forslag-till-villkor-for-inlosen-av-aktier-i-elekta/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/arsredovisning-2002-2003/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/niomanadersrapport-1-maj---31-januari-200203/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-far-bestallningar-pa-leksell-gamma-knifer-i-usa-japan-kina-taiwan-och-frankrike-pa-totalt-315-miljoner-krono/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-nyrekryterar-till-sin-informationsavdelning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/niomanadersrapport-1-maj---31-januari-200203-2003-03-11/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-forstarker-sin-ledande-stallning-inom-neurokirurgi-genom-forvarv-av-ett-foretag-verksamt-inom-registrering-av-hja/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-kommenterar-beslut-av-stockholmsborsens-disciplinnamnd/https://ir.elekta.com/sv/investerare/pressmeddelanden/2003/elekta-far-bestallningar-pa-leksell-gamma-knife-pa-totalt-123-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-finansierar-satsningar-inom-forskning-och-utveckling-med-langfristigt-lan/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/halvarsrapport-1-maj---31-oktober-200203/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallning-pa-utrustning-for-stralbehandling-av-cancer-i-nederlanderna-pa-160-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-och-mds-nordion-tecknar-ett-globalt-marknadssamarbete-inom-stralbehandling-av-cancer/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elektas-ordinarie-bolagsstamma-2002/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elektas-patenttvist-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-erhaller-domslut-i-forsta-instans-i-patenttvist/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/tremanadersrapport-1-maj---31-juli-200203/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/arsredovisning-2001-2002/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallningar-pa-leksell-gamma-knife-i-usa-japan-och-italien-pa-totalt-160-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elektas-optionsprogram/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-investerar-i-nystartat-svenskt-foretag-inom-cancervard/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-beslutar-om-ny-organisation-samt-forstarkt-koncernledning/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/bokslutskommunike-1-maj---30-april-200102/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallningar-pa-leksell-gamma-knife-i-usa-och-europa-pa-totalt-110-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/niomanadersrapport-1-maj---31-januari-200102/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallningar-pa-leksell-gamma-knifer-i-grekland-och-italien-pa-totalt-70-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallningar-pa-leksell-gamma-knifer-i-grekland-och-italien-pa-totalt-70-miljoner-kronor-2002-03-11/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallning-pa-leksell-gamma-knifer-i-kanada/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-domstolsutslag-i-amerikansk-patenttvist/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-tecknar-ett-strategiskt-avtal-om-distribution-av-magnetencefalografer-i-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-bestallningar-pa-leksell-gamma-knife-i-usa-pa-totalt-97-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-installerar-utrustning-for-stralbehandling-av-cancer-med-imrt-pa-akademiska-sjukhuset-i-uppsala/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-order-pa-80-miljoner-kronor-pa-utrustning-for-stralbehandling-av-cancer-i-frankrike-och-australien/https://ir.elekta.com/sv/investerare/pressmeddelanden/2002/elekta-far-order-pa-120-miljoner-kronor-pa-utrustning-for-stralbehandling-av-cancer-i-nordamerika/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/halvarsrapport-1-maj---31-oktober-200102/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-levererar-leksell-gamma-knife-till-sophiahemmet-i-stockholm/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-far-bestallningar-pa-leksell-gamma-knife-pa-totalt-155-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elektas-ordinarie-bolagsstamma-2001/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/tremanadersrapport-1-maj---31-juli-200102/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/arsredovisning-2000-2001/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-far-bestallningar-pa-utrustning-for-stralbehandling-av-cancer-pa-totalt-250-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-ingar-samarbete-med-adac-inom-stralbehandling-av-cancer-med-imrt-intensitetsmodulerad-stralbehandling/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-saljer-leksell-gamma-knife-c-stralkniv-till-usa/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-erhaller-pa-nytt-order-pa-linjaracceleratorer-i-storbritannien-och-tillkannager-utvigning-av-produktionskapacitet/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-saljer-leksell-gamma-knife-c-stralkniv-till-usa-2001-06-25/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/bokslutskommunike-1-maj---30-april-200001/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-far-bestallningar-pa-leksell-gamma-knife-pa-totalt-280-miljoner-kronor/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/elekta-har-fatt-godkannande-fran-amerikanska-food-and-drug-administration-att-distribuera-sitt-system-for-bildregistreri/https://ir.elekta.com/sv/investerare/pressmeddelanden/2001/niomanadersrapport-1-maj---31-januari-200001/https://ir.elekta.com/sv/investerare/pressmeddelanden/2000/halvarsrapport-1-maj---31-oktober-200001/https://ir.elekta.com/sv/investerare/pressmeddelanden/2000/tremanadersrapport-1-maj---31-juli-20002001/https://ir.elekta.com/sv/investerare/pressmeddelanden/2000/arsredovisning-19992000/https://ir.elekta.com/sv/investerare/pressmeddelanden/2000/bokslutskommunike-1-maj---30-april-19992000/https://ir.elekta.com/sv/investerare/pressmeddelanden/2000/niomanadersrapport-1-maj---31-januari-19992000/https://ir.elekta.com/sv/investerare/pressmeddelanden/1999/halvarsrapport-1-maj---31-oktober-19992000/https://ir.elekta.com/sv/investerare/pressmeddelanden/1999/tremanadersrapport-1-maj-1999---31-juli-1999/https://ir.elekta.com/sv/investerare/pressmeddelanden/1999/bokslutskommunike-1-maj-1998---30-april-1999/https://ir.elekta.com/sv/investerare/pressmeddelanden/1999/arsredovisning-1998-1999/https://ir.elekta.com/sv/investerare/pressmeddelanden/1999/niomanadersrapport-1-maj-1998---31-januari-1999/https://ir.elekta.com/sv/investerare/ir-kalender/https://ir.elekta.com/sv/investerare/ir-kalender/2023/jefferies-pan-european-mid-cap-konferens/https://ir.elekta.com/sv/investerare/ir-kalender/2023/bofa-global-healthcare-conference-london/https://ir.elekta.com/sv/investerare/ir-kalender/2026/https://ir.elekta.com/sv/investerare/ir-kontakter/https://ir.elekta.com/sv/investerare/prenumerera/https://ir.elekta.com/sv/investerare/prenumerera/subscription-conditions/https://ir.elekta.com/sv/bolagsstyrning/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2024/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2021/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2020/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2019/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2018/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2017/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2016/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2015/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2014/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2013/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2011/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2010/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2009/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2008/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2007/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2006/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2004/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/extra-bolagsstamma-2021/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/extra-bolagsstamma-2012/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2022/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2022/vds-anforande/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2022/intervju/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2023/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2025/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/arstamma/arsstamma-2026/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/valberedning/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/valberedning/elektas-valberedning-infor-arsstamman-2024x/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/valberedning/vbas2023/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/valberedning/elektas-valberedning-infor-arsstamman-2025_sida/https://ir.elekta.com/sv/bolagsstyrning/arsstamma/valberedning/elektas-valberedning-infor-arsstamman-2024x-2/https://ir.elekta.com/sv/bolagsstyrning/styrelsen/https://ir.elekta.com/sv/bolagsstyrning/styrelsen/medlemmar/https://ir.elekta.com/sv/bolagsstyrning/styrelsen/insynshandel/https://ir.elekta.com/sv/bolagsstyrning/styrelsen/ersattning/https://ir.elekta.com/sv/bolagsstyrning/styrelsen/revisionsutskott/https://ir.elekta.com/sv/bolagsstyrning/styrelsen/ersattnings-och-hallbarhetsutskott/https://ir.elekta.com/sv/bolagsstyrning/koncernledning/https://ir.elekta.com/sv/bolagsstyrning/koncernledning/medlemmar/https://ir.elekta.com/sv/bolagsstyrning/koncernledning/insynshandel/https://ir.elekta.com/sv/bolagsstyrning/koncernledning/ersattning/https://ir.elekta.com/sv/bolagsstyrning/revisorer/https://ir.elekta.com/sv/bolagsstyrning/rapporter/https://ir.elekta.com/sv/bolagsstyrning/rapporter/rapportarkiv/https://ir.elekta.com/sv/bolagsstyrning/glossary-svenska/https://ir.elekta.com/sv/side-navigation/https://ir.elekta.com/sv/var-ska-dessa/revisorer/